TY - JOUR A1 - Tesfamariam, Y. A1 - Jakob, T. A1 - Wöckel, A. A1 - Adams, A. A1 - Weigl, A. A1 - Monsef, I. A1 - Kuhr, K. A1 - Skoetz, N. T1 - Adjuvant bisphosphonates or RANK-ligand inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis JF - Critical Reviews in Oncology / Hematology N2 - Bone-modifying agents like bisphosphonates and receptor activator of nuclear factor kappaβ ligand (RANK-L) inhibitors are used as supportive treatments in breast cancer patients with bone metastases to prevent skeletal-related events (SREs). Due to missing head-to-head comparisons, a network meta-analysis was performed to provide a hierarchy of these therapeutic options. Through a systematic literature search, 21 randomized controlled trials (RCTs) that fulfilled the inclusion criteria were identified. To prevent SREs, the ranking through P-scores showed denosumab (RR: 0.62; 95%CI: 0.50-0.76), zoledronic acid (RR: 0.72; 95%CI: 0.61-0.84) and pamidronate (RR: 0.76; 95%CI: 0.67-0.85) to be significantly superior to placebo. Due to insufficient or heterogeneous data, overall survival, quality of life, pain response and adverse events were not able to be analyzed within the network. Although data were sparse on adverse events, the risk of significant adverse events appeared low. The results of this review can therefore be used to formulate clinical studies more precisely in order to standardise and focus on patient-relevant outcomes. KW - bisphosphonates KW - RANK-L inhibitors KW - SREs KW - RCTs Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-240827 VL - 137 ER - TY - JOUR A1 - Brinker, Titus J. A1 - Hekler, Achim A1 - Hauschild, Axel A1 - Berking, Carola A1 - Schilling, Bastian A1 - Enk, Alexander H. A1 - Haferkamp, Sebastian A1 - Karoglan, Ante A1 - von Kalle, Christof A1 - Weichenthal, Michael A1 - Sattler, Elke A1 - Schadendorf, Dirk A1 - Gaiser, Maria R. A1 - Klode, Joachim A1 - Utikal, Jochen S. T1 - Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark JF - European Journal of Cancer N2 - Background Several recent publications have demonstrated the use of convolutional neural networks to classify images of melanoma at par with board-certified dermatologists. However, the non-availability of a public human benchmark restricts the comparability of the performance of these algorithms and thereby the technical progress in this field. Methods An electronic questionnaire was sent to dermatologists at 12 German university hospitals. Each questionnaire comprised 100 dermoscopic and 100 clinical images (80 nevi images and 20 biopsy-verified melanoma images, each), all open-source. The questionnaire recorded factors such as the years of experience in dermatology, performed skin checks, age, sex and the rank within the university hospital or the status as resident physician. For each image, the dermatologists were asked to provide a management decision (treat/biopsy lesion or reassure the patient). Main outcome measures were sensitivity, specificity and the receiver operating characteristics (ROC). Results Total 157 dermatologists assessed all 100 dermoscopic images with an overall sensitivity of 74.1%, specificity of 60.0% and an ROC of 0.67 (range = 0.538–0.769); 145 dermatologists assessed all 100 clinical images with an overall sensitivity of 89.4%, specificity of 64.4% and an ROC of 0.769 (range = 0.613–0.9). Results between test-sets were significantly different (P < 0.05) confirming the need for a standardised benchmark. Conclusions We present the first public melanoma classification benchmark for both non-dermoscopic and dermoscopic images for comparing artificial intelligence algorithms with diagnostic performance of 145 or 157 dermatologists. Melanoma Classification Benchmark should be considered as a reference standard for white-skinned Western populations in the field of binary algorithmic melanoma classification. KW - benchmark KW - artificial intelligence KW - deep learning KW - melanoma Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-220569 VL - 111 ER - TY - JOUR A1 - Brinker, Titus J. A1 - Hekler, Achim A1 - Enk, Alexander H. A1 - Berking, Carola A1 - Haferkamp, Sebastian A1 - Hauschild, Axel A1 - Weichenthal, Michael A1 - Klode, Joachim A1 - Schadendorf, Dirk A1 - Holland-Letz, Tim A1 - von Kalle, Christof A1 - Fröhling, Stefan A1 - Schilling, Bastian A1 - Utikal, Jochen S. T1 - Deep neural networks are superior to dermatologists in melanoma image classification JF - European Journal of Cancer N2 - Background Melanoma is the most dangerous type of skin cancer but is curable if detected early. Recent publications demonstrated that artificial intelligence is capable in classifying images of benign nevi and melanoma with dermatologist-level precision. However, a statistically significant improvement compared with dermatologist classification has not been reported to date. Methods For this comparative study, 4204 biopsy-proven images of melanoma and nevi (1:1) were used for the training of a convolutional neural network (CNN). New techniques of deep learning were integrated. For the experiment, an additional 804 biopsy-proven dermoscopic images of melanoma and nevi (1:1) were randomly presented to dermatologists of nine German university hospitals, who evaluated the quality of each image and stated their recommended treatment (19,296 recommendations in total). Three McNemar's tests comparing the results of the CNN's test runs in terms of sensitivity, specificity and overall correctness were predefined as the main outcomes. Findings The respective sensitivity and specificity of lesion classification by the dermatologists were 67.2% (95% confidence interval [CI]: 62.6%–71.7%) and 62.2% (95% CI: 57.6%–66.9%). In comparison, the trained CNN achieved a higher sensitivity of 82.3% (95% CI: 78.3%–85.7%) and a higher specificity of 77.9% (95% CI: 73.8%–81.8%). The three McNemar's tests in 2 × 2 tables all reached a significance level of p < 0.001. This significance level was sustained for both subgroups. Interpretation For the first time, automated dermoscopic melanoma image classification was shown to be significantly superior to both junior and board-certified dermatologists (p < 0.001). KW - deep learning KW - melanoma KW - skin cancer KW - artificial intelligence Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-220539 VL - 119 ER - TY - THES A1 - Zuber, Jonas Maximilian T1 - Evaluation von Sedierungen und Allgemeinanästhesien zur Durchführung bildgebender Verfahren bei Säuglingen bis zum 6. Lebensmonat T1 - Evaluation of sedation and general anesthesia for performing imaging procedures in infants up to 6 months of age N2 - Vorliegende Untersuchung am Universitätsklinikum Würzburg sowie die Befragung von Anästhesisten/Anästhesistinnen im Raum der 3 DACH-Länder zeigen, dass bildgebende Verfahren bei Säuglingen mit einer niedrigen Rate an Komplikationen, zumeist in medikamentöser Sedierung mit Propofol, durchgeführt werden. Wie international üblich ist im Säuglingsalter die Magnetresonanztomographie das bildgebende Verfahren der Wahl und wird, mit überzeugender Häufigkeit, erfolgreich durchgeführt. Die Untersuchung am Universitätsklinikum Würzburg legt nahe, dass männliche Säuglinge häufiger eine Bildgebung benötigen und häufiger höheren ASA-Kategorie zugeschrieben werden. Dabei scheinen sie auch häufiger Komplikationen zu erleben und bedürfen daher besonderer Aufmerksamkeit. Eine eventuelle Alternative zur Sedierung kann dabei die „feed-and-sleep“ Methode darstellen. In unserer Umfrage konnten wir erheben, dass diese Methode bisher wenig verbreitet ist, obwohl in diesem Zusammenhang eventuell Abläufe und Prozesszeiten strukturiert und optimiert werden können, da beispielsweise die Nachüberwachung entfällt. Vorstellbar wäre beispielsweise, mehrere Säuglinge zum gleichen Zeitpunkt ins MRT zu bestellen, um gegebenenfalls den am frühesten eingeschlafenen Säugling vorzuziehen. Diese Methode sollte zukünftig Einzug in die wissenschaftliche Untersuchung von bildgebenden Verfahren bei Säuglingen finden. Die Umfrage im deutschsprachigen Raum zeigt eine Leitlinien-gerechte Betreuung von Säuglingen für bildgebende Verfahren, die mit einer hohen Qualität, und zumeist erfolgreich von erfahrenen Anästhesisten/Anästhesistinnen durchgeführt wird. Eventuelle Verbesserungen können im Bereich der Ausbildung nachfolgender Ärztinnen/Ärzte und in der häufigeren Verwendung der „feed-and-sleep“ Methode liegen, die vielen Kollegen/Kolleginnen bekannt ist, aber nur selten durchgeführt wird. Ziel ist eine qualitativ hochwertige, schnellstmöglich durchgeführte Bildgebung, die ohne oder mit der niedrigst möglichen Dosierung eines sedierenden Medikamentes zu erreichen ist. N2 - The present study at the University Hospital of Würzburg and the survey of anesthesiologists in the three DACH countries show that imaging procedures are carried out in infants with a low rate of complications, mostly under medical sedation with propofol. As is common practice internationally, magnetic resonance imaging is the imaging method of choice in infancy and is mostly carried out successfully. The study at the University Hospital of Würzburg suggests that male infants require imaging procedures more frequently and are assigned to higher ASA categories in comparison with female infants.They also seem to experience complications more often and therefore require special attention. The “feed and sleep” method can be a potential alternative to sedation. In our survey, we found that this method is not yet used widely, although in this context processes and process times can potentially be restructured and optimized since, for example, follow-up monitoring is no longer necessary. It would be conceivable, for example, to order several infants for an MRI at the same time in order to prioritize the infant who fell asleep earliest. In the future, this method should find its way into the scientific study of imaging procedures in infants. The survey in German-speaking countries shows guideline-compliant care of infants for imaging procedures, which is carried out with high quality and mostly successfully by experienced anesthesiologists. Possible improvements could lie in the education of doctors in training and in the more frequent use of the “feed-and-sleep” method, which is known to many colleagues but is rarely carried out. The goal is a high-quality imaging that is performed as quickly as possible and can be achieved without or with the lowest possible dosage of a sedative medication. KW - Sedierung KW - Säugling KW - Narkose KW - Kernspintomografie KW - feed-and-sleep KW - Umfrage KW - Anästhesie KW - Monitoring Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-361111 ER - TY - THES A1 - Dalkmann, Theresa T1 - Evaluierung prognostischer und prädiktiver Biomarker beim neoadjuvant vorbehandelten Rektumkarzinom T1 - Evaluation of prognostic and predictive biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer (LARC) N2 - Fragestellung. Osteopontin (OPN) kann im Blut nachgewiesen werden und wird bei vielen Tumorentitäten exprimiert, wie auch der Tyrosinkinaserezeptor c-Met und sein Ligand, das Zytokin Hepatocyte Growth Factor (HGF). In der vorliegenden Arbeit untersuchten wir die prognostische und prädiktive Wertigkeit der Plasmakonzentrationen von OPN, c-Met und HGF bei Patienten mit lokal fortgeschrittenem Rektumkarzinom (LARC). Methodik. Das Plasma von 63 Patienten mit LARC wurde untersucht. Die Blutentnahmen (EDTA-Plasma) erfolgten vor Therapiebeginn sowie im Verlauf. Die Plasmaspiegel von OPN, c-Met und HGF wurden mittels Enzyme-Linked Immunosorbent Assay analysiert. Die Konzentrationen wurden auf eine Korrelation mit den klinischen Parametern untersucht. Ergebnisse. 68 Patienten wurden neoadjuvant mit einer Radiochemotherapie behandelt, 63 Blutproben wurden untersucht. Initial befanden sich nach UICC 14 Patienten in Stadium II, 47 in Stadium III und 7 in Stadium IV. Das mediane Follow-Up betrug 29,87 Monate. 20 der 68 Patienten (29,4 %) verstarben, 19 entwickelten Fernmetastasen. OPN korrelierte signifikant mit dem Überleben (p=0,001). OPN-Werte korrelierten mit dem pT-Stadium (R:0,445 p=0,018) und dem pUICC-Stadium (R:0,412 p=0,018), sowie mit dem Auftreten von Fernmetastasen (R:0,271 p=0,031). Eine Korrelation zwischen OPN und dem Therapieansprechen konnte gezeigt werden: pathologisch komplette Remission (pCR) (R:0,379 p=0,001), NAR-Score (R:0,373 p=0,015), TRG (R:0,380 p=0,020). Die logistische Regressionsanalyse ergab eine Prädiktivität OPNs für pCR (OR:0,990 p=0,009), NAR-Score (OR:1,008 p=0,007), TRG (OR:0,459 p=0,008). C-Met und HGF korrelierten nicht mit dem Überleben. Für c-Met und HGF ergab sich keine Korrelation zu initialen klinischen Daten und Therapieansprechen. Die logistische Regression ergab keinen prädiktiven Wert. Schlussfolgerung. Die Plasmakonzentration von OPN besitzt prognostische und prädiktive Wertigkeit beim LARC. Die Konzentrationen von c-Met und HGF sind nicht prognostisch für das Überleben oder prädiktiv für das Therapieansprechen. N2 - Purpose. The glycoprotein Osteopontin (OPN), tyrosine kinase receptor c-Met and it´s ligand Hepatocyte Growth Factor (HGF) can be detectet in blood and are known to be overexpressed in many kinds of human cancer. Here we examine their prognostic and predictive value in patients with locally advanced rectal cancer (LARC). Patients and methods. In a monocentric prospective study EDTA-plasma was drawn from patients who received neoadjuvant chemoradiotherapy (CRT) in LARC. Blood samples were taken before CRT and at different timepoints during the follow-up. We used an Enzyme-linked Immunosorbent Assay (ELISA) to analyse the plasma concentrations of OPN, c-Met and HGF. Results. 68 patients (48 males, 20 females) were included. Blood samples were drawn from 63 patients. Initially, 14 patients had UICC stage II, 47 had UICC stage III and 7 had UICC stage IV. Median follow-up was 29,9 months. 20 out of 68 patients died during follow-up (29,4 %), 19 developed metastasis (27,9 %). Patients with OPN median (91,8 % vs. 58,6 %, p = 0,001). Higher OPN-concentrations were correlated with pT (R = 0,445, p = 0,018), postoperative UICC (R = 0,412, p = 0,018) and metastasis (R = 0,271, p = 0,031). Pretherapeutical OPN levels were significantly different depending on the response to CRT: 415,9 ± 62,6 ng/ml in patients with pathological complete response (pCR) vs. 703,3 ± 285,9 ng/ml in patients with pathological incomplete response (pIR), p < 0,001). Logistic regression showed a predictive value of OPN for pCR (OR = 0,990, p = 0,009). Pretherapeutic c-Met and HGF concentrations were not associated with survival rates. There was no correlation between initial c-Met or HGF and clinical characteristics. There was von predictive value for c-Met or HGF. Conclusion. Osteopontin plasma levels might have prognostic and predictive value in LARC. We could not find a prognostic or predictive significance for c-Met or HGF. KW - Biomarker KW - Neoadjuvant vorbehandeltes Rektumkarzinom KW - prognostische und prädiktive Biomarker KW - prognostic and predictive biomarker KW - locally advanced rectal cancer KW - neoadjuvant radiochemotherapy KW - Mastdarmkrebs KW - Rektumkarzinom KW - Neodadjuvant KW - prognostische KW - prädiktive Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-363368 ER - TY - THES A1 - Junghanns, Lara Madeleine T1 - Resistenzmechanismen gegen Amphotericin B in humanpathogenen Hefepilzen T1 - Resistance mechanism to amphotericin B in human pathogenic yeasts N2 - Die 2009 erstmals entdeckte Spezies C. auris erlangte binnen kürzester Zeit zunehmend weltweite Aufmerksamkeit. Vor allem die Tendenz der Multiresistenzentwicklung und das rasche Auslösen von nosokomialen Infektionen erschweren den Umgang und die Therapie von C. auris Infektionen im Vergleich zu anderen Candida Spezien. Diese Dissertationsarbeit umfasst eine systematische Resistenzanalyse der im NRZMyk vorhandenen Stammsammlung aus C. auris und C. parapsilosis Isolaten, um Aufschluss über den Wirkmechanismus von Amphotericin B in Hefepilzen zu erlangen. Anhand der zunächst durchgeführten Amphotericin B-Resistenztestungen kristallisierten sich CAU37 und CAU43 mit MHK-Werten bis zu 12 µg/ml als stark Amphotericin B-resistente Isolate heraus. Die Analyse der Sequenzierungsergebnisse zeigte bei beiden Stämmen eine Mutation im ERG4 Gen an Position 576, welche nicht eindeutig als alleinige Ursache für die verminderte Amphotericin B-Empfindlichkeit festgelegt werden konnte. Dennoch wurde im Rahmen eines Survival Assays bei beiden Amphotericin B-resistenten Isolaten anfänglich eine konzentrationsabhängige Aktivität gegenüber Amphotericin B festgestellt, bevor ein Nachwachsen der Kulturen beobachtet wurde. Somit wurde die Vermutung aufgestellt, dass lediglich ein Teil der aufgebrachten Candida-Zellen abgetötet wird und dies in einer Vermehrung der überlebenden Zellen resultiert. Des Weiteren konnte im Rahmen von Resistenztestungen mit dem Sphingolipidinhibitor Myriocin nachgewiesen werden, dass vor allem in Amphotericin B-resistenten Isolaten eine deutliche Wirkungsverstärkung des Polyens hervorgerufen wird. Diese Sensitivitätssteigerung ist allgemein bei allen C. auris Isolaten zu beobachten, fällt bei resistenten Stämmen jedoch deutlich stärker aus. Hierdurch kam die Annahme auf, dass Amphotericin B-Resistenzen auch in möglichen Veränderungen des Sphingolipid-Haushaltes begründet sein könnten. Darüber hinaus scheint Myriocin keinen Einfluss auf Fluconazol-resistente oder FKS-mutierte Echinocandin-resistente C. auris Stämme zu haben. Das ebenfalls untersuchte und von Myriocin abgeleitete Medikament Fingolimod hatte jedoch ebenfalls keinen wirkungsverstärkenden Effekt. Allerdings reagierte ein Großteil der C. auris Isolate (57,6 %) sensitiv gegenüber dem neusten medizinisch bekannten Triazol Isavuconazol und es konnte erstmalig ein ECV-Wert von 0,03125 µg/ml festgelegt werden. Ein valider Vergleich von C. auris zu C. parapsilosis war aufgrund der mangelnden Anzahl an C. parapsilosis Isolaten jedoch nicht möglich N2 - The species C. auris, which was first discovered in 2009, quickly attracted worldwide attention. In particular, the development of multidrug resistance and the rapid onset of nosocomial infections complicate the management and treatment of C. auris infections compared to other Candida species. This dissertation comprises a systematic resistance analysis of the strain collection available at the NRZMyk from C. auris and C. parapsilosis isolates in order to shed light on the mechanism of action of amphotericin B in yeast fungi. CAU37 and CAU43 ermerged as highly amphotericin B-resistant isolates in the initially performed amphotericin B resistance tests, with MIC values up to 12 µg/ml. Sequencing results showed a mutation in the ERG4 gene at position 576 in both strains, which can`t be clearly identified as the main cause of the reduced susceptibility to amphotericin B. Nevertheless both amphotericin B-resistant isolates initially showed a concentration dependent activity against amphotericin B, followed by a regrowth of the cultures. The hypothesis is, that only some of the applied Candida cells are killed, resulting in a proliferation of the surviving cells. Furthermore the resistance tests with the sphingolipid inhibitor Myriocin in combination with amphotericin B showed that sublethal myriocin concentrations increased the C. auris susceptibility to amphotericin B. This increase in sensitivity is generally observed in all C. auris isolates, but is significantly stronger in resistant strains. This leeds to the assumption that amphotericin B resistance can also be due to possible changes in the sphingolipid balance. Furthermore, myriocin does not appear to have any influence on fluconazole-resistant or FKS-mutated echinocandin-resistant C. auris strains. Fingolimod, a drug also investigated and derived from Myriocin, doesn`t have any enhancing effect either. However the majority of C. auris isolates (57.6 %) reacted sensitively to the latest medically known triazole isavuconazole and for the first time an ECV value of of 0.03125 µg/ml could be determined. A valid comparison of C. auris to C. parapsilosis was not possible due to the lack of C. parapsilosis isolates. KW - Candida KW - antifungal susceptibility KW - Multidrug-Resistenz KW - Amphotericin B KW - Sphingolipide KW - Fingolimod KW - Candida auris KW - Multiresistenz KW - Myriocin KW - Isavuconazol KW - Antimykotikaresistenz KW - C. auris KW - Empdindlichkeitsprüfung Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-369861 ER - TY - JOUR A1 - Jeanclos, Elisabeth A1 - Albersen, Monique A1 - Ramos, Rúben J. J. A1 - Raab, Annette A1 - Wilhelm, Christian A1 - Hommers, Leif A1 - Lesch, Klaus-Peter A1 - Verhoeven-Duif, Nanda M. A1 - Gohla, Antje T1 - Improved cognition, mild anxiety-like behavior and decreased motor performance in pyridoxal phosphatase-deficient mice JF - BBA - Molecular Basis of Disease N2 - Pyridoxal 5′-phosphate (PLP) is an essential cofactor in the catalysis of ~140 different enzymatic reactions. A pharmacological elevation of cellular PLP concentrations is of interest in neuropsychiatric diseases, but whole-body consequences of higher intracellular PLP levels are unknown. To address this question, we have generated mice allowing a conditional ablation of the PLP phosphatase PDXP. Ubiquitous PDXP deletion increased PLP levels in brain, skeletal muscle and red blood cells up to 3-fold compared to control mice, demonstrating that PDXP acts as a major regulator of cellular PLP concentrations in vivo. Neurotransmitter analysis revealed that the concentrations of dopamine, serotonin, epinephrine and glutamate were unchanged in the brains of PDXP knockout mice. However, the levels of γ-aminobutyric acid (GABA) increased by ~20%, demonstrating that elevated PLP levels can drive additional GABA production. Behavioral phenotyping of PDXP knockout mice revealed improved spatial learning and memory, and a mild anxiety-like behavior. Consistent with elevated GABA levels in the brain, PDXP loss in neural cells decreased performance in motor tests, whereas PDXP-deficiency in skeletal muscle increased grip strength. Our findings suggest that PDXP is involved in the fine-tuning of GABA biosynthesis. Pharmacological inhibition of PDXP might correct the excitatory/inhibitory imbalance in some neuropsychiatric diseases. KW - pyridoxal phosphatase KW - vitamin B6 KW - γ-Aminobutyric acid (GABA) KW - motor performance KW - neuropsychiatric diseases KW - neurotransmitter biosynthesis Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-323396 VL - 1865 ER - TY - JOUR A1 - Müller, Laura S. M. A1 - Cosentino, Raúl O. A1 - Förstner, Konrad U. A1 - Guizetti, Julien A1 - Wedel, Carolin A1 - Kaplan, Noam A1 - Janzen, Christian J. A1 - Arampatzi, Panagiota A1 - Vogel, Jörg A1 - Steinbiss, Sascha A1 - Otto, Thomas D. A1 - Saliba, Antoine-Emmanuel A1 - Sebra, Robert P. A1 - Siegel, T. Nicolai T1 - Genome organization and DNA accessibility control antigenic variation in trypanosomes JF - Nature N2 - Many evolutionarily distant pathogenic organisms have evolved similar survival strategies to evade the immune responses of their hosts. These include antigenic variation, through which an infecting organism prevents clearance by periodically altering the identity of proteins that are visible to the immune system of the host1. Antigenic variation requires large reservoirs of immunologically diverse antigen genes, which are often generated through homologous recombination, as well as mechanisms to ensure the expression of one or very few antigens at any given time. Both homologous recombination and gene expression are affected by three-dimensional genome architecture and local DNA accessibility2,3. Factors that link three-dimensional genome architecture, local chromatin conformation and antigenic variation have, to our knowledge, not yet been identified in any organism. One of the major obstacles to studying the role of genome architecture in antigenic variation has been the highly repetitive nature and heterozygosity of antigen-gene arrays, which has precluded complete genome assembly in many pathogens. Here we report the de novo haplotype-specific assembly and scaffolding of the long antigen-gene arrays of the model protozoan parasite Trypanosoma brucei, using long-read sequencing technology and conserved features of chromosome folding4. Genome-wide chromosome conformation capture (Hi-C) reveals a distinct partitioning of the genome, with antigen-encoding subtelomeric regions that are folded into distinct, highly compact compartments. In addition, we performed a range of analyses—Hi-C, fluorescence in situ hybridization, assays for transposase-accessible chromatin using sequencing and single-cell RNA sequencing—that showed that deletion of the histone variants H3.V and H4.V increases antigen-gene clustering, DNA accessibility across sites of antigen expression and switching of the expressed antigen isoform, via homologous recombination. Our analyses identify histone variants as a molecular link between global genome architecture, local chromatin conformation and antigenic variation. KW - histone variants KW - genome architecture KW - single molecule real time (SMRT) KW - brucei genome KW - distance-dependent decay Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-224265 VL - 563 ER - TY - JOUR A1 - Munz, Matthias A1 - Richter, Gesa M. A1 - Loos, Bruno G. A1 - Jepsen, Søren A1 - Divaris, Kimon A1 - Offenbacher, Steven A1 - Teumer, Alexander A1 - Holtfreter, Birte A1 - Kocher, Thomas A1 - Bruckmann, Corinna A1 - Jockel-Schneider, Yvonne A1 - Graetz, Christian A1 - Munoz, Loreto A1 - Bhandari, Anita A1 - Tennstedt, Stephanie A1 - Staufenbiel, Ingmar A1 - van der Velde, Nathalie A1 - Uitterlinden, André G. A1 - de Groot, Lisette C. P. G. M. A1 - Wellmann, Jürgen A1 - Berger, Klaus A1 - Krone, Bastian A1 - Hoffmann, Per A1 - Laudes, Matthias A1 - Lieb, Wolfgang A1 - Andre, Franke A1 - Dommisch, Henrik A1 - Erdmann, Jeanette A1 - Schaefer, Arne S. T1 - Genome-wide association meta-analysis of coronary artery disease and periodontitis reveals a novel shared risk locus JF - Scientific Reports N2 - Evidence for a shared genetic basis of association between coronary artery disease (CAD) and periodontitis (PD) exists. To explore the joint genetic basis, we performed a GWAS meta-analysis. In the discovery stage, we used a German aggressive periodontitis sample (AgP-Ger; 680 cases vs 3,973 controls) and the CARDIoGRAMplusC4D CAD meta-analysis dataset (60,801 cases vs 123,504 controls). Two SNPs at the known CAD risk loci ADAMTS7 (rs11634042) and VAMP8 (rs1561198) passed the pre-assigned selection criteria (PAgP-Ger < 0.05; PCAD < 5 × 10−8; concordant effect direction) and were replicated in an independent GWAS meta-analysis dataset of PD (4,415 cases vs 5,935 controls). SNP rs1561198 showed significant association (PD[Replication]: P = 0.008 OR = 1.09, 95% CI = [1.02–1.16]; PD [Discovery + Replication]: P = 0.0002, OR = 1.11, 95% CI = [1.05–1.17]). For the associated haplotype block, allele specific cis-effects on VAMP8 expression were reported. Our data adds to the shared genetic basis of CAD and PD and indicate that the observed association of the two disease conditions cannot be solely explained by shared environmental risk factors. We conclude that the molecular pathway shared by CAD and PD involves VAMP8 function, which has a role in membrane vesicular trafficking, and is manipulated by pathogens to corrupt host immune defense. KW - vesicle-associated membrane protein 8 (VAMP8) KW - ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS7) KW - shared genetic basis KW - genome-wide association studies (GWAS) KW - GWAS meta-analysis Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-231647 VL - 8 ER - TY - THES A1 - Pätzel [geb. Ditter], Katharina Sabine T1 - Molekulare Charakterisierung eines Mitgliedes der TNF-Rezeptor-Superfamilie des Fuchsbandwurmes \(Echinococcus\) \(multilocularis\) T1 - Molecular characterization of a TNF-receptor-superfamily member of \(Echinococcus\) \(multilocularis\) N2 - Die alveoläre Echinokokkose (AE), die durch den Fuchsbandwurm Echinococcus multilocularis verursacht wird, ist eine seltene jedoch schwere und oft tödlich verlaufende Erkrankung. Aufgrund der späten Diagnosestellung sind kurative Behandlungsmethoden häufig nicht durchführbar und als einzige Behandlungsmöglichkeit bleibt eine lebenslange und nebenwirkungsreiche Therapie mit Benzimidazolen. Verbesserte Therapieoptionen durch die Entwicklung neuer Medikamente sind dringend notwendig. Hierfür kann es hilfreich sein die Biologie des Fuchsbandwurmes und die Kommunikationswege zwischen Parasit und Wirt zu verstehen. Bereits in vorherigen Arbeiten als auch in dieser Arbeit erwiesen sich evolutionsgeschichtlich konservierte Signalwege als Kommunikationsweg zwischen dem Fuchsbandwurm und seinem Wirt von zentraler Rolle. Die Entschlüsselung des Echinococcus-Genoms gab Hinweise darauf, dass ein Mitglied der Tumornekrosefaktor-Rezeptor-Superfamilie, jedoch kein endogener TNF α ähnlicher Ligand im Genom kodiert wird. Ein Mitglied der TNFR-Superfamilie des Fuchsbandwurmes (EmTNFR) wurde in dieser Arbeit als membranständiger Rezeptor mit einer intrazellulären Todesdomäne (DD) und hoher Ähnlichkeit zum humanen Typ 16 der TNF-Rezeptor-Superfamilie, auch 〖p75〗^NTR genannt, charakterisiert. Sowohl in bioinformatischen als auch in Sequenzanalysen wurden drei alternative Splicing-Formen von emtnfr (emtnfr, emtnfr-v2 und emtnfr-v3) nachgewiesen. emtnfr-v2 entsteht durch Alternatives Splicing und kodiert ein Protein, das keine intrazelluläre Todesdomäne besitzt. emtnfr-v3 verwendet einen alternativen Transkriptionstart und wird von den letzten 3 Exons von emtnfr kodiert. emtnfr-v3, kodiert ein Protein ohne extrazelluläre Region, aber mit intrazellulärer Todesdomäne. Ein löslicher TNF-Rezeptor konnte auf Proteinebene nicht nachgewiesen werden. Aufgrund von phylogenetischen Analysen und der Rezeptor-Struktur ist zu vermuten, dass EmTNFR ein p75NTR Homolog ist und damit der ursprünglichen Form der TNF-Rezeptoren entspricht. Mitglieder eines intrazellulären TNF-Signalweges wurden in bioinformatischen Analysen beim Fuchsbandwurm E. multilocularis identifiziert. Expressionsuntersuchungen zeigten sowohl in Trankriptomdaten als auch auf Proteinebene eine starke Expression von EmTNFR in Primärzellen und im Metazestoden (MZ), dem pathogenen Stadium für den Zwischenwirt. Echinococcus-Stammzellkulturen zeigten nach RNA-Interferenz-basiertem Knockdown des EmTNFR-kodierenden Gens deutliche Entwicklungsdefekte. Des Weiteren zeigten Echinococcus-Stammzellkulturen nach einer Behandlung mit TNF-α, einem potentiellen Liganden des TNF-Rezeptors und einem zentralen Zytokin in der Immunabwehr des Zwischenwirtes, Entwicklungsfortschritte, wie eine verbesserte Bildung von MZ aus Stammzellen. Zusätzlich wurde in whole-mount in situ Hybridisierungs-Versuchen eine ubiquitäre Expression von emtnfr in der Germinalschicht des MZ sowie eine Spezifität von emtnfr für den MZ, welcher ursächlich für die AE ist, nachgewiesen. Somit scheinen sowohl EmTNFR als auch TNF-α eine wichtige Funktion bei der Entwicklung und Etablierung des Fuchsbandwurmes während der frühen Phase der Infektion des Zwischenwirtes zu haben. TNF-α könnte ein weiterer Faktor für den ausgeprägten Organtropismus des Parasiten zur Leber sein, denn dort bestehen durch Kupfferzellen produzierte hohe lokale Konzentration von TNF-α. Zusammenfassend deuten die hier erarbeiteten Daten darauf hin, dass EmTNFR über die Bindung von Wirts-TNF-α bei der frühen Entwicklung des Echincoccus-Metazestoden eine Rolle spielt. N2 - Alveolar echinococcosis (AE), which is caused by the metacestode larval stage of the fox tapeworm Echinococcus multilocularis, is a rare but severe, often fatal disease. Due to late diagnosis and advanced spread of the infection curative therapy is often not possible and the only treatment option is benzimidazole chemotherapy, which often must be taken lifelong and has adverse side effects. Improvement of therapeutic options is thus urgently needed. To this end, a closer understanding of parasite biology and communication mechanisms between parasite and host are helpful. In this work, focus was laid on the possibility of host-parasite cross-communication involving an evolutionarily conserved signalling pathway. By mining the Echinococcus genome sequence, a gene encoding a member of the tumor necrosis-factor-receptor family (TNF-R), was identified. In this work, EmTNFR, a member of the TNF-R superfamily, of the fox tapeworm was identified as a membrane bound receptor with intracellular death domain and highest similarity to human TNFRSF 16, also called p75NTR. In in silico analysis and cDNA sequencing, 3 alternative splice forms of emtnfr (emtnfr-v1, -v2 and -v3) were found. emtnfr-v2 is the result of alternative splicing and encodes a protein lacking the intracellular death domain. emtnfr-v3 employs an alternative transcription start and is encoded by the last 3 exons of emtnfr. emtnfr-v3 encodes a protein without extracellular domain, but containing an intracellular death domain. A soluble TNF-receptor could not be found in proteomic analysis. Based on phylogenetic analysis and receptor structure, EmTNFR is thought to be a homolog of p75NTR, corresponding to the ancient form of TNF receptors. Members of an intracellular TNF signaling pathway were identified in bioinformatic analyses in the fox tapeworm E. multilocularis, indicating the presence of a full TNFR signalling pathway. Expression studies showed in transcriptome data and at protein level a strong expression of EmTNFR in primary cells and in the metacestode (MZ), the pathogenic stage for the intermediate host. Echinococcus stem cell cultures showed marked developmental defects after RNAi based knockdown of the EmTNFR-encoding gene. Furthermore, Echinococcus stem cell culture displayed accelerated developmental progress such as enhanced formation of MZ from stem cells after treatment with TNF-α, a potential ligand of the TNF receptor, and a central cytokine in the immune defense of the intermediate host. In addition, whole-mount in situ hybridization experiments demonstrated ubiquitous expression of emtnfr in the germinal layer of MZ and specificity of emtnfr for MZ, the causative agent of AE. Thus, both EmTNFR and TNF-α appear to have an important function in development and establishment of the fox tapeworm during the early phase of infection of the intermediate host. TNF-α could be an additional factor for the pronounced organ tropism of the parasite to the liver, caused by a high local concentration of TNF-α produced by Kupffer cells. In summary, the data generated in this work suggest that EmTNFR plays a role in the early development of Echinococcus metacestode via binding of host TNF-α. KW - Fuchsbandwurm KW - Wirt-Parasit-Beziehung KW - Parasit KW - Tumor-Nekrose-Faktor KW - Echinococcus multilocularis KW - TNF-Rezeptor KW - Wirt-Parasiten-Interaktion KW - Molekulare Charakterisierung Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-369397 ER - TY - THES A1 - Reissland, Michaela T1 - USP10 is a \(de\) \(novo\) tumour-specific regulator of β-Catenin and contributes to cancer stem cell maintenance and tumour progression T1 - USP10 ist ein \(de\) \(novo\) tumorspezifischer Regulator von ß-Catenin und trägt zur Erhaltung von Krebsstammzellen und zur Tumorprogression bei N2 - Colorectal Cancer (CRC) is the third most common cancer in the US. The majority of CRC cases are due to deregulated WNT-signalling pathway. These alterations are mainly caused by mutations in the tumour suppressor gene APC or in CTNNB1, encoding the key effector protein of this pathway, β-Catenin. In canonical WNT-signalling, β-Catenin activates the transcription of several target genes, encoding for proteins involved in proliferation, such as MYC, JUN and NOTCH. Being such a critical regulator of these proto-oncogenes, the stability of β-Catenin is tightly regulated by the Ubiquitin-Proteasome System. Several E3 ligases that ubiquitylate and degrade β-Catenin have been described in the past, but the antagonists, the deubiquitylases, are still unknown. By performing an unbiased siRNA screen, the deubiquitylase USP10 was identified as a de novo positive regulator of β-Catenin stability in CRC derived cells. USP10 has previously been shown in the literature to regulate both mutant and wild type TP53 stability, to deubiquitylate NOTCH1 in endothelial cells and to be involved in the regulation of AMPKα signalling. Overall, however, its role in colorectal tumorigenesis remains controversial. By analysing publicly available protein and gene expression data from colorectal cancer patients, we have shown that USP10 is strongly upregulated or amplified upon transformation and that its expression correlates positively with CTNNB1 expression. In contrast, basal USP10 levels were found in non-transformed tissues, but surprisingly USP10 is upregulated in intestinal stem cells. Endogenous interaction studies in CRC-derived cell lines, with different extend of APCtruncation, revealed an APC-dependent mode of action for both proteins. Furthermore, by utilising CRISPR/Cas9, shRNA-mediated knock-down and overexpression of USP10, we could demonstrate a regulation of β-Catenin stability by USP10 in CRC cell lines. It is widely excepted that 2D cell culture systems do not reflect complexity, architecture and heterogeneity and are therefore not suitable to answer complex biological questions. To overcome this, we established the isolation, cultivation and genetically modification of murine intestinal organoids and utilised this system to study Usp10s role ex vivo. By performing RNA sequencing, dependent on different Usp10 levels, we were able to recapitulate the previous findings and demonstrated Usp10 as important regulator of β-dependent regulation of stem cell homeostasis. Since genetic depletion of USP10 resulted in down-regulation of β-Catenin-dependent transcription, therapeutic intervention of USP10 in colorectal cancer was also investigated. Commercial and newly developed inhibitors were tested for their efficacy against USP10, but failed to significantly inhibit USP10 activity in colorectal cancer cells. To validate the findings from this work also in vivo, development of a novel mouse model for colorectal cancer has begun. By combining CRISPR/Cas9 and classical genetic engineering with viral injection strategies, WT and genetically modified mice could be transformed and, at least in some animals, intestinal lesions were detectable at the microscopic level. The inhibition of USP10, which we could describe as a de novo tumour-specific regulator of β-Catenin, could become a new therapeutic strategy for colorectal cancer patients. N2 - Darmkrebs ist die dritthäufigste Krebsart in den USA. Die Mehrheit der Darmkrebsfälle sind auf einen deregulierten WNT-Signalweg zurückzuführen. Diese Veränderungen wer- den hauptsächlich durch Mutationen im Tumorsuppressor-Gen APC oder in CTNNB1 verursacht, welches für das zentrale Protein dieses Signalwegs, β-Catenin, kodiert. Beim kanonischen WNT-Signalweg aktiviert β-Catenin die Transkription mehrerer Gene, die für, an der Proliferation beteiligte Proteine wie MYC, JUN und NOTCH, kodieren. Da β-Catenin ein kritischer Regulator dieser proto-Onkogene ist, wird die Stabilität von β-Catenin durch das Ubiquitin-Proteasom-System streng reguliert. In der Vergangen- heit wurden mehrere E3-Ligasen beschrieben, die β-Catenin ubiquitylieren und abbauen, aber die Deubiquitylasen, sind grö𐀀tenteils noch unbekannt. Mit Hilfe eines unvoreingenommenen siRNA-Screens wurde die Deubiquitylase USP10 als de novo Regulator der β-Catenin-Stabilität in Darmkrebs-Zellen identifiziert. In der Literatur wurde bereits gezeigt, dass USP10 sowohl die Stabilität von mutiertem als auch von wild typ TP53 reguliert, NOTCH1 in Endothelzellen deubiquityliert und an der Regulation des AMPKα Signalwegs beteiligt ist. Insgesamt bleibt seine Rolle in der kolorektalen Tumorgenese aber bisher umstritten. Anhand der Analyse öffentlich zugänglicher Protein- und Genexpressionsdaten haben wir gezeigt, dass USP10 bei der Transformation stark hochreguliert oder amplifiziert wird und dass seine Expression positiv mit der von CTNNB1 korreliert. Im Gegensatz dazu wurden in nicht transformiertem Gewebe basale USP10-Spiegel gefunden, aber überraschenderweise ist USP10 in intestinalen Stammzellen hochreguliert. Endogene Interaktionsstudien in Darmkrebs-Zelllinien mit unterschiedlichem Ausma𐀀 an APC-Trunkierung zeigten eine APC-abhängige Interaktion für beide Proteine. Darüber hinaus konnten wir mit Hilfe von CRISPR/Cas9, shRNA-vermitteltem Knock-down und Überexpression von USP10 eine Regulation der β-Catenin-Stabilität durch USP10 in Darmkrebs-Zelllinien nachweisen. Es ist allgemein bekannt, dass 2D-Zellkultursysteme die Komplexität, Architektur und Heterogenität nicht widerspiegeln und daher nicht geeignet sind, um komplexe biologische Fragen zu beantworten. Um dies zu überwinden, haben wir die Isolierung, Kultivierung und genetische Veränderung von murinen Dar- morganoiden etabliert und dieses System genutzt, um die Rolle von Usp10 ex vivo zu untersuchen. Durch die Durchführung von RNA-Sequenzierungen in Abhängigkeit von unterschiedlichen Usp10-Spiegeln konnten wir die bisherigen Ergebnisse rekapitulieren und Usp10 als wichtigen Regulator der β-Catenin-abhängigen Regulation der Stammzell- homöostase nachweisen. Da die genetische Depletion von USP10 zu einer Herunterregulierung der β-Catenin- abhängigen Transkription führte, wurde auch die therapeutische Intervention von USP10 in Darmkrebs untersucht. Kommerzielle und neu entwickelte Inhibitoren wurden auf ihre Wirksamkeit gegen USP10 getestet, konnten jedoch die Aktivität von USP10 in Darmkrebs- Zellen nicht hemmen. Um die Erkenntnisse aus dieser Arbeit auch in vivo zu validieren, wurde mit der Entwicklung eines neuartigen Mausmodells für Darmkrebs begonnen. Durch die Kombination von CRISPR/Cas9 und klassischer Gentechnik mit viralen Injektionsstrategien konnten WT- und gentechnisch veränderte Mäuse trans- formiert werden und zumindest bei einigen Tieren waren Darmläsionen auf mikroskopis- cher Ebene nachweisbar. Die Inhibtierung von USP10, als de novo tumorspezifischer Regulator von β-Catenin, könnte eine neue therapeutische Strategie für Darmkrebs-Patienten werden. KW - Biomedizin KW - Biomedicine Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-319579 ER - TY - JOUR A1 - Morimoto, Yoshiro A1 - Shimada-Sugimoto, Mihoko A1 - Otowa, Takeshi A1 - Yoshida, Shintaro A1 - Kinoshita, Akira A1 - Mishima, Hiroyuki A1 - Yamaguchi, Naohiro A1 - Mori, Takatoshi A1 - Imamura, Akira A1 - Ozawa, Hiroki A1 - Kurotaki, Naohiro A1 - Ziegler, Christiane A1 - Domschke, Katharina A1 - Deckert, Jürgen A1 - Umekage, Tadashi A1 - Tochigi, Mamoru A1 - Kaiya, Hisanobu A1 - Okazaki, Yuji A1 - Tokunaga, Katsushi A1 - Sasaki, Tsukasa A1 - Yoshiura, Koh-ichiro A1 - Ono, Shinji T1 - Whole-exome sequencing and gene-based rare variant association tests suggest that PLA2G4E might be a risk gene for panic disorder JF - Translational Psychiatry N2 - Panic disorder (PD) is characterized by recurrent and unexpected panic attacks, subsequent anticipatory anxiety, and phobic avoidance. Recent epidemiological and genetic studies have revealed that genetic factors contribute to the pathogenesis of PD. We performed whole-exome sequencing on one Japanese family, including multiple patients with panic disorder, which identified seven rare protein-altering variants. We then screened these genes in a Japanese PD case–control group (384 sporadic PD patients and 571 controls), resulting in the detection of three novel single nucleotide variants as potential candidates for PD (chr15: 42631993, T>C in GANC; chr15: 42342861, G>T in PLA2G4E; chr20: 3641457, G>C in GFRA4). Statistical analyses of these three genes showed that PLA2G4E yielded the lowest p value in gene-based rare variant association tests by Efficient and Parallelizable Association Container Toolbox algorithms; however, the p value did not reach the significance threshold in the Japanese. Likewise, in a German case–control study (96 sporadic PD patients and 96 controls), PLA2G4E showed the lowest p value but again did not reach the significance threshold. In conclusion, we failed to find any significant variants or genes responsible for the development of PD. Nonetheless, our results still leave open the possibility that rare protein-altering variants in PLA2G4E contribute to the risk of PD, considering the function of this gene. KW - clinical genetics KW - medical genetics Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-224192 VL - 8 ER - TY - JOUR A1 - Nerreter, Thomas A1 - Letschert, Sebastian A1 - Götz, Ralph A1 - Doose, Sören A1 - Danhof, Sophia A1 - Einsele, Hermann A1 - Sauer, Markus A1 - Hudecek, Michael T1 - Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T JF - Nature Communications N2 - Immunotherapy with chimeric antigen receptor-engineered T-cells (CAR-T) is under investigation in multiple myeloma. There are reports of myeloma remission after CD19 CAR-T therapy, although CD19 is hardly detectable on myeloma cells by flow cytometry (FC). We apply single molecule-sensitive direct stochastic optical reconstruction microscopy (dSTORM), and demonstrate CD19 expression on a fraction of myeloma cells (10.3–80%) in 10 out of 14 patients (density: 13–5,000 molecules per cell). In contrast, FC detects CD19 in only 2 of these 10 patients, on a smaller fraction of cells. Treatment with CD19 CAR-T in vitro results in elimination of CD19-positive myeloma cells, including those with <100 CD19 molecules per cell. Similar data are obtained by dSTORM analyses of CD20 expression on myeloma cells and CD20 CAR-T. These data establish a sensitivity threshold for CAR-T and illustrate how super-resolution microscopy can guide patient selection in immunotherapy to exploit ultra-low density antigens. KW - cancer imaging KW - cancer immunotherapy KW - imaging Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-232258 VL - 10 ER - TY - JOUR A1 - Odin, Per A1 - Chaudhuri, K. Ray A1 - Volkmann, Jens A1 - Antonini, Angelo A1 - Storch, Alexander A1 - Dietrichs, Espen A1 - Pirtošek, Zvezdan A1 - Henriksen, Tove A1 - Horne, Malcolm A1 - Devos, David A1 - Bergquist, Filip T1 - Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease JF - npj Parkinson's Disease N2 - Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson’s disease (PD) is defining cutoff values that separate “controlled” from “uncontrolled” symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base. KW - Parkinson's disease Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-234435 VL - 4 ER - TY - JOUR A1 - Scholz, S. L. A1 - Cosgarea, I. A1 - Süßkind, D. A1 - Murali, R. A1 - Möller, I. A1 - Reis, H. A1 - Leonardelli, S. A1 - Schilling, B. A1 - Schimming, T. A1 - Hadaschik, E. A1 - Franklin, C. A1 - Paschen, A. A1 - Sucker, A. A1 - Steuhl, K. P. A1 - Schadendorf, D. A1 - Westekemper, H. A1 - Griewank, K. G. T1 - NF1 mutations in conjunctival melanoma JF - British Journal of Cancer N2 - Background Conjunctival melanoma is a potentially deadly eye tumour. Despite effective local therapies, tumour recurrence and metastasis remain frequent. The genetics of conjunctival melanomas remain incompletely understood. Methods A large cohort of 63 conjunctival melanomas was screened for gene mutations known to be important in other melanoma subtypes by targeted next-generation sequencing. Mutation status was correlated with patient prognosis. Results Frequent mutations in genes activating the MAP kinase pathway were identified. NF1 mutations were most frequent (n = 21, 33%). Recurrent activating mutations were also identified in BRAF (n = 16, 25%) and RAS genes (n = 12, 19%; 11 NRAS and 1 KRAS). Conclusions Similar to cutaneous melanomas, conjunctival melanomas can be grouped genetically into four groups: BRAF-mutated, RAS-mutated, NF1-mutated and triple wild-type melanomas. This genetic classification may be useful for assessment of therapeutic options for patients with metastatic conjunctival melanoma KW - cancer genetics KW - eye cancer Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-233329 VL - 118 ER - TY - JOUR A1 - Bruchhagen, Christin A1 - Jarick, Marcel A1 - Mewis, Carolin A1 - Hertlein, Tobias A1 - Niemann, Silke A1 - Ohlsen, Knut A1 - Peters, Georg A1 - Planz, Oliver A1 - Ludwig, Stephan A1 - Ehrhardt, Christina T1 - Metabolic conversion of CI-1040 turns a cellular MEK-inhibitor into an antibacterial compound JF - Scientific Reports N2 - Influenza virus (IV) infections cause severe respiratory illnesses that can be complicated by bacterial super-infections. Previously, we identified the cellular Raf-MEK-ERK cascade as a promising antiviral target. Inhibitors of MEK, such as CI-1040, showed potent antiviral activity. However, it remained unclear if this inhibitor and its active form, ATR-002, might sensitize host cells to either IV or secondary bacterial infections. To address these questions, we studied the anti-pathogen activity of ATR-002 in comparison to CI-1040, particularly, its impact on Staphylococcus aureus (S. aureus), which is a major cause of IV super-infections. We analysed IV and S. aureus titres in vitro during super-infection in the presence and absence of the drugs and characterized the direct impact of ATR-002 on bacterial growth and phenotypic changes. Importantly, neither CI-1040 nor ATR-002 treatment led to increased bacterial titres during super-infection, indicating that the drug does not sensitize cells for bacterial infection. In contrast, we rather observed reduced bacterial titres in presence of ATR-002. Surprisingly, ATR-002 also led to reduced bacterial growth in suspension cultures, reduced stress- and antibiotic tolerance without resistance induction. Our data identified for the first time that a particular MEK-inhibitor metabolite exhibits direct antibacterial activity, which is likely due to interference with the bacterial PknB kinase/Stp phosphatase signalling system. KW - antimicrobials KW - pathogens Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-221648 VL - 8 ER - TY - JOUR A1 - Castilho, Miguel A1 - Hochleitner, Gernot A1 - Wilson, Wouter A1 - van Rietbergen, Bert A1 - Dalton, Paul D. A1 - Groll, Jürgen A1 - Malda, Jos A1 - Ito, Keita T1 - Mechanical behavior of a soft hydrogel reinforced with three-dimensional printed microfibre scaffolds JF - Scientific Reports N2 - Reinforcing hydrogels with micro-fibre scaffolds obtained by a Melt-Electrospinning Writing (MEW) process has demonstrated great promise for developing tissue engineered (TE) constructs with mechanical properties compatible to native tissues. However, the mechanical performance and reinforcement mechanism of the micro-fibre reinforced hydrogels is not yet fully understood. In this study, FE models, implementing material properties measured experimentally, were used to explore the reinforcement mechanism of fibre-hydrogel composites. First, a continuum FE model based on idealized scaffold geometry was used to capture reinforcement effects related to the suppression of lateral gel expansion by the scaffold, while a second micro-FE model based on micro-CT images of the real construct geometry during compaction captured the effects of load transfer through the scaffold interconnections. Results demonstrate that the reinforcement mechanism at higher scaffold volume fractions was dominated by the load carrying-ability of the fibre scaffold interconnections, which was much higher than expected based on testing scaffolds alone because the hydrogel provides resistance against buckling of the scaffold. We propose that the theoretical understanding presented in this work will assist the design of more effective composite constructs with potential applications in a wide range of TE conditions. KW - biomedical engineering KW - biomedical materials KW - gels and hydrogels Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-222280 VL - 8 ER - TY - JOUR A1 - Al-Zaben, Naim A1 - Medyukhina, Anna A1 - Dietrich, Stefanie A1 - Marolda, Alessandra A1 - Hünniger, Kerstin A1 - Kurzai, Oliver A1 - Figge, Marc Thilo T1 - Automated tracking of label-free cells with enhanced recognition of whole tracks JF - Scientific Reports N2 - Migration and interactions of immune cells are routinely studied by time-lapse microscopy of in vitro migration and confrontation assays. To objectively quantify the dynamic behavior of cells, software tools for automated cell tracking can be applied. However, many existing tracking algorithms recognize only rather short fragments of a whole cell track and rely on cell staining to enhance cell segmentation. While our previously developed segmentation approach enables tracking of label-free cells, it still suffers from frequently recognizing only short track fragments. In this study, we identify sources of track fragmentation and provide solutions to obtain longer cell tracks. This is achieved by improving the detection of low-contrast cells and by optimizing the value of the gap size parameter, which defines the number of missing cell positions between track fragments that is accepted for still connecting them into one track. We find that the enhanced track recognition increases the average length of cell tracks up to 2.2-fold. Recognizing cell tracks as a whole will enable studying and quantifying more complex patterns of cell behavior, e.g. switches in migration mode or dependence of the phagocytosis efficiency on the number and type of preceding interactions. Such quantitative analyses will improve our understanding of how immune cells interact and function in health and disease. KW - image processing KW - software Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-221093 VL - 9 ER - TY - JOUR A1 - de Jong, Simone A1 - Diniz, Mateus Jose Abdalla A1 - Saloma, Andiara A1 - Gadelha, Ary A1 - Santoro, Marcos L. A1 - Ota, Vanessa K. A1 - Noto, Cristiano A1 - Curtis, Charles A1 - Newhouse, Stephen J. A1 - Patel, Hamel A1 - Hall, Lynsey S. A1 - O'Reilly, Paul F. A1 - Belangero, Sintia I. A1 - Bressan, Rodrigo A. A1 - Breen, Gerome T1 - Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder JF - Communications Biology N2 - Psychiatric disorders are thought to have a complex genetic pathology consisting of interplay of common and rare variation. Traditionally, pedigrees are used to shed light on the latter only, while here we discuss the application of polygenic risk scores to also highlight patterns of common genetic risk. We analyze polygenic risk scores for psychiatric disorders in a large pedigree (n ~ 260) in which 30% of family members suffer from major depressive disorder or bipolar disorder. Studying patterns of assortative mating and anticipation, it appears increased polygenic risk is contributed by affected individuals who married into the family, resulting in an increasing genetic risk over generations. This may explain the observation of anticipation in mood disorders, whereby onset is earlier and the severity increases over the generations of a family. Joint analyses of rare and common variation may be a powerful way to understand the familial genetics of psychiatric disorders. KW - bipolar disorder KW - depression KW - genetic association study KW - genetic linkage study Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-223622 VL - 1 ER - TY - JOUR A1 - Dekker, Annelot M. A1 - Diekstra, Frank P. A1 - Pulit, Sara L. A1 - Tazelaar, Gijs H. P. A1 - van der Spek, Rick A. A1 - van Rheenen, Wouter A1 - van Eijk, Kristel R. A1 - Calvo, Andrea A1 - Brunetti, Maura A1 - Van Damme, Philip A1 - Robberecht, Wim A1 - Hardiman, Orla A1 - McLaughlin, Russell A1 - Chiò, Adriano A1 - Sendtner, Michael A1 - Ludolph, Albert C. A1 - Weishaupt, Jochen H. A1 - Pardina, Jesus S. Mora A1 - van den Berg, Leonard H. A1 - Veldink, Jan H. T1 - Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis JF - Scientific Reports N2 - Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects 1 in ~350 individuals. Genetic association studies have established ALS as a multifactorial disease with heritability estimated at ~61%, and recent studies show a prominent role for rare variation in its genetic architecture. To identify rare variants associated with disease onset we performed exome array genotyping in 4,244 cases and 3,106 controls from European cohorts. In this largest exome-wide study of rare variants in ALS to date, we performed single-variant association testing, gene-based burden, and exome-wide individual set-unique burden (ISUB) testing to identify single or aggregated rare variation that modifies disease risk. In single-variant testing no variants reached exome-wide significance, likely due to limited statistical power. Gene-based burden testing of rare non-synonymous and loss-of-function variants showed NEK1 as the top associated gene. ISUB analysis did not show an increased exome-wide burden of deleterious variants in patients, possibly suggesting a more region-specific role for rare variation. Complete summary statistics are released publicly. This study did not implicate new risk loci, emphasizing the immediate need for future large-scale collaborations in ALS that will expand available sample sizes, increase genome coverage, and improve our ability to detect rare variants associated to ALS. KW - amyotrophic lateral sclerosis KW - genome-wide association studies Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-223686 VL - 9 ER - TY - JOUR A1 - Diehl-Schmid, Janine A1 - Licata, Abigail A1 - Goldhardt, Oliver A1 - Förstl, Hans A1 - Yakushew, Igor A1 - Otto, Markus A1 - Anderl-Straub, Sarah A1 - Beer, Ambros A1 - Ludolph, Albert Christian A1 - Landwehrmeyer, Georg Bernhard A1 - Levin, Johannes A1 - Danek, Adrian A1 - Fliessbach, Klaus A1 - Spottke, Annika A1 - Fassbender, Klaus A1 - Lyros, Epameinondas A1 - Prudlo, Johannes A1 - Krause, Bernd Joachim A1 - Volk, Alexander A1 - Edbauer, Dieter A1 - Schroeter, Matthias Leopold A1 - Drzezga, Alexander A1 - Kornhuber, Johannes A1 - Lauer, Martin A1 - Grimmer, Timo T1 - FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations JF - Translational Psychiatry N2 - C9ORF72 mutations are the most common cause of familial frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). MRI studies have investigated structural changes in C9ORF72-associated FTLD (C9FTLD) and provided first insights about a prominent involvement of the thalamus and the cerebellum. Our multicenter, 18F-fluorodeoxyglucose positron-emission tomography study of 22 mutation carriers with FTLD, 22 matched non-carriers with FTLD, and 23 cognitively healthy controls provided valuable insights into functional changes in C9FTLD: compared to non-carriers, mutation carriers showed a significant reduction of glucose metabolism in both thalami, underscoring the key role of the thalamus in C9FTLD. Thalamic metabolism did not correlate with disease severity, duration of disease, or the presence of psychotic symptoms. Against our expectations we could not demonstrate a cerebellar hypometabolism in carriers or non-carriers. Future imaging and neuropathological studies in large patient cohorts are required to further elucidate the central role of the thalamus in C9FTLD. KW - diagnostic markers KW - psychiatric disorders Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-225308 VL - 9 ER - TY - JOUR A1 - Dietrich, Thomas A1 - Krug, Ralf A1 - Krastl, Gabriel A1 - Tomson, Philip L. T1 - Restoring the unrestorable! Developing coronal tooth tissue with a minimally invasive surgical extrusion technique JF - British Dental Journal N2 - Surgical extrusion is a recognised treatment option for teeth that have insufficient coronal tooth structure remaining due to deep caries, resorption or traumatic injury. However, the technique has not been widely adopted, arguably because extraction of a severely compromised tooth may be difficult to achieve in a gentle and predictable way. In this paper, we present our novel approach to surgical extrusion and subsequent management of teeth using a vertical extraction system (Benex), which has become the method of choice in the authors' practice for many teeth that would otherwise be deemed unrestorable. We describe the clinical procedure in detail and discuss the advantages and disadvantages compared to alternative approaches, including surgical crown lengthening and orthodontic extrusion. Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-225333 VL - 226 ER - TY - JOUR A1 - Hauer, Nadine N. A1 - Popp, Bernt A1 - Schoeller, Eva A1 - Schuhmann, Sarah A1 - Heath, Karen E. A1 - Hisado-Oliva, Alfonso A1 - Klinger, Patricia A1 - Kraus, Cornelia A1 - Trautmann, Udo A1 - Zenker, Martin A1 - Zweier, Christiane A1 - Wiesener, Antje A1 - Jamra, Rami Abou A1 - Kunstmann, Erdmute A1 - Wieczorek, Dagmar A1 - Uebe, Steffen A1 - Ferrazzi, Fulvia A1 - Büttner, Christian A1 - Ekici, Arif B. A1 - Rauch, Anita A1 - Sticht, Heinrich A1 - Dörr, Helmuth-Günther A1 - Reis, André A1 - Thiel, Christian T. T1 - Clinical relevance of systematic phenotyping and exome sequencing in patients with short stature JF - Genetics in Medicine N2 - Purpose Short stature is a common condition of great concern to patients and their families. Mostly genetic in origin, the underlying cause often remains elusive due to clinical and genetic heterogeneity. Methods We systematically phenotyped 565 patients where common nongenetic causes of short stature were excluded, selected 200 representative patients for whole-exome sequencing, and analyzed the identified variants for pathogenicity and the affected genes regarding their functional relevance for growth. Results By standard targeted diagnostic and phenotype assessment, we identified a known disease cause in only 13.6% of the 565 patients. Whole-exome sequencing in 200 patients identified additional mutations in known short-stature genes in 16.5% of these patients who manifested only part of the symptomatology. In 15.5% of the 200 patients our findings were of significant clinical relevance. Heterozygous carriers of recessive skeletal dysplasia alleles represented 3.5% of the cases. Conclusion A combined approach of systematic phenotyping, targeted genetic testing, and whole-exome sequencing allows the identification of the underlying cause of short stature in at least 33% of cases, enabling physicians to improve diagnosis, treatment, and genetic counseling. Exome sequencing significantly increases the diagnostic yield and consequently care in patients with short stature. KW - growth KW - phenotypic spectrum KW - short stature KW - skeletal dysplasia KW - whole-exome sequencing Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227888 VL - 20 ER - TY - JOUR A1 - Ludwig, Heinz A1 - Delforge, Michel A1 - Facon, Thierry A1 - Einsele, Hermann A1 - Gay, Francesca A1 - Moreau, Philippe A1 - Avet-Loiseau, Hervé A1 - Boccadoro, Mario A1 - Hajek, Roman A1 - Mohty, Mohamad A1 - Cavo, Michele A1 - Dimopoulos, Meletios A A1 - San-Miguel, Jesús F A1 - Terpos, Evangelos A1 - Zweegman, Sonja A1 - Garderet, Laurent A1 - Mateos, María-Victoria A1 - Cook, Gordon A1 - Leleu, Xavier A1 - Goldschmidt, Hartmut A1 - Jackson, Graham A1 - Kaiser, Martin A1 - Weisel, Katja A1 - van de Donk, Niels W. C. J. A1 - Waage, Anders A1 - Beksac, Meral A1 - Mellqvist, Ulf H. A1 - Engelhardt, Monika A1 - Caers, Jo A1 - Driessen, Christoph A1 - Bladé, Joan A1 - Sonneveld, Pieter T1 - Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network JF - Leukemia N2 - During the last few years, several new drugs have been introduced for treatment of patients with multiple myeloma, which have significantly improved the treatment outcome. All of these novel substances differ at least in part in their mode of action from similar drugs of the same drug class, or are representatives of new drug classes, and as such present with very specific side effect profiles. In this review, we summarize these adverse events, provide information on their prevention, and give practical guidance for monitoring of patients and for management of adverse events. KW - disease prevention KW - myeloma Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-237338 VL - 32 ER - TY - THES A1 - Machwart, Khaled T1 - Modulatorischer Einfluss von Levosimendan bei dem Ischämie-Reperfusionsschaden auf die myokardiale Mitochondrienfunktion T1 - Impact of Levosimendan in the ischemia-reperfusion damage on the myocardial Mitochondrial function N2 - Die vorliegende Studie untersuchte den Effekt von Levosimendan auf die mitochondriale Funktionen im Herzmuskel, insbesondere im Zusammenhang mit dem Ischämie/Reperfusions-Schaden. Methoden: In der Studie wurde ein retrogrades Langendorff-Modell verwendet, um die Auswirkungen von Levosimendan, dem Ischämie/Reperfusions-Schaden sowie deren Kombination auf die mitochondrialen Funktionen im Herzmuskel zu untersuchen. Dazu wurden vier verschiedene Gruppen von Rattenherzen entsprechend den experimentellen Bedingungen perfundiert, und ihre Funktionen wurden analysiert. Ergebnisse: Der Ischämie/Reperfusions-Schaden beeinträchtigte die myokardiale Ventrikelfunktion. Zusätzlich wurde eine Hypopolarisation des mithochondrialen Membranpotentials in den mit Levosimendan oder Ischämie behandelten Gruppen festgestellt. Die ATP-Synthese in den Gruppen mit Levosimendan und Ischämie war reduziert. Schlussfolgerung: Levosimendan zeigt signifikante Einflüsse auf die Atmungsfunktion der mitochondrialen Komplexe IV und V sowie auf das Membranpotential. Diese Phänomene könnten einem mito-K+ ATP-abhängigen Mechanismus zugrunde liegen. Obwohl Levosimendan während des Ischämie/Reperfusionsschadens eine protektive Wirkung hinsichtlich einer Ca2+- Überlastung aufweist, bleibt der kumulative Einfluss der beeinträchtigten ATP-Generierung auf die gesamte Myokardfunktion zu klären. N2 - The present study investigated the effect of levosimendan on mitochondrial functions in the heart muscle, particularly in connection with ischemia/reperfusion injury. Methods: In the study, a retrograde Langendorff model was used to examine the effects of levosimendan, ischemia/reperfusion injury, and their combination on mitochondrial functions in the heart muscle. For this purpose, four different groups of rat hearts were perfused according to the experimental conditions, and their functions were analyzed. Results: Ischemia/reperfusion injury impaired myocardial ventricular function. Additionally, a hypopolarization of the mitochondrial membrane potential was observed in the groups treated with levosimendan or ischemia. ATP synthesis was reduced in the groups with levosimendan and ischemia. Conclusion: Levosimendan shows significant effects on the respiratory function of mitochondrial complexes IV and V, as well as on the membrane potential. These phenomena could be based on a mito-K+ ATP-dependent mechanism. Although levosimendan has a protective effect during ischemia/reperfusion injury regarding Ca2+ overload, the cumulative impact of impaired ATP generation on overall myocardial function remains to be clarified. KW - Ischämie KW - Ischämie Reperfusion Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-361021 ER - TY - JOUR A1 - Prusty, Bhupesh K. A1 - Gulve, Nitish A1 - Govind, Sheila A1 - Krueger, Gerhard R. F. A1 - Feichtinger, Julia A1 - Larcombe, Lee A1 - Aspinall, Richard A1 - Ablashi, Dharam V. A1 - Toro, Carla T. T1 - Active HHV-6 Infection of Cerebellar Purkinje Cells in Mood Disorders JF - Frontiers in Microbiology N2 - Early-life infections and associated neuroinflammation is incriminated in the pathogenesis of various mood disorders. Infection with human roseoloviruses, HHV-6A and HHV-6B, allows viral latency in the central nervous system and other tissues, which can later be activated causing cognitive and behavioral disturbances. Hence, this study was designed to evaluate possible association of HHV-6A and HHV-6B activation with three different groups of psychiatric patients. DNA qPCR, immunofluorescence and FISH studies were carried out in post-mortem posterior cerebellum from 50 cases each of bipolar disorder (BPD), schizophrenia, 15 major depressive disorder (MDD) and 50 appropriate control samples obtained from two well-known brain collections (Stanley Medical Research Institute). HHV-6A and HHV-6B late proteins (indicating active infection) and viral DNA were detected more frequently (p < 0.001 for each virus) in human cerebellum in MDD and BPD relative to controls. These roseolovirus proteins and DNA were found less frequently in schizophrenia cases. Active HHV-6A and HHV-6B infection in cerebellar Purkinje cells were detected frequently in BPD and MDD cases. Furthermore, we found a significant association of HHV-6A infection with reduced Purkinje cell size, suggesting virus-mediated abnormal Purkinje cell function in these disorders. Finally, gene expression analysis of cerebellar tissue revealed changes in pathways reflecting an inflammatory response possibly to HHV-6A infection. Our results provide molecular evidence to support a role for active HHV-6A and HHV-6B infection in BPD and MDD. KW - HHV-6 KW - bipolar disorder KW - schizophrenia KW - major depressive disorder KW - Purkinje cells Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-369222 VL - 9 ER - TY - JOUR A1 - Ticha, Olga A1 - Moos, Lukas A1 - Wajant, Harald A1 - Bekeredjian-Ding, Isabelle T1 - Expression of Tumor Necrosis Factor Receptor 2 Characterizes TLR9-Driven Formation of Interleukin-10-Producing B Cells JF - Frontiers in Immunology N2 - B cell-derived interleukin-10 (IL-10) production has been described as a hallmark for regulatory function in B lymphocytes. However, there is an ongoing debate on the origin of IL-10-secreting B cells and lack of specific surface markers has turned into an important obstacle for studying human B regulatory cells. In this study, we propose that tumor necrosis factor receptor 2 (TNFR2) expression can be used for enrichment of IL-10-secreting B cells. Our data confirm that IL-10 production can be induced by TLR9 stimulation with CpG ODN and that IL-10 secretion accompanies differentiation of peripheral blood B cells into plasma blasts. We further show that CpG ODN stimulation induces TNFR2 expression, which correlates with IL-10 secretion and terminal differentiation. Indeed, flow cytometric sorting of TNFR2+ B cells revealed that TNFR2+ and TNFR2− fractions correspond to IL-10+ and IL-10− fractions, respectively. Furthermore, CpG-induced TNFR2+ B cells were predominantly found in the IgM+ CD27+ B cell subset and spontaneously released immunoglobulin. Finally, our data corroborate the functional impact of TNFR2 by demonstrating that stimulation with a TNFR2 agonist significantly augments IL-10 and IL-6 production in B cells. Altogether, our data highlight a new role for TNFR2 in IL-10-secreting human B lymphocytes along with the potential to exploit this finding for sorting and isolation of this currently ill-defined B cell subset. KW - human KW - B cells KW - interleukin-10 KW - tumor necrosis factor receptor 2 KW - TLR 9 KW - Breg Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-241323 VL - 8 ER - TY - JOUR A1 - Klotz, Peter A1 - Higgins, Paul G. A1 - Schaubmar, Andreas R. A1 - Failing, Klaus A1 - Leidner, Ursula A1 - Seifert, Harald A1 - Scheufen, Sandra A1 - Semmler, Torsten A1 - Ewers, Christa T1 - Seasonal Occurrence and Carbapenem Susceptibility of Bovine Acinetobacter baumannii in Germany JF - Frontiers in Microbiology N2 - Acinetobacter baumannii is one of the leading causes of nosocomial infections in humans. To investigate its prevalence, distribution of sequence types (STs), and antimicrobial resistance in cattle, we sampled 422 cattle, including 280 dairy cows, 59 beef cattle, and 83 calves over a 14-month period. Metadata, such as the previous use of antimicrobial agents and feeding, were collected to identify putative determining factors. Bacterial isolates were identified via MALDI-TOF/MS and PCR, antimicrobial susceptibility was evaluated via VITEK2 and antibiotic gradient tests, resistance genes were identified by PCR. Overall, 15.6% of the cattle harbored A. baumannii, predominantly in the nose (60.3% of the A. baumannii isolates). It was more frequent in dairy cows (21.1%) than in beef cattle (6.8%) and calves (2.4%). A seasonal occurrence was shown with a peak between May and August. The rate of occurrence of A. baumannii was correlated with a history of use of 3rd generation cephalosporins in the last 6 months prior to sampling Multilocus sequence typing (Pasteur scheme) revealed 83 STs among 126 unique isolates. Nine of the bovine STs have previously been implicated in human infections. Besides known intrinsic resistance of the species, the isolates did not show additional resistance to the antimicrobial substances tested, including carbapenems. Our data suggest that cattle are not a reservoir for nosocomial A. baumannii but carry a highly diverse population of this species. Nevertheless, some STs seem to be able to colonize both cattle and humans. KW - ESKAPE KW - Acinetobacter baumannii KW - antimicrobial susceptibility KW - MLST KW - cattle KW - epidemiology Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-325927 VL - 10 ER - TY - JOUR A1 - Schroeter, Matthias L. A1 - Pawelke, Sarah A1 - Bisenius, Sandrine A1 - Kynast, Jana A1 - Schuemberg, Katharina A1 - Polyakova, Maryna A1 - Anderl-Straub, Sarah A1 - Danek, Adrian A1 - Fassbender, Klaus A1 - Jahn, Holger A1 - Jessen, Frank A1 - Kornhuber, Johannes A1 - Lauer, Martin A1 - Prudlo, Johannes A1 - Schneider, Anja A1 - Uttner, Ingo A1 - Thöne-Otto, Angelika A1 - Otto, Markus A1 - Diehl-Schmid, Janine T1 - A Modified Reading the Mind in the Eyes Test Predicts Behavioral Variant Frontotemporal Dementia Better Than Executive Function Tests JF - Frontiers in Aging Neuroscience N2 - Behavioral variant frontotemporal dementia (bvFTD) is characterized by deep alterations in behavior and personality. Although revised diagnostic criteria agree for executive dysfunction as most characteristic, impairments in social cognition are also suggested. The study aimed at identifying those neuropsychological and behavioral parameters best discriminating between bvFTD and healthy controls. Eighty six patients were diagnosed with possible or probable bvFTD according to Rascovsky et al. (2011) and compared with 43 healthy age-matched controls. Neuropsychological performance was assessed with a modified Reading the Mind in the Eyes Test (RMET), Stroop task, Trail Making Test (TMT), Hamasch-Five-Point Test (H5PT), and semantic and phonemic verbal fluency tasks. Behavior was assessed with the Apathy Evaluation Scale, Frontal Systems Behavioral Scale, and Bayer Activities of Daily Living Scale. Each test’s discriminatory power was investigated by Receiver Operating Characteristic curves calculating the area under the curve (AUC). bvFTD patients performed significantly worse than healthy controls in all neuropsychological tests. Discriminatory power (AUC) was highest in behavioral questionnaires, high in verbal fluency tasks and the RMET, and lower in executive function tests such as the Stroop task, TMT and H5PT. As fluency tasks depend on several cognitive functions, not only executive functions, results suggest that the RMET discriminated better between bvFTD and control subjects than other executive tests. Social cognition should be incorporated into diagnostic criteria for bvFTD in the future, such as in the International Classification of Diseases (ICD)-11, as already suggested in the Diagnostic and Statistical Manual for Mental Disorders (DSM)-5. KW - behavioral variant frontotemporal dementia KW - diagnostic criteria KW - executive function KW - social cognition KW - theory of mind Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-234254 VL - 10 ER - TY - JOUR A1 - Lang, Isabell A1 - Füllsack, Simone A1 - Wajant, Harald T1 - Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies JF - Frontiers in Immunology N2 - Progranulin (PGRN) is a secreted anti-inflammatory protein which can be processed by neutrophil proteases to various granulins. It has been reported that at least a significant portion of the anti-inflammatory effects of PGRN is due to direct high affinity binding to tumor necrosis factor receptor-1 (TNFR1) and TNFR2 and inhibition of tumor necrosis factor (TNF)-induced TNFR1/2 signaling. Two studies failed to reproduce the interaction of TNFR1 and TNFR2 with PGRN, but follow up reports speculated that this was due to varying experimental circumstances and/or the use of PGRN from different sources. However, even under consideration of these speculations, there is still a striking discrepancy in the literature between the concentrations of PGRN needed to inhibit TNF signaling and the concentrations required to block TNF binding to TNFR1 and TNFR2. While signaling events induced by 0.2–2 nM of TNF have been efficiently inhibited by low, near to equimolar concentrations (0.5–2.5 nM) of PGRN in various studies, the reported inhibitory effects of PGRN on TNF-binding to TNFR1/2 required a huge excess of PGRN (100–1,000-fold). Therefore, we investigated the effect of PGRN on TNF binding to TNFR1 and TNFR2 in highly sensitive cellular binding studies. Unlabeled TNF inhibited >95% of the specific binding of a Gaussia princeps luciferase (GpL) fusion protein of TNF to TNFR1 and TNFR2 and blocked binding of soluble GpL fusion proteins of TNFR1 and TNFR2 to membrane TNF expressing cells to >95%, too. Purified PGRN, however, showed in both assays no effect on TNF–TNFR1/2 interaction even when applied in huge excess. To rule out that tags and purification- or storage-related effects compromise the potential ability of PGRN to bind TNF receptors, we directly co-expressed PGRN, and as control TNF, in TNFR1- and TNFR2-expressing cells and looked for binding of GpL-TNF. While expression of TNF strongly inhibited binding of GpL-TNF to TNFR1/2, co-expression of PGRN had not effect on the ability of the TNFR1/2-expressing cells to bind TNF. KW - binding studies KW - Gaussia princeps luciferase fusion protein KW - progranulin KW - tumor necrosis factor KW - tumor necrosis factor receptor-1 KW - tumor necrosis factor receptor-2 Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-236373 VL - 9 ER - TY - JOUR A1 - Weiss, Esther A1 - Ziegler, Sabrina A1 - Fliesser, Mirjam A1 - Schmitt, Anna-Lena A1 - Hünniger, Kerstin A1 - Kurzai, Oliver A1 - Morton, Charles-Oliver A1 - Einsele, Hermann A1 - Loeffler, Juergen T1 - First Insights in NK—DC Cross-Talk and the Importance of Soluble Factors During Infection With Aspergillus fumigatus JF - Frontiers in Cellular and Infection Microbiology N2 - Invasive aspergillosis (IA) is an infectious disease caused by the fungal pathogen Aspergillus fumigatus that mainly affects immunocompromised hosts. To investigate immune cell cross-talk during infection with A. fumigatus, we co-cultured natural killer (NK) cells and dendritic cells (DC) after stimulation with whole fungal structures, components of the fungal cell wall, fungal lysate or ligands for distinct fungal receptors. Both cell types showed activation after stimulation with fungal components and were able to transfer activation signals to the counterpart not stimulated cell type. Interestingly, DCs recognized a broader spectrum of fungal components and thereby initiated NK cell activation when those did not recognize fungal structures. These experiments highlighted the supportive function of DCs in NK cell activation. Furthermore, we focused on soluble DC mediated NK cell activation and showed that DCs stimulated with the TLR2/Dectin-1 ligand zymosan could maximally stimulate the expression of CD69 on NK cells. Thus, we investigated the influence of both receptors for zymosan, Dectin-1 and TLR2, which are highly expressed on DCs but show only minimal expression on NK cells. Specific focus was laid on the question whether Dectin-1 or TLR2 signaling in DCs is important for the secretion of soluble factors leading to NK cell activation. Our results show that Dectin-1 and TLR2 are negligible for NK cell activation. We conclude that besides Dectin-1 and TLR2 other receptors on DCs are able to compensate for the missing signal. KW - natural killer cells KW - dendritic cells KW - NK-DC cross-talk KW - Aspergillus fumigatus KW - soluble factors KW - innate immunity Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-233565 VL - 8 ER - TY - JOUR A1 - Schurig, Johannes A1 - Haeusler, Karl Georg A1 - Grittner, Ulrike A1 - Nolte, Christian H. A1 - Fiebach, Jochen B. A1 - Audebert, Heinrich J. A1 - Endres, Matthias A1 - Rocco, Andrea T1 - Frequency of Hemorrhage on Follow Up Imaging in Stroke Patients Treated With rt-PA Depending on Clinical Course JF - Frontiers in Neurology N2 - Background: According to current guidelines, stroke patients treated with rt-PA should undergo brain imaging to exclude intracerebral bleeding 24 h after thrombolysis, before the start of medical secondary prevention. However, the usefulness of routine follow-up imaging with regard to changes in therapeutic management in patients without neurological deterioration is unclear. We hypothesized that follow up brain imaging solely to exclude bleeding in patients who clinically improved after rt-PA application may not be necessary. Methods: Retrospective single-center analysis including stroke patients treated with rt-PA. Records were reviewed for hemorrhagic transformation one day after systemic thrombolysis and brain imaging-based changes in therapeutic management. Twenty-four hour after thrombolysis patients were divided into four groups: (1) increased NIHSS score; (2) unchanged NIHSS score; (3) improved NIHSS score and; (4) NIHSS score = 0. Results: Out of 188 patients (mean age 73 years, 100 female) receiving rt-PA, 32 (17%) had imaging-proven hemorrhagic transformation including 11 (6%) patients with parenchymal hemorrhage. Patients in group (1, 2) more often had hypertension (p = 0.015) and more often had parenchymal hemorrhage (9 vs. 4%; p < 0.206) compared to group (3, 4) and imaging-based changes in therapeutic management were more frequent (19% vs. 6%; p = 0.007). Patients of group (3, 4) had no changes in therapeutic management in 94% of the cases. Patients in group (4) had no hemorrhagic transformation in routine follow-up brain imaging. Conclusions: Frequency of hemorrhagic transformation in Routine follow-up brain imaging and consecutive changes in therapeutic management were different depending on clinical course measured by NHISS score. KW - thrombolysis KW - stroke KW - stroke management KW - magnetic resonance imaging KW - computerized tomography KW - intracerebral hemorrhage Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-234947 VL - 10 ER - TY - THES A1 - Cruz de Casas, Paulina T1 - Sphingolipids as modulators of T cell function T1 - Sphingolipide als Modulatoren der T-Zell-Funktion N2 - The immune system is responsible for the preservation of homeostasis whenever a given organism is exposed to distinct kinds of perturbations. Given the complexity of certain organisms like mammals, and the diverse types of challenges that they encounter (e.g. infection or disease), the immune system evolved to harbor a great variety of distinct immune cell populations with specialized functions. For instance, the family of T cells is sub-divided into conventional (Tconv) and unconventional T cells (UTCs). Tconv form part of the adaptive arm of the immune system and are comprised of αβ CD4+ or CD8+ cells that differentiate from naïve to effector and memory populations upon activation and are essential during infection and cancer. Furthermore, UTCs, which include γδ T cells, NKT and MAIT, are involved in innate and adaptive immune responses, due to their dual mode of activation, through cytokines (innate-like) or TCR (adaptive), and function. Despite our understanding of the basic functions of T cells in several contexts, a great number of open questions related to their basic biology remain. For instance, the mechanism behind the differentiation of naïve CD4+ and CD8+ T cells into effector and memory populations is not fully understood. Moreover, the exact function and relevance of distinct UTC subpopulations in a physiological context have not been fully clarified. Here, we investigated the factors mediating naïve CD8+ T cell differentiation into effector and memory cells. By using flow cytometry, mass spectrometry, enzymatic assays, and transgenic mouse models, we found that the membrane bound enzyme sphingomyelin-phosphodiesterase acid-like 3b (Smpdl3b) is crucial for the maintenance of memory CD8+ T cells. Our data show that the absence of Smpdl3b leads to diminished CD8+ T cell memory, and a loss of stem-like memory populations due to an aggravated contraction. Our scRNA-seq data suggest that Smpdl3b could be involved in clathrinmediated endocytosis through modulation of Huntingtin interacting protein 1 (Hip1) levels, likely regulating TCR-independent signaling events. Furthermore, in this study we explored the role of UTCs in lymph node-specific immune responses. By using transgenic mouse models for photolabeling, lymph node transplantation models, infection models and flow cytometry, we demonstrate that S1P regulates the migration of tissue-derived UTC from tissues to draining lymph nodes, resulting in heterogeneous immune responses mounted by lymph nodes draining different tissues. Moreover, our unbiased scRNAseq and single lineage-deficient mouse models analysis revealed that all UTC lineages (γδ T cells, NKT and MAIT) are organized in functional units, based on transcriptional homogeneity, shared microanatomical location and migratory behavior, and numerical and functional redundancy. Taken together, our studies describe additional cell intrinsic (Smpdl3b) and extrinsic (S1Pmediated migration) functions of sphingolipid metabolism modulating T cell biology. We propose the S1P/S1PR1/5 signaling axis as the potential survival pathway for Smpdl3b+ memory CD8+ T cells and UTCs, mainly in lymph nodes. Possibly, Smpdl3b regulates S1P/S1PR signaling by balancing ligandreceptor endocytosis, while UTCs migrate to lymph nodes during homeostasis to be exposed to specific levels of S1P that assure their maintenance. Our results are clinically relevant, since several drugs modulating the S1P/S1PR signaling axis or the levels of Smpdl3b are currently used to treat human diseases, such as multiple sclerosis and B cell-mediated diseases. We hope that our discoveries will inspire future studies focusing on sphingolipid metabolism in immune cell biology. N2 - Das Immunsystem ist für die Aufrechterhaltung der Homöostase verantwortlich, wenn ein bestimmter Organismus verschiedenen Arten von Störungen ausgesetzt ist. In Anbetracht der Komplexität bestimmter Organismen wie Säugetiere und der verschiedenen Arten von Störungen, denen sie ausgesetzt sein können (z. B. Infektionen oder Krankheiten), hat sich das Immunsystem so entwickelt, dass es eine große Vielfalt verschiedener Immunzellpopulationen mit spezialisierten Funktionen beherbergt. So wird beispielsweise die Familie der T-Zellen in konventionelle (Tconv) und unkonventionelle T-Zellen (UTC) unterteilt. Tconv sind Teil des adaptiven Arms des Immunsystems und bestehen aus αβ-CD4+- oder CD8+-Zellen, die sich bei der Aktivierung von naiven zu Effektor- und Gedächtnispopulationen differenzieren und bei Infektionen und Krebs eine wichtige Rolle spielen. Darüber hinaus sind UTCs, zu denen γδ-T-Zellen, NKT und MAIT gehören, aufgrund ihrer dualen Aktivierungsweise durch Zytokine (angeboren) oder TCR (adaptiv) und ihrer Funktion an angeborenen und adaptiven Immunantworten beteiligt. Trotz unseres Verständnisses der grundlegenden Funktionen von T-Zellen in verschiedenen Zusammenhängen gibt es nach wie vor eine große Anzahl offener Fragen im Zusammenhang mit ihrer grundlegenden Biologie. So ist beispielsweise der Mechanismus der Differenzierung naiver CD4+ und CD8+ T-Zellen in Effektor- und Gedächtnispopulationen noch nicht ausreichend verstanden. Auch die genaue Funktion und Bedeutung der verschiedenen UTCSubpopulationen im physiologischen Kontext sind noch nicht vollständig geklärt. Wir haben die Faktoren untersucht, die die Differenzierung naiver CD8+ T-Zellen in Effektorund Gedächtniszellen vermitteln. Mithilfe von Durchflusszytometrie, Massenspektrometrie, enzymatischen Assays und transgenen Mausmodellen konnten wir feststellen, dass das membrangebundene Enzym Sphingomyelin-Phosphodiesterase acid-like 3b (Smpdl3b) für die Aufrechterhaltung der CD8+ T-Zell-Gedächtnisfunktion entscheidend ist. Unsere Daten zeigen, dass das Fehlen von Smpdl3b zu einer verminderten Anzahl and CD8+ T Gedächtniszellen durch eine verstärke Kontraktion sowie einem Verlust von stammzellartigen Gedächtnispopulationen führt. Unsere scRNAseq- Daten deuten jedoch darauf hin, dass Smpdl3b an der Clathrin-vermittelten Endozytose beteiligt sein könnte, indem es die Spiegel des Huntingtin interacting protein 1 (Hip1) moduliert und wahrscheinlich TCR-unabhängige Signalereignisse reguliert. Darüber hinaus untersuchten wir in dieser Studie die Rolle von UTCs bei lymphknotenspezifischen Immunantworten. Mit Hilfe von transgenen Mausmodellen für Photolabeling, Lymphknotentransplantationsmodellen, Infektionsmodellen und Durchflusszytometrie konnten wir zeigen, dass S1P die Migration von UTCs aus dem Gewebe in die drainierenden Lymphknoten reguliert, was zu heterogenen Immunantworten in den Lymphknoten führt, die verschiedene Gewebe drainieren. Ausserdem ergab unsere Analyse von scRNA-seq-Daten, sowie Mausmodelle mit einer genetischen Defizienz einzelner UTC-Linien (γδ-T-Zellen, NKT und MAIT), dass diese zusammen in funktionellen Einheiten organisiert sind, die auf transkriptioneller Homogenität, gemeinsamer mikroanatomischer Lage und Migrationsverhalten sowie numerischer und funktioneller Redundanz basieren. Zusammengenommen beschreiben unsere Studien zusätzliche zellinterne (Smpdl3b) und - externe (S1P-vermittelte Migration) Funktionen des Sphingolipid-Stoffwechsels, welche die T-Zell- Biologie modulieren. Wir schlagen die S1P/S1PR1/5-Signalachse als potenziellen Überlebensweg für Smpdl3b+ Gedächtnis-CD8+-T-Zellen und UTCs ausschließlich in Lymphknoten vor. Möglicherweise reguliert Smpdl3b die S1P/S1PR-Signalübertragung, indem es die Endozytose des Liganden-Rezeptors reguliert. Dadurch könnte deren Exposition zu bestimmten S1P-Mengen in der Homöostase im Lymphknoten reguliert werden, die wiederum das Überleben der UTC steuern. Unsere Ergebnisse sind klinisch relevant, da mehrere Medikamente, die die S1P/S1PR-Signalachse oder die Smpdl3b- Konzentration modulieren, derzeit zur Behandlung menschlicher Krankheiten eingesetzt werden, z. B. bei Multipler Sklerose und B-Zell-vermittelten Krankheiten. Wir hoffen, dass unsere Entdeckungen zukünftige Studien anregen werden, die sich auf den Sphingolipid-Stoffwechsel in der Immunzellbiologie konzentrieren. KW - T-Lymphozyt KW - Infektion KW - Lymphknoten KW - Cytokine KW - Sphingolipide KW - CD8+ T cell differentiation KW - Unconventional T cells KW - Sphingolipid biology KW - Immunology Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-359698 ER - TY - THES A1 - Wußmann, Maximiliane T1 - Humane organotypische 3D Modelle des Malignen Melanoms als in vitro Testsystem für die Bewertung der Wirksamkeit von anti-Tumor Therapeutika T1 - Human organotypic 3D models of malignant melanoma as an in vitro test system to evaluate the efficacy of anti-tumor therapeutics N2 - Das maligne Melanom, eine der seltensten, aber gleichzeitig auch die tödlichste dermatologische Malignität, gekennzeichnet durch die Neigung zu einer frühen Metastasierung sowie die rasche Entwicklung von Therapieresistenzen, zählt zu den Tumorentitäten mit dem höchsten Anstieg der Inzidenz weltweit. Mausmodelle werden häufig verwendet, um die Melanomagenese zu erforschen und neue effektive therapeutische Strategien zu entwickeln, spiegeln die menschliche Physiologie allerdings nur unzureichend wider. In zweidimensionalen (2D) Zellkulturen mangelt es dagegen an wichtigen Komponenten der Mikroumgebung des Tumors und dem dreidimensionalen Gewebekontext. Um dieses Manko zu beheben und die Entwicklung von auf den Menschen übertragbaren Tumormodellen in der onkologischen Forschung voranzutreiben, wurde als Alternative zu Zellkulturen und Tierversuchen humane organotypische dreidimensionale (3D) Melanom-Modelle als in vitro Testsystem für die Bewertung der Wirksamkeit von anti-Tumor Therapeutika entwickelt. Im Zuge dieser Arbeit konnte das in vitro Melanom-Modell entscheidend weiterentwickelt werden. So konnten Modelle unterschiedlichster Komplexität etabliert werden, wobei abhängig von der Fragestellung einfachere epidermale bis hin zu unterschiedlich komplexen Vollhautmodellen Anwendung finden. Durch Simulation der Tumor-Mikroumgebung eignen sich diese zur präklinischen Validierung neuer Tumor-Therapeutika, sowie der Erforschung pathologischer Vorgänge, von der Tumor-Formierung bis zur Metastasierung. Zudem konnten erfolgreich unterschiedlichste humane Melanomzelllinien ins Modell integriert werden; dadurch, dass sich diese durch ihre Treibermutationen, die zur Krankheitsentstehung beitragen, unterscheiden, stellen sie unterschiedliche Ansprüche an potentielle therapeutische Angriffspunkte und ermöglichen das Widerspiegeln vieler Melanom-Subtypen im Modell. Ferner ist es möglich, verschiedene Stadien der Tumor-Entwicklung über die Zugabe von Melanomzellen in Einzelsuspension bzw. von Melanom-Sphäroiden widerzuspiegeln. Es konnte für bestimmte Therapie-Ansätze, wie zielgerichtete Therapien, z.B. die Gabe von sich in der Klinik im Einsatz befindlicher BRAF-/MEK-Inhibitoren, gezeigt werden, dass sich die etablierten Modelle hervorragend als präklinische Testsysteme zur Wirksamkeitsbewertung eignen. Zudem bieten sich einzigartige Möglichkeiten, um die Interaktion humaner Tumorzellen und gesunder Zellen in einem Gewebeverband zu untersuchen. Ferner konnten drei neue technische Analyse-Verfahren zur nicht-invasiven Detektion der Tumor- Pro- und Regression, Beurteilung der Wirksamkeit von potenziellen Anti-Tumor-Therapien sowie der Evaluierung des Tumor-Metabolismusses implementiert werden. Perspektivisch ermöglichen immun-kompetente Melanom-Modelle die Austestung neuer Immun- und Zelltherapien in einem voll humanen System; gleichzeitig leisten die etablierten Modelle einen signifikanten Beitrag zur Reduktion von Tierexperimenten. N2 - Malignant melanoma, one of the rarest but also the most lethal dermatological malignancies, characterized by a propensity for early metastasis as well as the rapid development of therapy resistance, is among the tumor entities with the highest increase in incidence worldwide. Mouse models are widely used to study melanomagenesis and develop new effective therapeutic strategies, but do not adequately reflect human physiology. In contrast, twodimensional (2D) cell cultures lack important components of the tumor microenvironment and three-dimensional tissue context. To address this shortcoming and to advance the development of human-transferable tumor models in oncology research, human organotypic three-dimensional (3D) models of malignant melanoma were developed as an alternative to cell cultures and animal experiments as an in vitro test system for evaluating the efficacy of anti-tumor therapeutics. In the course of this work, the in vitro melanoma model could be significantly further developed. Thus, melanoma models of different complexity could be established, with simpler epidermal to differently complex full skin models being applied, depending on the research question. By simulating the tumor microenvironment, these are suitable for the preclinical validation of new tumor therapeutics, as well as the study of pathological processes, from tumor shaping to metastasis. In addition, a wide variety of human melanoma cell lines have been successfully integrated into the model; by differing in their driver mutations that contribute to disease development, they pose different requirements for potential therapeutic targets and allow many melanoma subtypes to be reflected in the model. Furthermore, it is possible to reflect different stages of tumor development via the addition of melanoma cells in single suspension or melanoma spheroids. For certain therapeutic approaches in malignant melanoma, such as targeted therapies, e.g. the administration of BRAF/MEK inhibitors currently in use in the clinic, it could be shown that the established models are excellently suited as preclinical test systems for efficacy evaluation. In addition, unique opportunities are provided to study the interaction of human tumor cells and healthy cells in a tissue composite. Furthermore, three new technical analysis methods for non-invasive detection of tumor progression and regression, assessment of efficacy of potential anti-tumor therapies, and evaluation of tumor metabolism could be implemented. In perspective, immune-competent melanoma models enable the testing of new immune and cell therapies in a fully human system; at the same time, the established models contribute significantly to the reduction of animal experiments. KW - Melanom KW - In vitro KW - anti-Tumor Therapeutika KW - Wirksamkeitsbewertung KW - 3D Modell KW - Dreidimensionales Modell Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-361005 ER - TY - THES A1 - Adhikari, Bikash T1 - Targeted degradation of Myc-interacting oncoproteins T1 - Gezielte Degradation von mit Myc interagierenden Onkoproteinen N2 - The hallmark oncoprotein Myc is a major driver of tumorigenesis in various human cancer entities. However, Myc’s structural features make it challenging to develop small molecules against it. A promising strategy to indirectly inhibit the function of Myc is by targeting its interactors. Many Myc-interacting proteins have reported scaffolding functions which are difficult to target using conventional occupancy- driven inhibitors. Thus, in this thesis, the proteolysis targeting chimera (PROTAC) approach was used to target two oncoproteins interacting with Myc which promote the oncogenicity of Myc, Aurora-A and WDR5. PROTACs are bifunctional small molecules that bind to the target protein with one ligand and recruit a cellular E3- ligase with the other ligand to induce target degradation via the ubiquitin- proteasome system. So far, the most widely used E3-ligases for PROTAC development are Cereblon (CRBN) and von Hippel–Lindau tumor suppressor (VHL). Furthermore, there are cases of incompatibility between some E3-ligases and proteins to bring about degradation. Hence there is a need to explore new E3- ligases and a demand for a tool to predict degradative E3-ligases for the target protein in the PROTAC field. In the first part, a highly specific mitotic kinase Aurora-A degrader, JB170, was developed. This compound utilized Aurora-A inhibitor alisertib as the target ligand and thalidomide as the E3-ligase CRBN harness. The specificity of JB170 and the ternary complex formation was supported by the interactions between Aurora-A and CRBN. The PROTAC-mediated degradation of Aurora-A induced a distinct S- phase defect rather than mitotic arrest, shown by its catalytic inhibition. The finding demonstrates that Aurora-A has a non-catalytic role in the S-phase. Furthermore, the degradation of Aurora-A led to apoptosis in various cancer cell lines. In the second part, two different series of WDR5 PROTACs based on two protein- protein inhibitors of WDR5 were evaluated. The most efficient degraders from both series recruited VHL as a E3-ligase and showed partial degradation of WDR5. In addition, the degradation efficiency of the PROTACs was significantly affected by the linker nature and length, highlighting the importance of linker length and composition in PROTAC design. The degraders showed modest proliferation defects at best in cancer cell lines. However, overexpression of VHL increased the degradation efficiency and the antiproliferative effect of the PROTACs. In the last part, a rapamycin-based assay was developed to predict the degradative E3-ligase for a target. The assay was validated using the WDR5/VHL and Aurora- A/CRBN pairs. The result that WDR5 is degraded by VHL but not CRBN and Aurora-A is degraded by CRBN, matches observations made with PROTACs. This technique will be used in the future to find effective tissue-specific and essential E3-ligases for targeted degradation of oncoproteins using PROTACs. Collectively, the work presented here provides a strategy to improve PROTAC development and a starting point for developing Aurora-A and WDR5 PROTACs for cancer therapy. N2 - Das Onkoprotein Myc ist ein wichtiger Faktor bei der Tumorentstehung in verschiedenen menschlichen Krebsarten. Die strukturellen Merkmale von Myc machen es jedoch schwierig, kleine Moleküle gegen dieses Protein zu entwickeln. Eine vielversprechende Strategie zur indirekten Hemmung der Funktion von Myc besteht darin, auf seine Interaktoren abzuzielen. Viele Proteine, die mit Myc interagieren, haben Gerüstfunktionen, die mit herkömmlichen Inhibitoren nur schwer zu hemmen sind. Daher wurde in dieser Arbeit der PROTAC-Ansatz (Proteolysis Targeting Chimera) verwendet, um zwei Onkoproteine, die mit Myc interagieren und die Onkogenität von Myc fördern, ins Visier zu nehmen: Aurora-A und WDR5. PROTACs sind bifunktionale kleine Moleküle, die mit einem Liganden an das Zielprotein binden und mit dem anderen Liganden eine zelluläre E3-Ligase rekrutieren, um den Abbau des Zielproteins über das Ubiquitin-Proteasom-System einzuleiten. Die bisher am häufigsten verwendeten E3-Ligasen für die Entwicklung von PROTACs sind Cereblon (CRBN) und der von Hippel-Lindau-Tumorsuppressor (VHL). Außerdem gibt es Fälle von Inkompatibilität zwischen einigen E3-Ligasen und Proteinen, die abgebaut werden sollen. Daher besteht die Notwendigkeit, neue E3-Ligasen zu erforschen und Werkzeuge zur Vorhersage abbauender E3-Ligasen für das Zielprotein zu entwickeln. Im ersten Teil wurde ein hochspezifischer Degrader der mitotischen Kinase Aurora-A, JB170, entwickelt. Bei dieser Verbindung wurde der Aurora-A-Inhibitor Alisertib als Zielligand und Thalidomid als Binder für die E3-Ligase CRBN verwendet. Die Spezifität von JB170 und die ternäre Komplexbildung wurden durch die Wechselwirkungen zwischen Aurora-A und CRBN unterstützt. Der durch PROTAC vermittelte Abbau von Aurora-A führte zu einem deutlichen Defekt in der S-Phase und nicht zu einem mitotischen Stillstand, wie es für dessen katalytische Hemmung beobachtet wurde. Dies zeigt, dass Aurora-A eine nicht-katalytische Funktion in der S-Phase hat. Außerdem führte der Abbau von Aurora-A in verschiedenen Krebszelllinien zur Apoptose. Im zweiten Teil wurden zwei verschiedene Serien von WDR5 PROTACs auf der Grundlage von zwei Protein-Protein-Inhibitoren von WDR5 untersucht. Die effizientesten Degrader aus beiden Serien rekrutierten VHL als E3-Ligase und zeigten einen teilweisen Abbau von WDR5. Darüber hinaus wurde die Abbaueffizienz der PROTACs erheblich von der Art und Länge des Linkers beeinflusst, was die Bedeutung der Linkerlänge und -zusammensetzung bei der Entwicklung von PROTACs unterstreicht. Die Abbauprodukte zeigten bestenfalls bescheidene Proliferationsdefekte in Krebszelllinien. Eine Überexpression von VHL erhöhte jedoch die Abbaueffizienz und den antiproliferativen Effekt der PROTACs. Im letzten Teil wurde ein auf Rapamycin basierender Assay entwickelt, um die abbauende E3-Ligase für ein Target vorherzusagen. Der Assay wurde anhand der Paare WDR5/VHL und Aurora-A/CRBN validiert. Das Ergebnis, dass WDR5 von VHL, aber nicht von CRBN abgebaut wird und Aurora-A von CRBN abgebaut wird, stimmt mit den Beobachtungen überein, die mit PROTACs gemacht wurden. Diese Technik wird in Zukunft eingesetzt werden, um wirksame gewebespezifische und essentielle E3-Ligasen für den gezielten Abbau von Onkoproteinen mit Hilfe von PROTACs zu finden. Insgesamt bieten die hier vorgestellten Arbeiten eine Strategie zur Verbesserung der PROTAC-Entwicklung und einen Ausgangspunkt für die Entwicklung von Aurora-A- und WDR5-PROTACs für die Krebstherapie. KW - Degradation KW - PROTACs KW - Oncoprotein KW - Cancer KW - Onkoprotein Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-317326 ER - TY - THES A1 - Bakirci, Ezgi T1 - Development of \(In\) \(vitro\) Models for Tissue Engineering Applications Using a High-Resolution 3D Printing Technology T1 - Entwicklung von \(In\) \(vitro\)-Modellen für Tissue-Engineering-Anwendungen mithilfe einer hochauflösenden 3D-Drucktechnologie N2 - In vitro models mimic the tissue-specific anatomy and play essential roles in personalized medicine and disease treatments. As a sophisticated manufacturing technology, 3D printing overcomes the limitations of traditional technologies and provides an excellent potential for developing in vitro models to mimic native tissue. This thesis aims to investigate the potential of a high-resolution 3D printing technology, melt electrowriting (MEW), for fabricating in vitro models. MEW has a distinct capacity for depositing micron size fibers with a defined design. In this thesis, three approaches were used, including 1) extending the MEW polymer library for different biomedical applications, 2) developing in vitro models for evaluation of cell growth and migration toward the different matrices, and 3) studying the effect of scaffold designs and biochemical cues of microenvironments on cells. First, we introduce the MEW processability of (AB)n and (ABAC)n segmented copolymers, which have thermally reversible network formulation based on physical crosslinks. Bisurea segments are combined with hydrophobic poly(dimethylsiloxane) (PDMS) or hydrophilic poly(propylene oxide)-poly(ethylene oxide)-poly(propylene oxide) (PPO-PEG-PPO) segments to form the (AB)n segmented copolymers. (ABAC)n segmented copolymers contain all three segments: in addition to bisurea, both hydrophobic and hydrophilic segments are available in the same polymer chain, resulting in tunable mechanical and biological behaviors. MEW copolymers either support cells attachment or dissolve without cytotoxic side effects when in contact with the polymers at lower concentrations, indicating that this copolymer class has potential in biological applications. The unique biological and surface properties, transparency, adjustable hydrophilicity of these copolymers could be beneficial in several in vitro models. The second manuscript addresses the design and development of a melt electrowritten competitive 3D radial migration device. The approach differs from most of the previous literature, as MEW is not used here to produce cell invasive scaffolds but to fabricate an in vitro device. The device is utilized to systematically determine the matrix which promotes cell migration and growth of glioblastoma cells. The glioblastoma cell migration is tested on four different Matrigel concentrations using a melt electrowritten radial device. The glioblastoma U87 cell growth and migration increase at Matrigel concentrations 6 and 8 mg mL-1 In the development of this radial device, the accuracy, and precision of melt electrowritten circular shapes were investigated. The results show that the printing speed and design diameter are essential parameters for the accuracy of printed constructs. It is the first instance where MEW is used for the production of in vitro devices. The influence of biochemical cues and scaffold designs on astrocytes and glioblastoma is investigated in the last manuscript. A fiber comprising the box and triangle-shaped pores within MEW scaffolds are modified with biochemical cues, including RGD and IKVAV peptides using a reactive NCO-sP(EO-stat-PO) macromer. The results show that astrocytes and glioblastoma cells exhibit different phenotypes on scaffold designs and peptide-coated scaffolds. N2 - In-vitro-Modelle sind Werkzeuge, die die gewebespezifische Anatomie nachbilden und eine wesentliche Rolle in der personalisierten Medizin und bei der Behandlung von Krankheiten spielen. Als hochentwickelte, multifunktionale Fertigungstechnologie überwindet der 3D-Druck die Grenzen herkömmlicher Technologien und bietet ein hervorragendes Potenzial für die Herstellung von In-vitro-Modellen. Der 3D-Druck ist eine der vielversprechendsten Techniken, um biologische Materialien in einer komplexen Anordnung zusammenzusetzen, die das natürliche Gewebe nachahmt. In dieser Arbeit soll das Potenzial der hochauflösenden 3D-Drucktechnologie melt electrowriting (MEW), für die Herstellung von In-vitro-Modellen untersucht werden. Wir konzentrieren uns auf drei Ansätze: 1) die Erweiterung der MEW-Polymerbibliothek für verschiedene biomedizinische Anwendungen, 2) die Entwicklung von In-vitro-Modellen zur Bewertung des Zellwachstums und der Zellmigration in Richtung der verschiedenen Matrizes und 3) die Untersuchung der Auswirkungen von MEW-Gerüstdesigns und biochemischen Faktoren der Mikroumgebung auf Zellen. Zunächst haben wir die MEW-Verarbeitbarkeit von segmentierten (AB)n- und (ABAC)n-Copolymeren vorgestellt, die eine thermisch reversible Netzwerkformulierung auf der Grundlage physikalischer Vernetzungen aufweisen. Bisurea-Segmente werden mit hydrophoben hydrophobic poly(dimethyl siloxane) (PDMS) oder hydrophilen poly(propylene oxide)-poly(ethylene oxide)-poly(propylene oxide) (PPO-PEG-PPO) Segmenten kombiniert, um die (AB)n segmentierten Copolymere zu bilden. Segmentierte (ABAC)n-Copolymere enthalten alle drei Segmente: Zusätzlich zu den Bisurea-Segmenten sind sowohl hydrophobe als auch hydrophile Segmente in derselben Polymerkette vorhanden, was den segmentierten (ABAC)n-Copolymeren abstimmbare mechanische und biologische Eigenschaften verleiht. MEW-Copolymere unterstützten entweder die Anhaftung an Zellen oder lösten sich ohne zytotoxische Nebenwirkungen auf, wenn sie in niedrigeren Konzentrationen mit ihnen in Berührung kamen, was darauf hindeutet, dass diese Copolymerklasse über umfassende biologische Eigenschaften verfügt. Die einzigartigen biologischen Eigenschaften und Oberflächeneigenschaften, die Transparenz und die einstellbare Hydrophilie dieser Copolymere könnten in verschiedenen In-vitro-Modellen von Vorteil sein. Das zweite Manuskript befasst sich mit einem durch MEW hergestellten wettbewerbsfähigen 3D-Radialmigrationsdesign. Der Ansatz unterscheidet sich vom Großteil der MEW-Literatur, da MEW nicht zur Herstellung von invasiven Zellgerüsten verwendet wurde, sondern zur Herstellung eines In-vitro-Designs diente. Das Design wurde verwendet, um systematisch die Matrix zu bestimmen, die die Zellmigration und das Wachstum von Glioblastomzellen fördert. Die Migration der Glioblastomzellen wurde auf vier verschiedenen Matrigel-Konzentrationen unter Verwendung einer durch MEW hergestellten Radialvorrichtung getestet. Das Wachstum und die Migration der Glioblastomzellen U87 nahmen bei Matrigelkonzentrationen von 6 und 8 mg mL-1 zu. Wir untersuchten auch die Genauigkeit und Präzision der durch MEW erzeugten Kreisformen. Die Ergebnisse zeigten, dass die Druckgeschwindigkeit und der Designdurchmesser wesentliche Parameter für die Genauigkeit der gedruckten Konstrukte sind. Die Arbeit ist die erste Studie, die MEW für die Herstellung von In-vitro-Modellen verwendet. Im letzten Manuskript wurde der Einfluss von biochemische Funktionalisierung in Kombination mit Gerüstdesigns auf Astrozyten und Glioblastome untersucht. Die kastenförmigen und achteckigen MEW-Gerüste wurden mit biochemischen Wirkstoffen modifiziert, darunter RGD- und IKVAV-Peptide unter Verwendung von reaktivem NCO-sP(EO-stat-PO). Wir fanden heraus, dass Astrozyten und Glioblastomzellen unterschiedliche Phänotypen auf den verschiedenen Designs und mit Peptiden beschichteten Gerüsten aufweisen. KW - Melt electrowriting KW - 3D-Druck KW - 3D printing KW - In vitro model Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-251645 ER - TY - JOUR A1 - Snaebjornsson, Marteinn T A1 - Schulze, Almut T1 - Non-canonical functions of enzymes facilitate cross-talk between cell metabolic and regulatory pathways JF - Experimental & Molecular Medicine N2 - The metabolic rewiring that occurs during cell transformation is a hallmark of cancer. It is diverse in different cancers as it reflects different combinations of oncogenic drivers, tumor suppressors, and the microenvironment. Metabolic rewiring is essential to cancer as it enables uncontrolled proliferation and adaptation to the fluctuating availability of nutrients and oxygen caused by poor access to the vasculature due to tumor growth and a foreign microenvironment encountered during metastasis. Increasing evidence now indicates that the metabolic state in cancer cells also plays a causal role in tumor growth and metastasis, for example through the action of oncometabolites, which modulate cell signaling and epigenetic pathways to promote malignancy. In addition to altering the metabolic state in cancer cells, some multifunctional enzymes possess non-metabolic functions that also contribute to cell transformation. Some multifunctional enzymes that are highly expressed in cancer, such as pyruvate kinase M2 (PKM2), have non-canonical functions that are co-opted by oncogenic signaling to drive proliferation and inhibit apoptosis. Other multifunctional enzymes that are frequently downregulated in cancer, such as fructose-bisphosphatase 1 (FBP1), are tumor suppressors, directly opposing mitogenic signaling via their non-canonical functions. In some cases, the enzymatic and non-canonical roles of these enzymes are functionally linked, making the modulation of non-metabolic cellular processes dependent on the metabolic state of the cell. KW - cancer metabolism Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-238763 VL - 50 ER - TY - JOUR A1 - Sirtl, Simon A1 - Knoll, Gertrud A1 - Dieu Thuy, Trinh A1 - Lang, Isabell A1 - Siegmund, Daniela A1 - Gross, Stefanie A1 - Schuler-Thurner, Beatrice A1 - Neubert, Patrick A1 - Jantsch, Jonathan A1 - Wajant, Harald A1 - Ehrenschwender, Martin T1 - Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors JF - Oncogene N2 - Attempts to exploit the cytotoxic activity of death receptors (DR) for treating cancer have thus far been disappointing. DR activation in most malignant cells fails to trigger cell death and may even promote tumor growth by activating cell death-independent DR-associated signaling pathways. Overcoming apoptosis resistance is consequently a prerequisite for successful clinical exploitation of DR stimulation. Here we show that hyperosmotic stress in the tumor microenvironment unleashes the deadly potential of DRs by enforcing BCL-2 addiction of cancer cells. Hypertonicity robustly enhanced cytotoxicity of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and other DR ligands in various cancer entities. Initial events in TRAIL DR signaling remained unaffected, but hypertonic conditions unlocked activation of the mitochondrial death pathway and thus amplified the apoptotic signal. Mechanistically, we demonstrate that hyperosmotic stress imposed a BCL-2-addiction on cancer cells to safeguard the integrity of the outer mitochondrial membrane (OMM), essentially exhausting the protective capacity of BCL-2-like pro-survival proteins. Deprivation of these mitochondrial safeguards licensed DR-generated truncated BH3-interacting domain death agonist (tBID) to activate BCL-2-associated X protein (BAX) and initiated mitochondrial outer membrane permeabilization (MOMP). Our work highlights that hyperosmotic stress in the tumor environment primes mitochondria for death and lowers the threshold for DR-induced apoptosis. Beyond TRAIL-based therapies, our findings could help to strengthen the efficacy of other apoptosis-inducing cancer treatment regimens. KW - apoptosis KW - cancer microenvironment KW - cytokines Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-238327 VL - 37 ER - TY - JOUR A1 - Stegmann, Yannik A1 - Reicherts, Philipp A1 - Andreatta, Marta A1 - Pauli, Paul A1 - Wieser, Matthias J. T1 - The effect of trait anxiety on attentional mechanisms in combined context and cue conditioning and extinction learning JF - Scientific Reports N2 - Sensory processing and attention allocation are shaped by threat, but the role of trait-anxiety in sensory processing as a function of threat predictability remains incompletely understood. Therefore, we measured steady-state visual evoked potentials (ssVEPs) as an index of sensory processing of predictable and unpredictable threat cues in 29 low (LA) and 29 high (HA) trait-anxious participants during a modified NPU-paradigm followed by an extinction phase. Three different contextual cues indicated safety (N), predictable (P) or unpredictable threat (U), while foreground cues signalled shocks in the P-condition only. All participants allocated increased attentional resources to the central P-threat cue, replicating previous findings. Importantly, LA individuals exhibited larger ssVEP amplitudes to contextual threat (U and P) than to contextual safety cues, while HA individuals did not differentiate among contextual cues in general. Further, HA exhibited higher aversive ratings of all contexts compared to LA. These results suggest that high trait-anxious individuals might be worse at discriminating contextual threat stimuli and accordingly overestimate the probability and aversiveness of unpredictable threat. These findings support the notion of aberrant sensory processing of unpredictable threat in anxiety disorders, as this processing pattern is already evident in individuals at risk of these disorders. KW - attention KW - fear conditioning Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-239394 VL - 9 ER - TY - JOUR A1 - Solimando, A G A1 - Brandl, A A1 - Mattenheimer, K A1 - Graf, C A1 - Ritz, M A1 - Ruckdeschel, A A1 - Stühmer, T A1 - Mokhtari, Z A1 - Rudelius, M A1 - Dotterweich, J A1 - Bittrich, M A1 - Desantis, V A1 - Ebert, R A1 - Trerotoli, P A1 - Frassanito, M A A1 - Rosenwald, A A1 - Vacca, A A1 - Einsele, H A1 - Jakob, F A1 - Beilhack, A T1 - JAM-A as a prognostic factor and new therapeutic target in multiple myeloma JF - Leukemia N2 - Cell adhesion in the multiple myeloma (MM) microenvironment has been recognized as a major mechanism of MM cell survival and the development of drug resistance. Here we addressed the hypothesis that the protein junctional adhesion molecule-A (JAM-A) may represent a novel target and a clinical biomarker in MM. We evaluated JAM-A expression in MM cell lines and in 147 MM patient bone marrow aspirates and biopsies at different disease stages. Elevated JAM-A levels in patient-derived plasma cells were correlated with poor prognosis. Moreover, circulating soluble JAM-A (sJAM-A) levels were significantly increased in MM patients as compared with controls. Notably, in vitro JAM-A inhibition impaired MM migration, colony formation, chemotaxis, proliferation and viability. In vivo treatment with an anti-JAM-A monoclonal antibody (αJAM-A moAb) impaired tumor progression in a murine xenograft MM model. These results demonstrate that therapeutic targeting of JAM-A has the potential to prevent MM progression, and lead us to propose JAM-A as a biomarker in MM, and sJAM-A as a serum-based marker for clinical stratification. KW - haematological cancer KW - myeloma Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-239069 VL - 32 ER - TY - JOUR A1 - Siegmund, Daniela A1 - Ehrenschwender, Martin A1 - Wajant, Harald T1 - TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling JF - Cell Death & Disease N2 - TNF is not only a major effector molecule of PAMP/DAMP-activated macrophages, but also regulates macrophage function and viability. We recently demonstrated that TNFR2 triggers necroptosis in macrophages with compromised caspase activity by two cooperating mechanisms: induction of endogenous TNF with subsequent stimulation of TNFR1 and depletion of cytosolic TRAF2-cIAP complexes. Here we show that TNFR2 activation in caspase-inhibited macrophages results in the production of endogenous TNF and TNFR1 stimulation followed by upregulation of A20, TRAF1, IL-6, and IL-1β. Surprisingly, TNFR1-mediated induction of IL-6 and IL-1β was clearly evident in response to TNFR2 stimulation but occurred not or only weakly in macrophages selectively and directly stimulated via TNFR1. Moreover, TNFR2-induced TNFR1-mediated gene induction was largely inhibited by necrostatin-1, whereas upregulation of A20 and TRAF1 by direct and exclusive stimulation of TNFR1 remained unaffected by this compound. Thus, treatment with TNFR2/ZVAD enables TNFR1 in macrophages to stimulate gene induction via a pathway requiring RIPK1 kinase activity. TNFR2/ZVAD-induced production of IL-6 and IL-1β was largely blocked in necroptosis-resistant MLKL- and RIPK3-deficient macrophages, whereas induction of A20 and TRAF1 remained unaffected. In sum, our results show that in caspase-inhibited macrophages TNFR2 not only triggers TNF/TNFR1-mediated necroptosis but also TNF/TNFR1-mediated RIPK3/MLKL-dependent and -independent gene induction. Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-238034 VL - 9 ER - TY - JOUR A1 - Vaeth, Martin A1 - Wang, Yin-Hu A1 - Eckstein, Miriam A1 - Yang, Jun A1 - Silverman, Gregg J. A1 - Lacruz, Rodrigo S. A1 - Kannan, Kasthuri A1 - Feske, Stefan T1 - Tissue resident and follicular Treg cell differentiation is regulated by CRAC channels JF - Nature Communications N2 - T regulatory (Treg) cells maintain immunological tolerance and organ homeostasis. Activated Treg cells differentiate into effector Treg subsets that acquire tissue-specific functions. Ca2+ influx via Ca2+ release-activated Ca2+ (CRAC) channels formed by STIM and ORAI proteins is required for the thymic development of Treg cells, but its function in mature Treg cells remains unclear. Here we show that deletion of Stim1 and Stim2 genes in mature Treg cells abolishes Ca2+ signaling and prevents their differentiation into follicular Treg and tissue-resident Treg cells. Transcriptional profiling of STIM1/STIM2-deficient Treg cells reveals that Ca2+ signaling regulates transcription factors and signaling pathways that control the identity and effector differentiation of Treg cells. In the absence of STIM1/STIM2 in Treg cells, mice develop a broad spectrum of autoantibodies and fatal multiorgan inflammation. Our findings establish a critical role of CRAC channels in controlling lineage identity and effector functions of Treg cells. KW - gene regulation in immune cells KW - lymphocytes KW - regulatory T cells KW - signal transduction Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-232148 VL - 10 ER - TY - JOUR A1 - Sulzer, David A1 - Cassidy, Clifford A1 - Horga, Guillermo A1 - Kang, Un Jung A1 - Fahn, Stanley A1 - Casella, Luigi A1 - Pezzoli, Gianni A1 - Langley, Jason A1 - Hu, Xiaoping P. A1 - Zucca, Fabio A. A1 - Isaias, Ioannis U. A1 - Zecca, Luigi T1 - Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease JF - npj Parkinson's Disease N2 - The diagnosis of Parkinson’s disease (PD) occurs after pathogenesis is advanced and many substantia nigra (SN) dopamine neurons have already died. Now that therapies to block this neuronal loss are under development, it is imperative that the disease be diagnosed at earlier stages and that the response to therapies is monitored. Recent studies suggest this can be accomplished by magnetic resonance imaging (MRI) detection of neuromelanin (NM), the characteristic pigment of SN dopaminergic, and locus coeruleus (LC) noradrenergic neurons. NM is an autophagic product synthesized via oxidation of catecholamines and subsequent reactions, and in the SN and LC it increases linearly during normal aging. In PD, however, the pigment is lost when SN and LC neurons die. As shown nearly 25 years ago by Zecca and colleagues, NM’s avid binding of iron provides a paramagnetic source to enable electron and nuclear magnetic resonance detection, and thus a means for safe and noninvasive measure in living human brain. Recent technical improvements now provide a means for MRI to differentiate between PD patients and age-matched healthy controls, and should be able to identify changes in SN NM with age in individuals. We discuss how MRI detects NM and how this approach might be improved. We suggest that MRI of NM can be used to confirm PD diagnosis and monitor disease progression. We recommend that for subjects at risk for PD, and perhaps generally for older people, that MRI sequences performed at regular intervals can provide a pre-clinical means to detect presymptomatic PD. Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-240207 VL - 4 ER - TY - JOUR A1 - Ullrich, M A1 - Weber, M A1 - Post, A M A1 - Popp, S A1 - Grein, J A1 - Zechner, M A1 - González, H Guerrero A1 - Kreis, A A1 - Schmitt, A G A1 - Üҫeyler, N A1 - Lesch, K-P A1 - Schuh, K T1 - OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency JF - Molecular Psychiatry N2 - Obsessive-compulsive disorder (OCD) is a common neuropsychiatric disease affecting about 2% of the general population. It is characterized by persistent intrusive thoughts and repetitive ritualized behaviors. While gene variations, malfunction of cortico-striato-thalamo-cortical (CSTC) circuits, and dysregulated synaptic transmission have been implicated in the pathogenesis of OCD, the underlying mechanisms remain largely unknown. Here we show that OCD-like behavior in mice is caused by deficiency of SPRED2, a protein expressed in various brain regions and a potent inhibitor of Ras/ERK-MAPK signaling. Excessive self-grooming, reflecting OCD-like behavior in rodents, resulted in facial skin lesions in SPRED2 knockout (KO) mice. This was alleviated by treatment with the selective serotonin reuptake inhibitor fluoxetine. In addition to the previously suggested involvement of cortico-striatal circuits, electrophysiological measurements revealed altered transmission at thalamo-amygdala synapses and morphological differences in lateral amygdala neurons of SPRED2 KO mice. Changes in synaptic function were accompanied by dysregulated expression of various pre- and postsynaptic proteins in the amygdala. This was a result of altered gene transcription and triggered upstream by upregulated tropomyosin receptor kinase B (TrkB)/ERK-MAPK signaling in the amygdala of SPRED2 KO mice. Pathway overactivation was mediated by increased activity of TrkB, Ras, and ERK as a specific result of SPRED2 deficiency and not elicited by elevated brain-derived neurotrophic factor levels. Using the MEK inhibitor selumetinib, we suppressed TrkB/ERK-MAPK pathway activity in vivo and reduced OCD-like grooming in SPRED2 KO mice. Altogether, this study identifies SPRED2 as a promising new regulator, TrkB/ERK-MAPK signaling as a novel mediating mechanism, and thalamo-amygdala synapses as critical circuitry involved in the pathogenesis of OCD. KW - molecular biology KW - neuroscience KW - physiology KW - psychiatric disorders Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-232096 VL - 23 ER - TY - JOUR A1 - Trautz, Florian A1 - Franke, Heike A1 - Bohnert, Simone A1 - Hammer, Niels A1 - Müller, Wolf A1 - Stassart, Ruth A1 - Tse, Rexson A1 - Zwirner, Johann A1 - Dreßler, Jan A1 - Ondruschka, Benjamin T1 - Survival-time dependent increase in neuronal IL-6 and astroglial GFAP expression in fatally injured human brain tissue JF - Scientific Reports N2 - Knowledge on trauma survival time prior to death following a lethal traumatic brain injury (TBI) may be essential for legal purposes. Immunohistochemistry studies might allow to narrow down this survival interval. The biomarkers interleukin-6 (IL-6) and glial fibrillary acidic protein (GFAP) are well known in the clinical setting for their usability in TBI prediction. Here, both proteins were chosen in forensics to determine whether neuronal or glial expression in various brain regions may be associated with the cause of death and the survival time prior to death following TBI. IL-6 positive neurons, glial cells and GFAP positive astrocytes all concordantly increase with longer trauma survival time, with statistically significant changes being evident from three days post-TBI (p < 0.05) in the pericontusional zone, irrespective of its definite cortical localization. IL-6 staining in neurons increases significantly in the cerebellum after trauma, whereas increasing GFAP positivity is also detected in the cortex contralateral to the focal lesion. These systematic chronological changes in biomarkers of pericontusional neurons and glial cells allow for an estimation of trauma survival time. Higher numbers of IL-6 and GFAP-stained cells above threshold values in the pericontusional zone substantiate the existence of fatal traumatic changes in the brain with reasonable certainty. KW - cell death in the nervous system KW - diagnostic markers KW - outcomes research Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-229037 VL - 9 ER - TY - JOUR A1 - Tylek, Tina A1 - Schilling, Tatjana A1 - Schlegelmilch, Katrin A1 - Ries, Maximilian A1 - Rudert, Maximilian A1 - Jakob, Franz A1 - Groll, Jürgen T1 - Platelet lysate outperforms FCS and human serum for co-culture of primary human macrophages and hMSCs JF - Scientific Reports N2 - In vitro co-cultures of different primary human cell types are pivotal for the testing and evaluation of biomaterials under conditions that are closer to the human in vivo situation. Especially co-cultures of macrophages and mesenchymal stem cells (MSCs) are of interest, as they are both present and involved in tissue regeneration and inflammatory reactions and play crucial roles in the immediate inflammatory reactions and the onset of regenerative processes, thus reflecting the decisive early phase of biomaterial contact with the host. A co-culture system of these cell types might thus allow for the assessment of the biocompatibility of biomaterials. The establishment of such a co-culture is challenging due to the different in vitro cell culture conditions. For human macrophages, medium is usually supplemented with human serum (hS), whereas hMSC culture is mostly performed using fetal calf serum (FCS), and these conditions are disadvantageous for the respective other cell type. We demonstrate that human platelet lysate (hPL) can replace hS in macrophage cultivation and appears to be the best option for co-cultivation of human macrophages with hMSCs. In contrast to FCS and hS, hPL maintained the phenotype of both cell types, comparable to that of their respective standard culture serum, as well as the percentage of each cell population. Moreover, the expression profile and phagocytosis activity of macrophages was similar to hS. KW - biomaterials – cells KW - tissue engineering Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-229174 VL - 9 ER - TY - JOUR A1 - Straub, Tobias A1 - Freudenberg, Marina A. A1 - Schleicher, Ulrike A1 - Bogdan, Christian A1 - Gasteiger, Georg A1 - Pircher, Hanspeter T1 - Bacterial coinfection restrains antiviral CD8 T-cell response via LPS-induced inhibitory NK cells JF - Nature Communications N2 - Infection of specific pathogen-free mice with lymphocytic choriomeningitis virus (LCMV) is a widely used model to study antiviral T-cell immunity. Infections in the real world, however, are often accompanied by coinfections with unrelated pathogens. Here we show that in mice, systemic coinfection with E. coli suppresses the LCMV-specific cytotoxic T-lymphocyte (CTL) response and virus elimination in a NK cell- and TLR2/4-dependent manner. Soluble TLR4 ligand LPS also induces NK cell-mediated negative CTL regulation during LCMV infection. NK cells in LPS-treated mice suppress clonal expansion of LCMV-specific CTLs by a NKG2D- or NCR1-independent but perforin-dependent mechanism. These results suggest a TLR4-mediated immunoregulatory role of NK cells during viral-bacterial coinfections. KW - Bacterial infection KW - infection KW - lymphocyte activation KW - viral infection Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-240075 VL - 9 ER - TY - JOUR A1 - Went, Molly A1 - Sud, Amit A1 - Speedy, Helen A1 - Sunter, Nicola J. A1 - Försti, Asta A1 - Law, Philip J. A1 - Johnson, David C. A1 - Mirabella, Fabio A1 - Holroyd, Amy A1 - Li, Ni A1 - Orlando, Giulia A1 - Weinhold, Niels A1 - van Duin, Mark A1 - Chen, Bowang A1 - Mitchell, Jonathan S. A1 - Mansouri, Larry A1 - Juliusson, Gunnar A1 - Smedby, Karin E A1 - Jayne, Sandrine A1 - Majid, Aneela A1 - Dearden, Claire A1 - Allsup, David J. A1 - Bailey, James R. A1 - Pratt, Guy A1 - Pepper, Chris A1 - Fegan, Chris A1 - Rosenquist, Richard A1 - Kuiper, Rowan A1 - Stephens, Owen W. A1 - Bertsch, Uta A1 - Broderick, Peter A1 - Einsele, Hermann A1 - Gregory, Walter M. A1 - Hillengass, Jens A1 - Hoffmann, Per A1 - Jackson, Graham H. A1 - Jöckel, Karl-Heinz A1 - Nickel, Jolanta A1 - Nöthen, Markus M. A1 - da Silva Filho, Miguel Inacio A1 - Thomsen, Hauke A1 - Walker, Brian A. A1 - Broyl, Annemiek A1 - Davies, Faith E. A1 - Hansson, Markus A1 - Goldschmidt, Hartmut A1 - Dyer, Martin J. S. A1 - Kaiser, Martin A1 - Sonneveld, Pieter A1 - Morgan, Gareth J. A1 - Hemminki, Kari A1 - Nilsson, Björn A1 - Catovsky, Daniel A1 - Allan, James M. A1 - Houlston, Richard S. T1 - Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology JF - Blood Cancer Journal N2 - The clustering of different types of B-cell malignancies in families raises the possibility of shared aetiology. To examine this, we performed cross-trait linkage disequilibrium (LD)-score regression of multiple myeloma (MM) and chronic lymphocytic leukaemia (CLL) genome-wide association study (GWAS) data sets, totalling 11,734 cases and 29,468 controls. A significant genetic correlation between these two B-cell malignancies was shown (Rg = 0.4, P = 0.0046). Furthermore, four of the 45 known CLL risk loci were shown to associate with MM risk and five of the 23 known MM risk loci associate with CLL risk. By integrating eQTL, Hi-C and ChIP-seq data, we show that these pleiotropic risk loci are enriched for B-cell regulatory elements and implicate B-cell developmental genes. These data identify shared biological pathways influencing the development of CLL and, MM and further our understanding of the aetiological basis of these B-cell malignancies. KW - cancer genetics KW - myeloma Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-233627 VL - 9 ER - TY - JOUR A1 - Wen, Lai A1 - Feil, Susanne A1 - Wolters, Markus A1 - Thunemann, Martin A1 - Regler, Frank A1 - Schmidt, Kjestine A1 - Friebe, Andreas A1 - Olbrich, Marcus A1 - Langer, Harald A1 - Gawaz, Meinrad A1 - de Wit, Cor A1 - Feil, Robert T1 - A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis JF - Nature Communications N2 - Mechanisms that limit thrombosis are poorly defined. One of the few known endogenous platelet inhibitors is nitric oxide (NO). NO activates NO sensitive guanylyl cyclase (NO-GC) in platelets, resulting in an increase of cyclic guanosine monophosphate (cGMP). Here we show, using cGMP sensor mice to study spatiotemporal dynamics of platelet cGMP, that NO-induced cGMP production in pre-activated platelets is strongly shear-dependent. We delineate a new mode of platelet-inhibitory mechanotransduction via shear-activated NO-GC followed by cGMP synthesis, activation of cGMP-dependent protein kinase I (cGKI), and suppression of Ca2+ signaling. Correlative profiling of cGMP dynamics and thrombus formation in vivo indicates that high cGMP concentrations in shear-exposed platelets at the thrombus periphery limit thrombosis, primarily through facilitation of thrombus dissolution. We propose that an increase in shear stress during thrombus growth activates the NO-cGMP-cGKI pathway, which acts as an auto-regulatory brake to prevent vessel occlusion, while preserving wound closure under low shear. KW - calcium signalling KW - fluorescence imaging KW - platelets KW - thrombosis Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-233616 VL - 9 ER - TY - JOUR A1 - Welz, M. A1 - Eickhoff, S. A1 - Abdullah, Z. A1 - Trebicka, J. A1 - Gartlan, K. H. A1 - Spicer, J. A. A1 - Demetris, A. J. A1 - Akhlaghi, H. A1 - Anton, M. A1 - Manske, K. A1 - Zehn, D. A1 - Nieswandt, B. A1 - Kurts, C. A1 - Trapani, J. A. A1 - Knolle, P. A1 - Wohlleber, D. A1 - Kastenmüller, W. T1 - Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis JF - Nature Communications N2 - CD8 T cells protect the liver against viral infection, but can also cause severe liver damage that may even lead to organ failure. Given the lack of mechanistic insights and specific treatment options in patients with acute fulminant hepatitis, we develop a mouse model reflecting a severe acute virus-induced CD8 T cell-mediated hepatitis. Here we show that antigen-specific CD8 T cells induce liver damage in a perforin-dependent manner, yet liver failure is not caused by effector responses targeting virus-infected hepatocytes alone. Additionally, CD8 T cell mediated elimination of cross-presenting liver sinusoidal endothelial cells causes endothelial damage that leads to a dramatically impaired sinusoidal perfusion and indirectly to hepatocyte death. With the identification of perforin-mediated killing as a critical pathophysiologic mechanism of liver failure and the protective function of a new class of perforin inhibitor, our study opens new potential therapeutic angles for fulminant viral hepatitis. KW - cytotoxic T cells KW - hepatology KW - imaging the immune system KW - viral infection Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-233593 VL - 9 ER - TY - JOUR A1 - Walker, Brian A. A1 - Mavrommatis, Konstantinos A1 - Wardell, Christopher P. A1 - Ashby, T. Cody A1 - Bauer, Michael A1 - Davies, Faith A1 - Rosenthal, Adam A1 - Wang, Hongwei A1 - Qu, Pingping A1 - Hoering, Antje A1 - Samur, Mehmet A1 - Towfic, Fadi A1 - Ortiz, Maria A1 - Flynt, Erin A1 - Yu, Zhinuan A1 - Yang, Zhihong A1 - Rozelle, Dan A1 - Obenauer, John A1 - Trotter, Matthew A1 - Auclair, Daniel A1 - Keats, Jonathan A1 - Bolli, Niccolo A1 - Fulciniti, Mariateresa A1 - Szalat, Raphael A1 - Moreau, Phillipe A1 - Durie, Brian A1 - Stewart, A. Keith A1 - Goldschmidt, Hartmut A1 - Raab, Marc S. A1 - Einsele, Hermann A1 - Sonneveld, Pieter A1 - San Miguel, Jesus A1 - Lonial, Sagar A1 - Jackson, Graham H. A1 - Anderson, Kenneth C. A1 - Avet-Loiseau, Herve A1 - Munshi, Nikhil A1 - Thakurta, Anjan A1 - Morgan, Gareth T1 - A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis JF - Leukemia N2 - Patients with newly diagnosed multiple myeloma (NDMM) with high-risk disease are in need of new treatment strategies to improve the outcomes. Multiple clinical, cytogenetic, or gene expression features have been used to identify high-risk patients, each of which has significant weaknesses. Inclusion of molecular features into risk stratification could resolve the current challenges. In a genome-wide analysis of the largest set of molecular and clinical data established to date from NDMM, as part of the Myeloma Genome Project, we have defined DNA drivers of aggressive clinical behavior. Whole-genome and exome data from 1273 NDMM patients identified genetic factors that contribute significantly to progression free survival (PFS) and overall survival (OS) (cumulative R2 = 18.4% and 25.2%, respectively). Integrating DNA drivers and clinical data into a Cox model using 784 patients with ISS, age, PFS, OS, and genomic data, the model has a cumlative R2 of 34.3% for PFS and 46.5% for OS. A high-risk subgroup was defined by recursive partitioning using either a) bi-allelic TP53 inactivation or b) amplification (≥4 copies) of CKS1B (1q21) on the background of International Staging System III, comprising 6.1% of the population (median PFS = 15.4 months; OS = 20.7 months) that was validated in an independent dataset. Double-Hit patients have a dire prognosis despite modern therapies and should be considered for novel therapeutic approaches. KW - cancer genomics KW - risk factors Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-233299 VL - 33 ER - TY - JOUR A1 - Wegert, Jenny A1 - Vokuhl, Christian A1 - Collord, Grace A1 - Del Castillo Velasco-Herrera, Martin A1 - Farndon, Sarah J. A1 - Guzzo, Charlotte A1 - Jorgensen, Mette A1 - Anderson, John A1 - Slater, Olga A1 - Duncan, Catriona A1 - Bausenwein, Sabrina A1 - Streitenberger, Heike A1 - Ziegler, Barbara A1 - Furtwängler, Rhoikos A1 - Graf, Norbert A1 - Stratton, Michael R. A1 - Campbell, Peter J. A1 - Jones, David TW A1 - Koelsche, Christian A1 - Pfister, Stefan M. A1 - Mifsud, William A1 - Sebire, Neil A1 - Sparber-Sauer, Monika A1 - Koscielniak, Ewa A1 - Rosenwald, Andreas A1 - Gessler, Manfred A1 - Behjati, Sam T1 - Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants JF - Nature Communications N2 - Soft tissue tumors of infancy encompass an overlapping spectrum of diseases that pose unique diagnostic and clinical challenges. We studied genomes and transcriptomes of cryptogenic congenital mesoblastic nephroma (CMN), and extended our findings to five anatomically or histologically related soft tissue tumors: infantile fibrosarcoma (IFS), nephroblastomatosis, Wilms tumor, malignant rhabdoid tumor, and clear cell sarcoma of the kidney. A key finding is recurrent mutation of EGFR in CMN by internal tandem duplication of the kinase domain, thus delineating CMN from other childhood renal tumors. Furthermore, we identify BRAF intragenic rearrangements in CMN and IFS. Collectively these findings reveal novel diagnostic markers and therapeutic strategies and highlight a prominent role of isolated intragenic rearrangements as drivers of infant tumors. KW - cancer KW - genetics Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-233446 VL - 9 ER - TY - JOUR A1 - Anany, Mohamed A. A1 - Kreckel, Jennifer A1 - Füllsack, Simone A1 - Rosenthal, Alevtina A1 - Otto, Christoph A1 - Siegmund, Daniela A1 - Wajant, Harald T1 - Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly(I:C)-induced RIPK1-mediated necroptosis JF - Cell Death & Disease N2 - TNF-like weak inducer of apoptosis (TWEAK) and inhibition of protein synthesis with cycloheximide (CHX) sensitize for poly(I:C)-induced cell death. Notably, although CHX preferentially enhanced poly(I:C)-induced apoptosis, TWEAK enhanced primarily poly(I:C)-induced necroptosis. Both sensitizers of poly(I:C)-induced cell death, however, showed no major effect on proinflammatory poly(I:C) signaling. Analysis of a panel of HeLa-RIPK3 variants lacking TRADD, RIPK1, FADD, or caspase-8 expression revealed furthermore similarities and differences in the way how poly(I:C)/TWEAK, TNF, and TRAIL utilize these molecules for signaling. RIPK1 turned out to be essential for poly(I:C)/TWEAK-induced caspase-8-mediated apoptosis but was dispensable for this response in TNF and TRAIL signaling. TRADD-RIPK1-double deficiency differentially affected poly(I:C)-triggered gene induction but abrogated gene induction by TNF completely. FADD deficiency abrogated TRAIL- but not TNF- and poly(I:C)-induced necroptosis, whereas TRADD elicited protective activity against all three death inducers. A general protective activity against poly(I:C)-, TRAIL-, and TNF-induced cell death was also observed in FLIPL and FLIPS transfectrants. Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-221104 VL - 9 ER - TY - JOUR A1 - Langhauser, Friederike A1 - Casas, Ana I. A1 - Dao, Vu-Thao-Vi A1 - Guney, Emre A1 - Menche, Jörg A1 - Geuss, Eva A1 - Kleikers, Pamela W. M. A1 - López, Manuela G. A1 - Barabási, Albert-L. A1 - Kleinschnitz, Christoph A1 - Schmidt, Harald H. H. W. T1 - A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection JF - npj Systems Biology and Applications N2 - Network medicine utilizes common genetic origins, markers and co-morbidities to uncover mechanistic links between diseases. These links can be summarized in the diseasome, a comprehensive network of disease–disease relationships and clusters. The diseasome has been influential during the past decade, although most of its links are not followed up experimentally. Here, we investigate a high prevalence unmet medical need cluster of disease phenotypes linked to cyclic GMP. Hitherto, the central cGMP-forming enzyme, soluble guanylate cyclase (sGC), has been targeted pharmacologically exclusively for smooth muscle modulation in cardiology and pulmonology. Here, we examine the disease associations of sGC in a non-hypothesis based manner in order to identify possibly previously unrecognized clinical indications. Surprisingly, we find that sGC, is closest linked to neurological disorders, an application that has so far not been explored clinically. Indeed, when investigating the neurological indication of this cluster with the highest unmet medical need, ischemic stroke, pre-clinically we find that sGC activity is virtually absent post-stroke. Conversely, a heme-free form of sGC, apo-sGC, was now the predominant isoform suggesting it may be a mechanism-based target in stroke. Indeed, this repurposing hypothesis could be validated experimentally in vivo as specific activators of apo-sGC were directly neuroprotective, reduced infarct size and increased survival. Thus, common mechanism clusters of the diseasome allow direct drug repurposing across previously unrelated disease phenotypes redefining them in a mechanism-based manner. Specifically, our example of repurposing apo-sGC activators for ischemic stroke should be urgently validated clinically as a possible first-in-class neuroprotective therapy. KW - neurology KW - pharmacology KW - systems biology Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-236381 VL - 4 ER - TY - JOUR A1 - Liao, Chunyu A1 - Ttofali, Fani A1 - Slotkowski, Rebecca A. A1 - Denny, Steven R. A1 - Cecil, Taylor D. A1 - Leenay, Ryan T. A1 - Keung, Albert J. A1 - Beisel, Chase L. T1 - Modular one-pot assembly of CRISPR arrays enables library generation and reveals factors influencing crRNA biogenesis JF - Nature Communications N2 - CRISPR-Cas systems inherently multiplex through CRISPR arrays—whether to defend against different invaders or mediate multi-target editing, regulation, imaging, or sensing. However, arrays remain difficult to generate due to their reoccurring repeat sequences. Here, we report a modular, one-pot scheme called CRATES to construct CRISPR arrays and array libraries. CRATES allows assembly of repeat-spacer subunits using defined assembly junctions within the trimmed portion of spacers. Using CRATES, we construct arrays for the single-effector nucleases Cas9, Cas12a, and Cas13a that mediated multiplexed DNA/RNA cleavage and gene regulation in cell-free systems, bacteria, and yeast. CRATES further allows the one-pot construction of array libraries and composite arrays utilized by multiple Cas nucleases. Finally, array characterization reveals processing of extraneous CRISPR RNAs from Cas12a terminal repeats and sequence- and context-dependent loss of RNA-directed nuclease activity via global RNA structure formation. CRATES thus can facilitate diverse multiplexing applications and help identify factors impacting crRNA biogenesis. KW - biotechnology KW - CRISPR-Cas systems KW - microbiology KW - small RNAs Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-236843 VL - 10 ER - TY - JOUR A1 - Levy, Marion J. F. A1 - Boulle, Fabien A1 - Emerit, Michel Boris A1 - Poilbout, Corinne A1 - Steinbusch, Harry W. M. A1 - Van den Hove, Daniel L. A. A1 - Kenis, Gunter A1 - Lanfumey, Laurence T1 - 5-HTT independent effects of fluoxetine on neuroplasticity JF - Scientific Reports N2 - Selective serotonin reuptake inhibitors are among the most prescribed antidepressants. Fluoxetine is the lead molecule which exerts its therapeutic effects, at least in part, by promoting neuroplasticity through increased brain-derived neurotrophic factor (BDNF)/tropomyosin-related receptor kinase B (TrkB) signalling. It is unclear however, to which extent the neuroplastic effects of fluoxetine are solely mediated by the inhibition of the serotonin transporter (5-HTT). To answer this question, the effects of fluoxetine on neuroplasticity were analysed in both wild type (WT) and 5-Htt knock-out (KO) mice. Using Western blotting and RT-qPCR approaches, we showed that fluoxetine 10 µM activated BDNF/TrkB signalling pathways in both CD1 and C57BL/6J mouse primary cortical neurons. Interestingly, effects on BDNF signalling were observed in primary cortical neurons from both 5-Htt WT and KO mice. In addition, a 3-week in vivo fluoxetine treatment (15 mg/kg/d; i.p.) increased the expression of plasticity genes in brains of both 5-Htt WT and KO mice, and tended to equally enhance hippocampal cell proliferation in both genotypes, without reaching significance. Our results further suggest that fluoxetine-induced neuroplasticity does not solely depend on 5-HTT blockade, but might rely, at least in part, on 5-HTT-independent direct activation of TrkB. KW - depression KW - neurotrophic factors Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-236759 VL - 9 ER - TY - JOUR A1 - Kurabi, Arwa A1 - Schaerer, Daniel A1 - Noack, Volker A1 - Bernhardt, Marlen A1 - Pak, Kwang A1 - Alexander, Thomas A1 - Husseman, Jacob A1 - Nguyen, Quyen A1 - Harris, Jeffrey P. A1 - Ryan, Allen F. T1 - Active Transport of Peptides Across the Intact Human Tympanic Membrane JF - Scientific Reports N2 - We previously identified peptides that are actively transported across the intact tympanic membrane (TM) of rats with infected middle ears. To assess the possibility that this transport would also occur across the human TM, we first developed and validated an assay to evaluate transport in vitro using fragments of the TM. Using this assay, we demonstrated the ability of phage bearing a TM-transiting peptide to cross freshly dissected TM fragments from infected rats or from uninfected rats, guinea pigs and rabbits. We then evaluated transport across fragments of the human TM that were discarded during otologic surgery. Human trans-TM transport was similar to that seen in the animal species. Finally, we found that free peptide, unconnected to phage, was transported across the TM at a rate comparable to that seen for peptide-bearing phage. These studies provide evidence supporting the concept of peptide-mediated drug delivery across the intact TM and into the middle ears of patients. KW - assay systems KW - biological models Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-230929 VL - 8 ER - TY - JOUR A1 - López, Cristina A1 - Kleinheinz, Kortine A1 - Aukema, Sietse M. A1 - Rohde, Marius A1 - Bernhart, Stephan H. A1 - Hübschmann, Daniel A1 - Wagener, Rabea A1 - Toprak, Umut H. A1 - Raimondi, Francesco A1 - Kreuz, Markus A1 - Waszak, Sebastian M. A1 - Huang, Zhiqin A1 - Sieverling, Lina A1 - Paramasivam, Nagarajan A1 - Seufert, Julian A1 - Sungalee, Stephanie A1 - Russell, Robert B. A1 - Bausinger, Julia A1 - Kretzmer, Helene A1 - Ammerpohl, Ole A1 - Bergmann, Anke K. A1 - Binder, Hans A1 - Borkhardt, Arndt A1 - Brors, Benedikt A1 - Claviez, Alexander A1 - Doose, Gero A1 - Feuerbach, Lars A1 - Haake, Andrea A1 - Hansmann, Martin-Leo A1 - Hoell, Jessica A1 - Hummel, Michael A1 - Korbel, Jan O. A1 - Lawerenz, Chris A1 - Lenze, Dido A1 - Radlwimmer, Bernhard A1 - Richter, Julia A1 - Rosenstiel, Philip A1 - Rosenwald, Andreas A1 - Schilhabel, Markus B. A1 - Stein, Harald A1 - Stilgenbauer, Stephan A1 - Stadler, Peter F. A1 - Szczepanowski, Monika A1 - Weniger, Marc A. A1 - Zapatka, Marc A1 - Eils, Roland A1 - Lichter, Peter A1 - Loeffler, Markus A1 - Möller, Peter A1 - Trümper, Lorenz A1 - Klapper, Wolfram A1 - Hoffmann, Steve A1 - Küppers, Ralf A1 - Burkhardt, Birgit A1 - Schlesner, Matthias A1 - Siebert, Reiner T1 - Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma JF - Nature Communications N2 - Burkitt lymphoma (BL) is the most common B-cell lymphoma in children. Within the International Cancer Genome Consortium (ICGC), we performed whole genome and transcriptome sequencing of 39 sporadic BL. Here, we unravel interaction of structural, mutational, and transcriptional changes, which contribute to MYC oncogene dysregulation together with the pathognomonic IG-MYC translocation. Moreover, by mapping IGH translocation breakpoints, we provide evidence that the precursor of at least a subset of BL is a B-cell poised to express IGHA. We describe the landscape of mutations, structural variants, and mutational processes, and identified a series of driver genes in the pathogenesis of BL, which can be targeted by various mechanisms, including IG-non MYC translocations, germline and somatic mutations, fusion transcripts, and alternative splicing. KW - cancer genomics KW - lymphocytes KW - lymphoid tissues KW - oncology Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-237281 VL - 10 ER - TY - JOUR A1 - Lu, Yuan A1 - Boswell, Wiliam A1 - Boswell, Mikki A1 - Klotz, Barbara A1 - Kneitz, Susanne A1 - Regneri, Janine A1 - Savage, Markita A1 - Mendoza, Cristina A1 - Postlethwait, John A1 - Warren, Wesley C. A1 - Schartl, Manfred A1 - Walter, Ronald B. T1 - Application of the Transcriptional Disease Signature (TDSs) to Screen Melanoma-Effective Compounds in a Small Fish Model JF - Scientific Reports N2 - Cell culture and protein target-based compound screening strategies, though broadly utilized in selecting candidate compounds, often fail to eliminate candidate compounds with non-target effects and/or safety concerns until late in the drug developmental process. Phenotype screening using intact research animals is attractive because it can help identify small molecule candidate compounds that have a high probability of proceeding to clinical use. Most FDA approved, first-in-class small molecules were identified from phenotypic screening. However, phenotypic screening using rodent models is labor intensive, low-throughput, and very expensive. As a novel alternative for small molecule screening, we have been developing gene expression disease profiles, termed the Transcriptional Disease Signature (TDS), as readout of small molecule screens for therapeutic molecules. In this concept, compounds that can reverse, or otherwise affect known disease-associated gene expression patterns in whole animals may be rapidly identified for more detailed downstream direct testing of their efficacy and mode of action. To establish proof of concept for this screening strategy, we employed a transgenic strain of a small aquarium fish, medaka (Oryzias latipes), that overexpresses the malignant melanoma driver gene xmrk, a mutant egfr gene, that is driven by a pigment cell-specific mitf promoter. In this model, melanoma develops with 100% penetrance. Using the transgenic medaka malignant melanoma model, we established a screening system that employs the NanoString nCounter platform to quantify gene expression within custom sets of TDS gene targets that we had previously shown to exhibit differential transcription among xmrk-transgenic and wild-type medaka. Compound-modulated gene expression was identified using an internet-accessible custom-built data processing pipeline. The effect of a given drug on the entire TDS profile was estimated by comparing compound-modulated genes in the TDS using an activation Z-score and Kolmogorov-Smirnov statistics. TDS gene probes were designed that target common signaling pathways that include proliferation, development, toxicity, immune function, metabolism and detoxification. These pathways may be utilized to evaluate candidate compounds for potential favorable, or unfavorable, effects on melanoma-associated gene expression. Here we present the logistics of using medaka to screen compounds, as well as, the development of a user-friendly NanoString data analysis pipeline to support feasibility of this novel TDS drug-screening strategy. KW - bioinformatics KW - phenotypic screening Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-237322 VL - 9 ER - TY - JOUR A1 - Meral, Derya A1 - Provasi, Davide A1 - Prada-Gracia, Diego A1 - Möller, Jan A1 - Marino, Kristen A1 - Lohse, Martin J. A1 - Filizola, Marta T1 - Molecular details of dimerization kinetics reveal negligible populations of transient µ-opioid receptor homodimers at physiological concentrations JF - Scientific Reports N2 - Various experimental and computational techniques have been employed over the past decade to provide structural and thermodynamic insights into G Protein-Coupled Receptor (GPCR) dimerization. Here, we use multiple microsecond-long, coarse-grained, biased and unbiased molecular dynamics simulations (a total of ~4 milliseconds) combined with multi-ensemble Markov state models to elucidate the kinetics of homodimerization of a prototypic GPCR, the µ-opioid receptor (MOR), embedded in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)/cholesterol lipid bilayer. Analysis of these computations identifies kinetically distinct macrostates comprising several different short-lived dimeric configurations of either inactive or activated MOR. Calculated kinetic rates and fractions of dimers at different MOR concentrations suggest a negligible population of MOR homodimers at physiological concentrations, which is supported by acceptor photobleaching fluorescence resonance energy transfer (FRET) experiments. This study provides a rigorous, quantitative explanation for some conflicting experimental data on GPCR oligomerization. KW - computational biophysics KW - fluorescence resonance energy transfer Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-223995 VL - 8 ER - TY - JOUR A1 - Medler, Juliane A1 - Nelke, Johannes A1 - Weisenberger, Daniela A1 - Steinfatt, Tim A1 - Rothaug, Moritz A1 - Berr, Susanne A1 - Hünig, Thomas A1 - Beilhack, Andreas A1 - Wajant, Harald T1 - TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity JF - Cell Death & Disease N2 - Antibodies specific for TNFRSF receptors that bind soluble ligands without getting properly activated generally act as strong agonists upon FcγR binding. Systematic analyses revealed that the FcγR dependency of such antibodies to act as potent agonists is largely independent from isotype, FcγR type, and of the epitope recognized. This suggests that the sole cellular attachment, achieved by Fc domain-FcγR interaction, dominantly determines the agonistic activity of antibodies recognizing TNFRSF receptors poorly responsive to soluble ligands. In accordance with this hypothesis, we demonstrated that antibody fusion proteins harboring domains allowing FcγR-independent cell surface anchoring also act as strong agonist provided they have access to their target. This finding defines a general possibility to generate anti-TNFRSF receptor antibodies with FcγR-independent agonism. Moreover, anti-TNFRSF receptor antibody fusion proteins with an anchoring domain promise superior applicability to conventional systemically active agonists when an anchoring target with localized disease associated expression can be addressed. KW - biologics KW - proteins Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-223948 VL - 10 ER - TY - THES A1 - Jorgacevic, Ivana T1 - Elucidating the interconnection of GvHD and Western diet-induced atherosclerosis T1 - Aufklärung des Zusammenhangs von GvHD und durch westliche Ernährung induzierter Atherosklerose N2 - Allogeneic hematopoietic cell transplantation (Allo-HCT) is the main and only treatment for many malignant and non-malignant haematological disorders. Even though the treatment has improved through the years and patient life expectancy has increased, graft versus host disease (GvHD) is still considered the main obstacle and one of the main reasons for increased mortality. Furthermore, improved patient’s survival and life expectancy brought into question the late post-HCT complications. The leading cause of late death after allo-HCT is the relapse of primary disease as well as chronic GvHD (cGvHD). However, a clear relationship was also described with pulmonary complications, endocrine dysfunction and infertility, and cataracts in post-HCT patients. In the last years big concern regarding a cumulative cardiovascular incidence in long-term survivors has been raised. Severe cardiovascular disease (CVD) is caused by atherosclerosis which is considered a chronic inflammatory disease of blood vessels. As such, it takes a long time from endothelial damage, as the onset event, and followed plaque formation to a manifestation of severe consequences, such as stroke, coronary heart disease, or peripheral arterial disease. Endothelial damage is well documented in patients post-HCT. In the context of allo-HCT, the endothelial damage is induced by the conditioning regimen with or without total body irradiation (TBI). Furthermore, endothelial cells (ECs) have been documented as a target of GvHD and increased concentration of circulating endothelial cells (CEC) coinciding with an increase in the number of circulating alloreactive T cells. According to 2021 ESC Guidelines on CVD prevention, the main atherosclerotic CVD (ASCVD) risk factors are blood apolipoprotein B (ApoB)-containing lipoproteins (of which low-density lipoprotein (LDL) is the most abundant), high blood pressure, cigarette smoking and diabetes mellitus (DM). GvHD is considered a high-risk factor for the onset of dyslipidaemia, hypertension, and DM. Overall, the risk of premature cardiovascular death is 2.7 fold increased in comparison to the general population, while the cumulative incidence of cardiovascular complications was shown to be up to 47% at ten years after reduced intensity conditioning (RIC), post-HCT. However, up to date, there are no available studies elucidating the interconnection between GvHD and atherosclerosis. The goal of this study was, therefore, to investigate the involvement of GvHD in the progression of atherosclerosis as well as to elucidate whether cytotoxic, CD8+ T cells that were shown to play a significant role in endothelial damage during the course of skin GvHD on one hand, and inducers of formation of unstable plaque on the other, are involved in this interconnection. For that purpose we established a novel minor histocompatibility anti gens (miHAg) allo-HCT Western diet (WD)-induced atherosclerosis mouse model. We were able to show that GvHD has a significant impact on atherosclerosis development in B6.Ldlr−/− recipient mice even in the absence of overt clinical disease activity. It seems that the impact is at least partly induced by CD8+ T cells, that showed significantly increased infiltration of aortic lesions in mice facing subclinical GvHD. As studies have shown in regular atherosclerotic mouse models as well as in humans, these CD8+ T cells exhibited not only increased expression of genes involved in activation, survival and differentiation to cytotoxic phenotype, but also some genes pointing out their exhaustion, that were absent in CD4+ T cell cluster. When anti-CD8β antibody was applied once per week along with WD feeding for eight weeks, the plaque formation was significantly reduced in aorta and aortic root pointing out the importance of these cells in an alloreactivity induced lesion formation. Furthermore, anti-CD8β treatment led to significantly decreased necrotic core formation followed by overall increase in plaque stability. Strikingly, bone marrow plus T cells (BMT) recipients fed WD showed significantly increased serum cholesterol levels in comparison to bone marrow (BM) (a group lacking alloreactive T cells that induce GvHD). This effect was reversed when anti-CD8β treatment was applied, suggesting, at least partly, an impact of alloreactive CD8+ T cells on cholesterol levels. Expression of genes responsible for lipid metabolism pointed out the tendency of the liver to regulate the increased cholesterol levels, however, the mechanism behind this phenotype still remains to be revealed. On the other hand, the impact of obesity, induced by chronic high-fat diet (HFD) feeding, has been shown to be an independent risk factor for gastrointestinal GvHD. Similarly, in major histocompatibility complex (MHC) disparate allo-HCT mouse model, we have noticed that even short-term WD intake leads to a significant decrease in survival of mice post-HCT. When the concentration of transplanted alloreactive T cells was reduced, the survival was improved, pointing out the involvement of these cells in the pathogenesis. Additionally, bioluminescence imaging (BLI) during initiation and effector phase of acute GvHD (aGvHD) revealed increased infiltration of alloreactive T cells in mice fed WD. Studies in an obesity model, we could confirm the involvement of specifically CD4+ T cells in WD induced impact, as the relative number of these cells was significantly increased in small intestine on day six post-HCT in mice fed WD. This increased intestinal infiltration was preceded by increase in the number of alloreactive T cells expressing intestine homing receptor (α4β7 integrin) in peripheral lymph nodes (LNs). Even though the number of T cells was not changed in the spleen of WD fed mice, the subset of CD4+ and CD8+ T cells that were highly secreting TNFα was increased as well as the expression of genes regulating pro-inflammatory cytokines such as IL-6 and interferon (IFN)γ pointing out significant WD-induced inflammation. Moreover, slight tendency towards increased intestinal permeability and load of translocated luminal bacteria, that we observed, could induce severe endotoxemia and dysregulated systemic immune response that could lead to detrimental induction of cell death. Justifying our speculations, we noted increased levels of transaminases and an increase in lactate dehydrogenase (LDH) levels (pointing out significant tissue damages). However, the exact mechanism behind this detrimental WD impact still remains to be elucidated. N2 - Die allogene hämatopoetische Zelltransplantation (engl.: allogeneic hematopoietic cell transplantation; allo-HCT) ist die wichtigste und einzige Behandlung für viele bösartige und nicht bösartige hämatologische Erkrankungen. Auch wenn sich die Behandlung im Laufe der Jahre verbessert hat und die Lebenserwartung der Patienten gestiegen ist, gilt die Transplantat-gegen-Wirt-Krankheit (engl.: graft versus host disease; GvHD) nach wie vor als Haupthindernis und ist einer der Hauptgründe für die erhöhte Sterblichkeit. Darüber hinaus hat die Verbesserung der Überlebensrate und der Lebenserwartung der Patienten dazu geführt, dass die Spätkomplikationen nach der HCT in Frage gestellt wer den. Die Hauptursache für den späten Tod nach einer allo-HCT ist das Wiederauftreten der Primärerkrankung und die chronische GvHD (cGvHD). Es wurde jedoch auch ein ein deutiger Zusammenhang mit pulmonalen Komplikationen, endokriner Dysfunktion und Unfruchtbarkeit sowie Katarakten bei Patienten nach einer HCT beschrieben. In den letzten Jahren wurde große Besorgnis hinsichtlich einer kumulativen kardio vaskulären Inzidenz bei Langzeitüberlebenden geäußert. Schwere Herz-Kreislauf Erkrankungen werden durch Atherosklerose verursacht, die als chronische Entzündu ngserkrankung der Blutgefäße gilt. Von der Endothelschädigung als Beginn und der anschließenden Plaquebildung bis zur Manifestation schwerwiegender Folgen wie Schla ganfall, koronare Herzkrankheit oder periphere arterielle Verschlusskrankheit vergeht eine lange Zeit. Endothelschäden sind bei Patienten nach HCT gut dokumen tiert. Im Zusammenhang mit der allo-HCT wird die Endothelschädigung durch das Konditionierungsschema mit oder ohne TBI induziert. Darüber hinaus wurde dokumentiert, dass Endothelzellen ein Ziel der GvHD sind und dass eine erhöhte Konzentration zirkulierender Endothelzellen (engl: circulating endothelial cells; CEC) mit einem Anstieg der Anzahl zirkulierender alloreaktiver T-Zellen korreliert. Nach den ESC-Leitlinien 2021 zur Prävention von Herz-Kreislauf-Erkrankungen sind die wichtigsten Risikofaktoren für atherosklerotische Herz-Kreislauf-Erkrankungen (engl.: atherosclerotic cardiovascular disease; ASCVD) Apolipoprotein B (ApoB)-haltige Lipoproteine im Blut (von denen das Low-Density-Lipoprotein (LDL) am häufigsten vorkommt), Bluthochdruck, Zigarettenrauchen und Diabetes mellitus (DM). GvHD gilt als Hochrisikofaktor für das Auftreten von Dyslipidämie, Bluthochdruck und DM. Insgesamt ist das Risiko eines vorzeitigen kardiovaskulären Todes im Vergleich zur Allgemeinbevölkerung um das 2,7-fache erhöht, während die kumulative Inzidenz kardiovaskulärer Komp likationen zehn Jahre nach einer Konditionierung mit reduzierter Intensität (RIC) nach einer HCT bei bis zu 47% lag. Bislang gibt es jedoch keine Studien, die den Zusam menhang zwischen GvHD und Atherosklerose aufklären. Ziel dieser Studie war es daher, die Beteiligung der GvHD am Fortschreiten der Atherosklerose zu untersuchen und zu klären, ob zytotoxische CD8+ T-Zellen, die einerseits eine bedeutende Rolle bei der En dothelschädigung im Verlauf der Haut-GvHD spielen und andererseits die Bildung insta biler Plaques induzieren, an diesem Zusammenhang beteiligt sind. Zu diesem Zweck haben wir ein neuartiges miHAg-allo-HCT Atherosklerose-Mausmodell etabliert. Wir konnten zeigen, dass GvHD einen signifikanten Einfluss auf die Entwicklung von Atherosklerose in B6.Ldlr−/−-Empfängermäusen hat, selbst wenn keine klinische Krankheitsaktivität vor 3 Chapter 1. Summary liegt. Es scheint, dass dieser Einfluss zumindest teilweise durch CD8+ T-Zellen induziert wird, die bei Mäusen mit subklinischer GvHD eine signifikant erhöhte Infiltration von Aortenläsionen zeigten. Dies wurde auch in Studien in regulären Atherosklerose-Modellen sowie beim Menschen gezeigt. Diese CD8+-T-Zellen wiesen nicht nur eine erhöhte Expression von Genen auf, die an der Aktivierung, dem Überleben und der Differenzierung zum zytotoxischen Phänotyp beteiligt sind, sondern auch einige Gene, die auf zelluläre Erschöpfung hinweisen, die im CD4+-T-Zell-Cluster fehlten. Wurde ein Anti-CD8β-Antikörper einmal wöchentlich zusammen mit der Fütterung von WD acht Wochen lang verabreicht, so wurde die Plaquebildung in der Aorta und der Aortenwurzel signifikant reduziert, was auf die Bedeutung dieser Zellen bei der durch Alloreaktivität induzierten Läsionsbildung hinweist. Darüber hinaus führte eine Anti-CD8β-Behandlung zu einer signifikant verringerten Bildung eines nekrotischen Kerns, gefolgt von einer allge meinen Zunahme der Plaquestabilität. Auffallend ist, dass BMT-Empfänger, die mit WD gefüttert wurden, im Vergleich zu BM (einer Gruppe ohne alloreaktive T-Zellen, die GvHD induzieren) signifikant erhöhte Serumcholesterinwerte aufwiesen. Dieser Effekt kehrte sich um, wenn eine Anti-CD8β-Behandlung durchgeführt wurde, was zumindest teilweise auf einen Einfluss alloreaktiver CD8+-T-Zellen auf den Cholesterinspiegel schließen lässt. Die Expression von Genen, die für den Lipidstoffwechsel verantwortlich sind, wies auf die Tendenz der Leber hin, den erhöhten Cholesterinspiegel zu regulieren; der Mechanismus, der diesem Phänotyp zugrunde liegt, muss jedoch noch aufgeklärt werden. Andererseits hat sich gezeigt, dass die durch chronische Fütterung induzierte Fettleibigkeit ein un abhängiger Risikofaktor für gastrointestinale GvHD ist. In ähnlicher Weise haben wir in dem MHC disparaten allo-HCT-Mausmodell festgestellt, dass selbst eine kurzfristige WD-Zufuhr zu einer signifikanten Verringerung des Überlebens der Mäuse nach der HCT führte. Wenn die Konzentration der transplantierten alloreaktiven T-Zellen reduziert wurde, verbesserte sich die Überlebensrate, was auf die Beteiligung dieser Zellen an der Pathogenese hinweist. Darüber hinaus zeigte die Biolumineszenz-Bildgebung (engl.: bio luminiscence imaging; BLI) während der Initiations- und Effektorphase der aGvHD eine erhöhte Infiltration alloreaktiver T-Zellen bei Mäusen, die mit WD gefüttert wurden. Wie Studien gezeigt in einem Adipositasmodell vorgeschlagen haben, konnten wir die Beteili gung von spezifisch CD4+ T-Zellen an der WD-induzierten Wirkung bestätigen, da die relative Anzahl dieser Zellen im Dünndarm am sechsten Tag nach der HCT bei Mäusen, die mit WD gefüttert wurden, signifikant erhöht war. Dieser erhöhten Darminfiltration ging ein Anstieg der Zahl alloreaktiver T-Zellen voraus, die den Darm-Homing-Rezeptor (α4β7-Integrin) in den peripheren LNs exprimieren. Obwohl sich die Anzahl der T-Zellen in der Milz von mit WD gefütterten Mäusen nicht veränderte, war die Untergruppe der CD4+- und CD8+-T-Zellen, die in hohem Maße TNFα sezernierten, ebenso erhöht wie die Expression von Genen, die pro-inflammatorische Zytokine wie IL-6 und IFNγ reg ulieren, was auf eine signifikante WD-induzierte Entzündung hinweist. Darüber hinaus könnte die von uns beobachtete leichte Tendenz zu einer erhöhten intestinalen Perme abilität und Belastung mit translozierten luminalen Bakterien eine schwere Endotoxämie und eine dysregulierte systemische Immunantwort auslösen, die zu einer schädlichen In duktion des Zelltods führen könnte. Zur Untermauerung unserer Spekulationen stellten wir erhöhte Transaminasenwerte und einen Anstieg der LDH-Werte fest (was auf erhe bliche Gewebeschäden hinweist).Jedoch verbleibt der genaue Mechanismus, der zu den verheerenden Auswirkungen von WD führt, ungeklärt. KW - Periphere Stammzellentransplantation KW - Arteriosklerose KW - GvHD KW - HCT KW - Atherosclerosis Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-325792 ER - TY - THES A1 - Papay, Marion T1 - Notwendigkeit der präoperativen Reposition von distalen, nach dorsal dislozierten Radiusfrakturen bei bestehender Operationsindikation im Hinblick auf das Schmerzniveau sowie postoperative Ergebnisse T1 - Necessity of preoperative closed reduction of dorsally displaced distal radius fractures with existing surgical indication with regard to the pain level and postoperative results N2 - Die distale Radiusfraktur gehört zu den häufigsten Frakturen in Deutschland mit einem Inzidenzanstieg im Alter unter Betonung des weiblichen Geschlechts. Dabei zeigt sich ein zunehmender Trend in Richtung operative Versorgung, allen voran die Versorgung mittels winkelstabiler Plattensysteme. Instabile, distale Radiusfrakturen werden dabei vor geplanter operativer Versorgung im Rahmen der Initialbehandlung üblicherweise geschlossen reponiert und im Gipsverband retiniert. Ziel der vorliegenden monozentrischen, prospektiv randomisierten Studie mit zwei Studiengruppen war es herauszufinden, ob sich das Unterlassen der Reposition vor geplanter Operation nachteilig auf das Schmerzniveau in der präoperativen Phase auswirkt und ob sich durch die Dislokation Nachteile in Bezug auf den Nervus medianus im Sinne eines Traktionsschadens sowie bezüglich des klinisch-radiologischen Ausheilungsergebnisses zeigen. Die Studie zeigte, dass das Schmerzempfinden während der präoperativen Gipsbehandlung unabhängig von einer vorherigen Reposition war. Für den primären Endpunkt an Tag 1 nach der Akutbehandlung konnte statistisch signifikante Nichtunterlegenheit der Gruppe ohne Reposition gegenüber der Gruppe mit Reposition nachgewiesen werden. Gleiches galt für Tag 2, sowohl für die absoluten Schmerzniveaus als auch für die Schmerzlinderung. Das Unterlassen der Reposition hatte zudem keine nachteiligen Effekte auf den Nervus medianus. Gleiches zeigte sich für das klinische und radiologische Ausheilungsergebnis. Für die funktionellen DASH- und Krimmer-Scores konnte ein Jahr postoperativ ebenfalls statistisch signifikante Nichtunterlegenheit der Gruppe ohne Reposition nachgewiesen werden. Diese Erkenntnisse bestätigen die in der Literatur vorhandenen Ergebnisse verschiedener Studien dahingehend, dass das Unterlassen der Reposition keine nachteiligen Effekte auf das postoperative Outcome hat. Einige Studien verdeutlichen zudem, dass es nach Reposition, insbesondere bei Vorliegen gewisser Risiko- und Instabilitätsfaktoren, ohnehin zur sekundären Dislokation kommt, sodass die generelle Notwendigkeit der Reposition vor Gipsanlage sowohl vor einer operativen als auch vor einer konservativen Weiterbehandlung angezweifelt werden muss. N2 - The distal radius fracture is one of the most common fractures in Germany, with an increase in incidence with age and an emphasis on the female sex. There is an increasing trend towards surgical treatment, above all treatments using locking plate systems. Prior to planned surgical treatment, unstable, distal radius fractures are usually reduced in a closed manner as part of the initial treatment and are retained in a plaster cast. The aim of the present monocentric, prospective randomized study with two study groups was to find out whether omitting reduction before planned surgery has a negative effect on the pain level in the preoperative phase and whether the dislocation has disadvantages with regard to the median nerve in terms of traction damage and with regard to the clinical and radiological healing result. The study showed that the sensation of pain during preoperative plaster treatment was independent of previous reduction. For the primary endpoint on day 1 after acute treatment, statistically significant non-inferiority of the group without reduction compared to the group with reduction was demonstrated. The same was true for day 2, both for absolute pain levels and pain relief. The omission of the reduction also had no adverse effects on the median nerve. The same was shown for the clinical and radiological healing results. For the functional DASH and Krimmer scores, statistically significant non-inferiority of the group without reduction was also demonstrated one year postoperatively. These findings confirm the results of various studies in the literature to the effect that omitting reduction has no detrimental effects on the postoperative outcome. Some studies also make it clear that secondary dislocation occurs anyway after reduction, especially in the presence of certain risk and instability factors, so that the general necessity of reduction prior to plaster application must be questioned both before surgical and conservative further treatment. KW - distale Radiusfraktur KW - Reposition KW - geschlossene präoperative Reposition KW - präoperatives Schmerzniveau KW - distale instabile Radiusfraktur KW - preoperative closed reduction KW - preoperative pain level KW - unstable distal radius fracture Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-363882 N1 - Erstellung der Disseration an folgendem Institut: Abteilung für Orthopädie und Unfallchirurgie Caritas Krankenhaus Bad Mergentheim Lehrkrankenhaus der Universität Würzburg ER - TY - THES A1 - von der Heide, Julia Magdalena T1 - Ist eine Berechnung der Geometrie der Halswirbelkörper anhand ihrer Morphologie im Kindesalter und somit eine Individualisierung der CVM-Methode möglich? T1 - Is it possible to calculate the geometry of the cervical vertebral bodies based on their morphology in childhood and thus individualize the CVM method? N2 - Ziel der vorliegenden Studie war es zu untersuchen, ob anhand geometrischer Merkmale der HWK im Kindesalter eine sichere individuelle Vorhersage der Morphologie der HWK zum Ende der Entwicklung möglich ist. Hierdurch könnte eine Individualisierung der CVM-Methode und somit eine Einschätzung des bereits verstrichenen Wachstums erfolgen. Zu diesem Zweck wurden insgesamt 1377 FRS-Aufnahmen von 267 Patienten – 110 weibliche und 157 männliche – aus dem Archiv der Poliklinik für Kieferorthopädie des Universitätsklinikums Würzburg digitalisiert und untersucht. Die HWK wurden im Programm OnyxCeph (Herst.: Image Instruments GmbH) quantifiziert und die berechneten Werte mit der Software SPSS statistisch ausgewertet. Mittels linearer Regressionen wurde versucht, anhand der Morphologie der Wirbelkörper vor dem puberalen Wachstumsschub auf die Geometrie der HWK im Erwachsenenalter zu schließen. Zur Illustrierung wurden Streudiagramm und die dazugehörigen Abfolgen von Röntgenbildern dargestellt. Eine Schätzung der Geometrie der HWK im Erwachsenenalter würde bei den separat betrachteten Parametern und bei einer gemeinsamen Betrachtung der Parameter kaum zu korrekten Einschätzungen führen. Die Streudiagramme mit den Bilderabfolgen stützen diese These ebenfalls und illustrieren die mögliche Fehleinschätzung der Geometrie. Die Ergebnisse der Studie zeigen erneut, dass die Geometrie der HWK im Erwachsenenalter sehr variabel ist, wie komplex die Entwicklung der HWK ist und dass anhand ihrer Geometrie im Kindesalter keine sichere Einschätzung der skelettalen Reife möglich ist. Eine Individualisierung der CVM-Methode ist anhand der in dieser Studie untersuchten Parameter nicht möglich. Somit lässt sich schlussfolgern, dass die CVM-Methode nicht als alleinige Methode zur präzisen skelettalen Alterseinschätzung verlässlich genutzt werden kann, sondern für eine sichere Beurteilung weitere Reifeindikatoren hinzugezogen werden sollten. Allerdings sollten hierzu zusätzliche radiologische Untersuchungen, wie beispielsweise die Handröntgenaufnahme, nur dann durchgeführt werden, wenn diese dem ALARA-Prinzip entsprechen. N2 - The aim of the present study was to investigate whether a reliable individual prediction of the morphology of the cervical vertebral bodies at the end of development is possible based on their geometric features in childhood. This could allow the CVM method to be individualized and thus an assessment of the growth that has already occurred. For this purpose, a total of 1377 FRS images of 267 patients - 110 female and 157 male - from the archive of the Department of Orthodontics at the University Hospital of Würzburg were digitized and examined. The cervical vertebrae were quantified using the OnyxCeph program and the calculated values were statistically evaluated using the SPSS software. Through linear regressions an attempt was made to use the morphology of the cervical vertebral bodies before the pubertal growth spurt to draw conclusions about the geometry of the cervical vertebrae in adulthood. A scatter diagram and the associated sequences of X-ray images were displayed to illustrate this. An estimate of the geometry of the cervical vertebral bodies in adulthood would hardly lead to correct assessments wheter the parameters were considered separately or together. The scatter diagrams with the image sequences also support this thesis and illustrate the possible misjudgement of the geometry. The results of the study show once again the geometrical variability and the complexity of the development of the cervical vertebral bodies, which makes it impossible to give a reliable assessment of skeletal maturity based on its geometry in childhood. It is not possible to individualize the CVM method based on the parameters examined in this study. It can therefore be concluded that the CVM method cannot be used reliably as the sole method for precise skeletal age assessment, but that further maturity indicators should be involved for a reliable assessment. However, additional radiological examinations, such as hand X-rays, should only be carried out if they comply with the ALARA principle. KW - Skelett KW - CVM-Methode KW - Altersbestimmung Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-360753 ER - TY - THES A1 - Krings, Moritz T1 - Universitäre Psychiatrie um 1900 : Die Anfangsjahre der psychiatrischen Klinik in Würzburg T1 - University psychiatry around 1900 : The early years of the psychiatric clinic in Würzburg N2 - Ende des 19. Jahrhunderts standen sich in Deutschland zwei verschiedene Arten psychiatrischer Institutionen gegenüber, die Anstaltspsychiatrien auf der einen, die universitären psychiatrischen Kliniken auf der anderen Seite. Die psychiatriehistorische Forschung widmete sich überwiegend psychiatrischen Anstalten während Kliniken hier unterrepräsentiert sind. Die vorliegende Arbeit möchte zur historischen Kenntnis universitärer psychiatrischer Einrichtungen beitragen. Hierzu werden die Charakteristika einer psychiatrischen Klinik um 1900 anhand des Beispiels der psychiatrischen Klinik der Universität Würzburg betrachtet. Der Fokus liegt hierbei neben Lage und Aufbau der Klinik sowie deren Personal auf den drei Bereichen Patient*innen, Forschung und Lehre. N2 - At the end of the 19th century, there were two different types of psychiatric institutions in Germany: asylums on the one hand and university psychiatric clinics on the other. Research into the history of psychiatry has mainly focused on asylums, while clinics are underrepresented. This study aims to contribute to the historical knowledge of university psychiatric institutions. To this end, the characteristics of a psychiatric clinic around 1900 are examined using the example of the psychiatric clinic at the University of Würzburg. In addition to the location and structure of the clinic and its staff, the focus is on the three main topics of patients, research and teaching. KW - Julius-Maximilians-Universität Würzburg KW - Psychiatrie KW - Rieger, Konrad KW - Psychiatriegeschichte KW - Universitäre Psychiatrie KW - History of Psychiatry KW - Wuerzburg KW - Clinical psychiatry KW - University of Wuerzburg KW - Würzburg Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-361407 ER - TY - THES A1 - Gaballa, Abdallah Hatem Hassan Hosny Ahmed T1 - PAF1c drives MYC-mediated immune evasion in pancreatic ductal adenocarcinoma T1 - PAF1c treibt die MYC-vermittelte Immunevasion im duktalen Adenokarzinom der Bauchspeicheldrüse an N2 - The expression of the MYC proto-oncogene is elevated in a large proportion of patients with pancreatic ductal adenocarcinoma (PDAC). Previous findings in PDAC have shown that this increased MYC expression mediates immune evasion and promotes S-phase progression. How these functions are mediated and whether a downstream factor of MYC mediates these functions has remained elusive. Recent studies identifying the MYC interactome revealed a complex network of interaction partners, highlighting the need to identify the oncogenic pathway of MYC in an unbiased manner. In this work, we have shown that MYC ensures genomic stability during S-phase and prevents transcription-replication conflicts. Depletion of MYC and inhibition of ATR kinase showed a synergistic effect to induce DNA damage. A targeted siRNA screen targeting downstream factors of MYC revealed that PAF1c is required for DNA repair and S-phase progression. Recruitment of PAF1c to RNAPII was shown to be MYC dependent. PAF1c was shown to be largely dispensable for cell proliferation and regulation of MYC target genes. Depletion of CTR9, a subunit of PAF1c, caused strong tumor regression in a pancreatic ductal adenocarcinoma model, with long-term survival in a subset of mice. This effect was not due to induction of DNA damage, but to restoration of tumor immune surveillance. Depletion of PAF1c resulted in the release of RNAPII with transcription elongation factors, including SPT6, from the bodies of long genes, promoting full-length transcription of short genes. This resulted in the downregulation of long DNA repair genes and the concomitant upregulation of short genes, including MHC class I genes. These data demonstrate that a balance between long and short gene transcription is essential for tumor progression and that interference with PAF1c levels shifts this balance toward a tumor-suppressive transcriptional program. It also directly links MYC-mediated S-phase progression to immune evasion. Unlike MYC, PAF1c has a stable, known folded structure; therefore, the development of a small molecule targeting PAF1c may disrupt the immune evasive function of MYC while sparing its physiological functions in cellular growth. N2 - Die Expression des MYC-Proto-Onkogens ist bei einem großen Teil der Patienten mit duktalem Adenokarzinom der Bauchspeicheldrüse (PDAC) erhöht. Bisherige Erkenntnisse in der Erforschung des ankreaskarzinoms zeigen, dass die erhöhte MYCExpression die Umgehung des Immunsystems bewirkt und die Progression der S-Phase fördert. Wie diese Funktionen vermittelt werden und ob ein nachgeschalteter Faktor von MYC für diese Funktion verantwortlich ist, blieb jedoch bisher ungeklärt. Jüngste Studien zur Identifizierung des MYC-Interaktoms haben ein sehr komplexes Netzwerk an Interaktionspartnern von MYC aufgedeckt, was die Notwendigkeit unterstreicht, die onkogenen Eigenschaften von MYC und seinen Interaktionspartnern unvoreingenommen und genau zu untersuchen. In dieser Arbeit konnte gezeigt werden, dass MYC die genomische Stabilität während der S-Phase herstellt und Konflikte zwischen Transkription und Replikation verhindert. Die Depletion von MYC und die Hemmung der ATR-Kinase zeigten bei der Induktion von DNA Schäden eine synergistische Wirkung. Ein siRNA-Screen, der Gene beinhaltete, die MYC nachgeschaltet sind, ergab, dass PAF1c für die DNA-Reparatur und die S-PhasenProgression erforderlich ist. Es zeigte sich außerdem, dass die Rekrutierung von PAF1c an RNAPII von MYC abhängig ist. Für die Zellproliferation und die Regulierung von MYCZielgenen ist PAF1c jedoch weitgehend entbehrlich. Es konnte gezeigt werden, dass die Depletion von CTR9, einer Untereinheit von PAF1c, in einem murinen Modell des duktalen Adenokarzinoms der Bauchspeicheldrüse zu einer starken Tumorregression mit langfristigem Überleben einiger Mäuse führte. Diese Wirkung war nicht auf die Induktion von DNA-Schäden zurückzuführen, sondern auf die Wiederherstellung der Immunüberwachung des Tumors. Die Deletion von PAF1c führte zu einer Umverteilung von RNAPII und Trankriptionselongationsfaktoren wie SPT6, von langen Genen hin zu kurzen Genen. Dadurch wurden lange Gene wie zum Beispiel DNA Reparaturgene nicht vollständig transkribiert, kurze Gene wie MHC-Klasse-I-Gene hingegen schon. Diese Daten zeigen, dass ein Gleichgewicht zwischen der Transkription langer und kurzer Gene für die Tumorprogression wichtig ist und dass eine Verminderung der PAF1c-Konzentration dieses Gleichgewicht in Richtung eines tumorsuppressiven Transkriptionsprogramms verschiebt. Außerdem besteht ein direkter Zusammenhang zwischen der MYCvermittelten S-Phasen-Progression und der Umgehung des Immunsystems. Im Gegensatz zu MYC verfügt PAF1c über eine stabile und gut bekannte gefaltete Struktur. Daher könnte die Entwicklung eines kleinen Moleküls, das PAF1c hemmt, die Funktion von MYC zur Umgehung des Immunsystems stören und gleichzeitig seine physiologischen Funktionen für das Zellwachstum nicht beeinträchtigen. KW - Myc KW - Transkription KW - PAF1c KW - Transcription elongation KW - Immune evasion KW - Immunevasion Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-360459 ER - TY - THES A1 - Polzin, Charlotte T1 - Entwicklung eines Screeningverfahrens für Linezolid-resistente Enterokokken und Aufnahme der Prävalenz T1 - Development of a screening method for linezolid-resistant enterococci and determination of prevalence N2 - Enterokokken gehören zu den bedeutendsten nosokomialen Keimen. Die Verbreitung von Multiresistenzen bei diesen Keimen stellt das deutsche Gesundheitssystem aufgrund von wenigen verbleibenden Therapieoptionen von Infektionen vor große Probleme. Die KRINKO des Robert-Koch-Instituts empfiehlt als mögliche Präventionsmaßnahme ein regelmäßiges Screening auf Enterokokken mit Vancomycin- bzw. Linezolid-Resistenzen. Ziel dieser Arbeit war es, ein kulturelles Screeningverfahren für Linezolid-resistente Enterokokken (LRE) zu entwickeln und dieses anschließend im Routinescreening des Universitätsklinikums Würzburg zu etablieren. Es wurde ein Verfahren entwickelt, welches sich aus einem Anreicherungsschritt mit 3 mg/l Linezolid versetzter selektiver Enterococcosel-Bouillon und einer anschließenden Subkultivierung auf Linezolid-Enterococcosel-Agar mit 4 mg/l Linezolid zusammensetzt. In einer Simulation von klinischen Bedingungen zeigte sich eine gute Sensitivität und Spezifität. Das entwickelte Screeningverfahren wurde mit einem geringen Sensitivitätsverlust und ohne zusätzliche Belastung für die Patienten in das bestehende Routinescreening für Vancomycin-resistente Enterokokken des Universitätsklinikums Würzburg eingegliedert. Die nachgewiesen LRE zeigten unterschiedliche Resistenzmechanismen, wobei bei dem Großteil der Isolate Resistenzgene nachgewiesen werden konnten. Des Weiteren zeigte sich ein breit gestreuter genetischer Hintergrund. Viele der Isolate gehörten genetischen Gruppen an, welche bisher kaum in hospitalisierten Patienten nachgewiesen wurden. Durch die labortechnische Weiterentwicklung von Screeningverfahren für LRE können diese möglicherweise bald routinemäßig in vielen Kliniken etabliert werden. N2 - Enterococci are one of the most important nosocomial pathogens. The spread of multiresistance in these pathogens poses a major problem for the German healthcare system due to the few remaining treatment options for infections. The Robert Koch Institute's KRINKO recommends regular screening for enterococci with vancomycin or linezolid resistance as a possible preventive measure. The aim of this work was to develop a cultural screening method for linezolid-resistant enterococci (LRE) and to establish it in routine screening at the University Hospital of Würzburg. A procedure was developed consisting of an enrichment step with 3 mg/l linezolid-added selective enterococcosel broth and a subsequent subcultivation on linezolid-enterococcosel agar with 4 mg/l linezolid. A simulation of clinical conditions showed good sensitivity and specificity. The developed screening method was integrated into the existing routine screening for vancomycin-resistant enterococci at the University Hospital of Würzburg with little loss of sensitivity and no additional burden for patients. The detected LRE showed different resistance mechanisms, with resistance genes being detected in the majority of isolates. In addition, a broad genetic background was found. Many of the isolates belonged to genetic groups that have rarely been detected in hospitalized patients. With further development of laboratory screening methods for LRE, it may soon be possible to establish them routinely in many hospitals. KW - Enterococcus KW - Linezolid KW - Multidrug-Resistenz KW - Linezolid-resistente Enterokokken KW - linezolid-resistant enterococci KW - Screeningverfahren KW - screening method KW - Screening Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-370665 ER - TY - JOUR A1 - Elliot, Perry M. A1 - Germain, Dominique P. A1 - Hilz, Max J. A1 - Spada, Marco A1 - Wanner, Christoph A1 - Falissard, Bruno T1 - Why systematic literature reviews in Fabry disease should include all published evidence JF - European Journal of Medical Genetics N2 - Fabry disease is an X-linked inherited, progressive disorder of lipid metabolism resulting from the deficient activity of the enzyme α-galactosidase. Enzyme replacement therapy (ERT) with recombinant agalsidase, with intravenous infusions of either agalsidase beta or agalsidase alfa, is available and clinical experience now exceeds 15 years. There are very few randomised, placebo-controlled clinical trials evaluating the outcomes of ERT. Data are often derived from observational, registry-based studies and case reports. Pooled analysis of data from different sources may be limited by the heterogeneity of the patient populations, outcomes and treatment. Therefore, comprehensive systematic literature reviews of unpooled data are needed to determine the effects of ERT on disease outcomes. A systematic literature search was conducted in the Embase and PubMed (MEDLINE) databases to retrieve original articles that evaluated outcomes of ERT in patients with Fabry disease; the outcome data were analysed unpooled. The literature analysis included the full range of published literature including observational studies and case series/case reports. Considerable heterogeneity was found among the studies, with differences in sample size, statistical methods, ERT regimens and patient demographic and clinical characteristics. We have demonstrated the value of performing an unpooled systematic literature review of all published evidence of ERT outcomes in Fabry disease, highlighting that in a rare genetic disorder like Fabry disease, which is phenotypically diverse, different patient populations can require different disease management and therapeutic goals depending on age, genotype, and disease severity/level of organ involvement. In addition, these findings are valuable to guide the design and reporting of new clinical studies. KW - Fabry disease KW - enzyme replacement therapy KW - systematic literature review Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-226654 VL - 62 ER - TY - JOUR A1 - Sondermann, Wiebke A1 - Utikal, Jochen Sven A1 - Enk, Alexander H. A1 - Schadendorf, Dirk A1 - Klode, Joachim A1 - Hauschild, Axel A1 - Weichenthal, Michael A1 - French, Lars E. A1 - Berking, Carola A1 - Schilling, Bastian A1 - Haferkamp, Sebastian A1 - Fröhling, Stefan A1 - von Kalle, Christof A1 - Brinker, Titus J. T1 - Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data JF - European Journal of Cancer N2 - Recent research revealed the superiority of artificial intelligence over dermatologists to diagnose melanoma from images. However, 30–50% of all melanomas and more than half of those in young patients evolve from initially benign lesions. Despite its high relevance for melanoma screening, neither clinicians nor computers are yet able to reliably predict a nevus’ oncologic transformation. The cause of this lies in the static nature of lesion presentation in the current standard of care, both for clinicians and algorithms. The status quo makes it difficult to train algorithms (and clinicians) to precisely assess the likelihood of a benign skin lesion to transform into melanoma. In addition, it inhibits the precision of current algorithms since ‘evolution’ image features may not be part of their decision. The current literature reveals certain types of melanocytic nevi (i.e. ‘spitzoid’ or ‘dysplastic’ nevi) and criteria (i.e. visible vasculature) that, in general, appear to have a higher chance to transform into melanoma. However, owing to the cumulative nature of oncogenic mutations in melanoma, a more fine-grained early morphologic footprint is likely to be detectable by an algorithm. In this perspective article, the concept of melanoma prediction is further explored by the discussion of the evolution of melanoma, the concept for training of such a nevi classifier and the implications of early melanoma prediction for clinical practice. In conclusion, the authors believe that artificial intelligence trained on prospective image data could be transformative for skin cancer diagnostics by (a) predicting melanoma before it occurs (i.e. pre-in situ) and (b) further enhancing the accuracy of current melanoma classifiers. Necessary prospective images for this research are obtained via free mole-monitoring mobile apps. KW - melanoma KW - skin cancer KW - artificial Intelligence KW - deep learning KW - prediction Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-239263 VL - 119 ER - TY - THES A1 - Danner, Elisabeth T1 - Systolische Ejektionszeit - Referenzwerte und Einfluss kardiovaskulärer Risikofaktoren in einer populationsbasierten Kohortenstudie T1 - Systolic ejection time - Reference values and impact of cardiovascular risk factors in a population-based cohort study N2 - Die systolische Ejektionszeit (SET) und die prä-Ejektionszeit (pET) sind Zeitintervalle, die sich zuverlässig mittels transthorakaler Echokardiographie erheben lassen und wichtige Aspekte in der kardialen Leistungsdiagnostik abbilden. Gleichwohl gibt es bislang für diese systolischen Zeitintervalle keine Normwerte. Die vorliegende Arbeit analysierte echokardiographische Daten von 4965 ProbandInnen der STAAB-Studie, einer umfänglich phänotypisierten populationsbasierten Kohortenstudie mit dem Ziel der Erstellung von Normwerten für die systolischen Zeitintervalle sowie der Identifizierung und Quantifizierung ihrer Determinanten mittels multivariable Regressionsanalysen. Aufgrund der starken Abhängigkeit der SET von der Herzfrequenz wurde die herzfrequenzkorrigierte SETc eingeführt, die in Anlehnung an die QTc-Zeit nach Fridericia berechnet wurde ("SET" /∛("RR-Intervall" )). Die Normwerte wurden anhand der gesunden Untergruppe (definiert durch Abwesenheit von kardiovaskulären Risikofaktoren oder Erkrankungen; N=966) aus STAAB generiert. Dem starken Einfluss von Geschlecht und Alter wurde dabei Rechnung getragen, indem für SET, SETc und pET alters- und geschlechtsspezifische Referenzwerte berechnet wurden. SETc war stark korreliert mit linksventrikulärer Ejektionsfraktion sowie enddiastolischem Volumen und Schlagvolumen. Zudem zeigte sich ein deutlicher Zusammenhang von SETc mit spezifischen Markern der Nachlast (Ea und Ees). Aus der großen Liste der klinischen Marker, die in STAAB erhoben wurden, ergab sich eine größere Anzahl von Einflussfaktoren. Bedeutsame Determinanten der systolischen Zeitintervalle waren insbesondere das metabolische Syndrom (sowie dessen Komponenten), das Rauchverhalten und die Einnahme von β Blockern. Die Ergebnisse zeigen, dass die systolischen Zeitintervalle, insbesondere SETc, reliable Informationen über das kardiale Kontraktionsverhalten liefern können. Derzeit werden neue Substanzklassen untersucht, die unter anderem über die Modifizierung von SET wirken sollen. Hier zu nennen sind insbesondere Myosin-Aktivatoren bei Herzinsuffizienz mit reduzierter Pumpfunktion wie zum Beispiel Omecamtiv Mecarbil oder Myosin-Inhibitoren bei Hypertropher Obstruktiver Kardiomyopathie. Die hierzu laufenden Studien betrachten auch die Effekte dieser Medikamente auf die systolischen Zeitintervalle als bedeutsame Surrogate der klinischen Effekte und letztlich der Prognose. Die nun vorliegenden Normwerte dieser Zeitintervalle erlauben es, die pathologisch veränderten Werte bei diesen spezifischen Krankheitsbildern und klinischen Studien besser einzuordnen und zu verstehen. N2 - The systolic ejection time (SET) and the pre-ejection time (pET) are time intervals that can be reliably recorded using transthoracic echocardiography and represent important aspects in cardiac performance diagnostics. However, there are currently no standard values for these systolic time intervals. The present research paper analyzed echocardiographic data from 4965 subjects from the STAAB study, a comprehensively characterized population-based cohort study with the aim of establishing standard values for the systolic time intervals and identifying and quantifying their determinants using multivariable regression analyses. Due to the strong dependency of SET on heart rate, the heart rate-corrected SETc was introduced which was calculated based on the QTc-time according to Fridericia ("SET" /∛("RR-Intervall" )). The standard values were generated from the STAAB study based on the healthy subgroup (defined by the absence of cardiovascular risk factors or diseases; N=966). Regarding the strong influence of gender and age, specific reference values for SET, SETc and pET implying gender and age affection were calculated. SETc was strongly correlated with left ventricular ejection fraction as well as end-diastolic volume and stroke volume. In addition, there was a notable correlation between SETc and specific markers of afterload (Ea and Ees). The large list of clinical markers collected in STAAB resulted in a number of affecting factors. Significant determinants of the systolic time intervals were in particular the metabolic syndrome (and its components), smoking behavior and the use of β-blockers. The results show that the systolic time intervals, especially SETc, can provide reliable information about cardiac contraction. New classes of substances are currently being investigated, which are supposed to work, among other things, by modifying SET. In particular, myosin activators in heart failure with reduced ejection fraction such as Omecamtiv Mecarbil or myosin inhibitors in hypertrophic obstructive cardiomyopathy should be mentioned here. The current studies also consider the effects of these drugs on the systolic time intervals as important surrogates of the clinical effects and the prognosis. The standard values for these time intervals enable better classifiying and unterstanding pathologically changed values in these specific disease pattern and clinical studies. KW - Referenzwert KW - Herzinsuffizienz KW - Risikofaktor KW - Systolische Ejektionszeit KW - kardiovaskuläre Risikofaktoren Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-370480 ER - TY - THES A1 - Engelbrecht, Elisabeth T1 - Retrospektive Auswertung des Therapieerfolges einer PTCD-Anlage bei Insuffizienz der Pankreatojejunostomie nach Pankreaskopfresektionen T1 - Retrospective evaluation of effective treatment of biliopancreatic fistulas due to leakage of the pancreatojejunostomy after pancreatic head resection by transhepatic biliary drainage N2 - Trotz stetiger Weiterentwicklung und Verbesserungen in chirurgischen Anastomosetechniken treten postoperative Pankreasfisteln (POPF) in 20 - 25 % der Patienten und Patientinnen als Komplikation nach partieller Pankreatikoduodenektomie (PPD) auf. Kommt es zu einer kombinierten Leckage aus Gallen- und Pankreassekret, wurde in dieser Arbeit die Definition einer komplizierten POPF (CPPF) eingeführt, welche eine seltene, aber schwerwiegende und gefährliche postoperative Komplikation darstellt. Neben einer Relaparotomie kann eine Restpankreatektomie als ultima ratio zur Beherrschung dieser schweren Komplikation notwendig werden, welche mit einer Mortalität von 50 % verbunden ist. Die Internationale Studiengruppe der Pankreaschirurgie (ISGPS) entwickelte ein Klassifikationssystem für POPF, welches auf Abweichungen der üblichen postoperativen Behandlungsstrategie beruht. Jedoch wurden keine spezifischen Behandlungsalgorithmen bzw. Therapiekonzepte, insbesondere im Falle einer CPPF, vorgeschlagen. In dieser Arbeit soll die therapeutische Effektivität einer perkutanen transhepatischen Cholangiodrainage (PTCD) bei Patienten und Patientinnen mit einer CPPF evaluiert werden. Dazu wurde eine retrospektive Analyse an Patienten und Patientinnen durchgeführt, welche eine CPPF nach PPD entwickelten. Die Patienten und Patientinnen wurden hinsichtlich der gewählten Behandlungsstrategie, des Outcomes, postoperativer Komplikationen nach Clavien-Dindo-Klassifikation, des CCI (Comprehensive Complication Index), der 30- und 90-Tage-Mortalität sowie Restpankreatektomie, postoperativer Arrosionsblutungen und der Hospitalisierungsdauer nach Behandlung einer CPPF analysiert. Zwischen 2007 und 2018 entwickelten 56 (19,1 %) von insgesamt 293 Patienten und Patientinnen eine relevante POPF (ISGPS Grad B/C) nach einer Pankreaskopfresektion. Darunter wurden 17 Patienten und Patientinnen mit einer komplizierten POPF (CPPF) identifiziert. 11 Patienten und Patientinnen erhielten als Behandlung eine PTCD und sechs Patienten und Patientinnen erhielten eine chirurgisch eingebrachte transhepatische Cholangiodrainage (CTCD) im Rahmen eines Revisionseingriffes. Es wurde keine Restpankreatektomie oder Reoperation nach einer initialen PTCD Therapie notwendig. In 4 von 17 Fällen kam es zu postoperativen Blutungen nach Einbringen einer transhepatischen Cholangiodrainage, der mediane CCI lag bei 44 ± 17,3, die mediane Hospitalisierungsdauer betrug 36 ± 19,2 Tage, die 30-Tage-Mortalität war 0 % und die 90-Tage-Mortalität 17,7 %. Es wurde kein Sterbefall in Verbindung mit einer PTCD beobachtet. Mit Hilfe dieser Studie kann gezeigt werden, dass eine PTCD eine praktikable, sichere und effektive Behandlungsoption für Patienten und Patientinnen mit einer CPPF bietet. Die Separierung von Galle und Pankreassaft stellt eine neuartige Behandlungsoption in ausgewählten Patienten und Patientinnen mit ausreichend drainierter CPPF nach PPD dar. N2 - Despite continuous advancements and improvements in surgical anastomosis techniques, postoperative pancreatic fistulas (POPF) occur as complications in 20-25 % of patients after partial pancreaticoduodenectomy (PPD). In cases of combined leakage of bile and pancreatic secretions, this work introduces the definition of a complicated POPF (CPPF), which is a rare but severe and dangerous postoperative complication. Besides a relaparotomy, a remaining pancreatectomy may be necessary as a last resort to control this severe complication, which is associated with a mortality rate of 50 %. The International Study Group of Pancreatic Surgery (ISGPS) developed a classification system for POPF based on deviations from the usual postoperative treatment strategy. However, no specific treatment algorithms or therapeutic concepts, especially in the case of a CPPF, have been proposed. This study aims to evaluate the therapeutic effectiveness of percutaneous transhepatic biliary drainage (PTCD) in patients with a CPPF. For this purpose, a retrospective analysis was conducted on patients who developed a CPPF after PPD. The patients were analyzed regarding the chosen treatment strategy, outcome, postoperative complications according to the Clavien-Dindo classification, the Comprehensive Complication Index (CCI), the 30- and 90-day mortality rates, as well as remaining pancreatectomy, postoperative erosive bleeding and hospitalization duration after treatment of a CPPF. Between 2007 and 2018, 56 (19.1%) out of a total of 293 patients developed a relevant POPF (ISGPS Grade B/C) after pancreatic head resection. Among them, 17 patients with a complicated POPF (CPPF) were identified. Eleven patients received PTCD as treatment, and six patients received surgically placed transhepatic biliary drainage (CTCD) as part of a revision procedure. No remaining pancreatectomy or reoperation was necessary after initial PTCD therapy. In 4 out of 17 cases, postoperative bleeding occurred after the introduction of a transhepatic biliary drainage; the median CCI was 44 ± 17.3, the median hospitalization duration was 36 ± 19.2 days, the 30-day mortality was 0%, and the 90-day mortality was 17.7%. No deaths associated with PTCD were observed. This study demonstrates that PTCD offers a feasible, safe and effective treatment option for patients with a CPPF. The separation of bile and pancreatic juice presents an innovative treatment option in selected patients with adequately drained CPPF after PPD. KW - Bauchspeicheldrüsenkrebs KW - Postoperative Komplikation KW - Pankreasfistel KW - PTCD KW - postoperative Pankreasfistel KW - Anastomoseninsuffizienz Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-370395 ER - TY - JOUR A1 - Franke, Barbara A1 - Michelini, Giorgia A1 - Asherson, Philip A1 - Banaschewski, Tobias A1 - Bilbow, Andrea A1 - Buitelaar, Jan K. A1 - Cormand, Bru A1 - Faraone, Stephen V. A1 - Ginsberg, Ylva A1 - Haavik, Jan A1 - Kuntsi, Jonna A1 - Larsson, Henrik A1 - Lesch, Klaus-Peter A1 - Ramos-Quiroga, J. Antoni A1 - Réthelyi, János M. A1 - Ribases, Marta A1 - Reif, Andreas T1 - Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan JF - European Neuropsychopharmacology N2 - Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies. KW - developmental trajectory KW - treatment KW - comorbidity KW - cognitive impairment KW - genetics KW - adult-onset ADHD Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-228407 VL - 28 ER - TY - JOUR A1 - Estes, Chris A1 - Anstee, Quentin M. A1 - Arias-Loste, Maria Teresa A1 - Bantel, Heike A1 - Bellentani, Stefano A1 - Caballeria, Joan A1 - Colombo, Massimo A1 - Craxi, Antonio A1 - Crespo, Javier A1 - Day, Christopher P. A1 - Eguchi, Yuichiro A1 - Geier, Andreas A1 - Kondili, Loreta A. A1 - Kroy, Daniela C. A1 - Lazarus, Jeffrey V. A1 - Loomba, Rohit A1 - Manns, Michael P. A1 - Marchesini, Giulio A1 - Nakajima, Atsushi A1 - Negro, Francesco A1 - Petta, Salvatore A1 - Ratziu, Vlad A1 - Romero-Gomez, Manuel A1 - Sanyal, Arun A1 - Schattenberg, Jörn M. A1 - Tacke, Frank A1 - Tanaka, Junko A1 - Trautwein, Christian A1 - Wei, Lai A1 - Zeuzem, Stefan A1 - Ravazi, Homie T1 - Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 JF - Journal of Hepatology N2 - Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. This burden is expected to increase as epidemics of obesity, diabetes and metabolic syndrome continue to grow. The goal of this analysis was to use a Markov model to forecast NAFLD disease burden using currently available data. Methods A model was used to estimate NAFLD and NASH disease progression in eight countries based on data for adult prevalence of obesity and type 2 diabetes mellitus (DM). Published estimates and expert consensus were used to build and validate the model projections. Results If obesity and DM level off in the future, we project a modest growth in total NAFLD cases (0–30%), between 2016–2030, with the highest growth in China as a result of urbanization and the lowest growth in Japan as a result of a shrinking population. However, at the same time, NASH prevalence will increase 15–56%, while liver mortality and advanced liver disease will more than double as a result of an aging/increasing population. Conclusions NAFLD and NASH represent a large and growing public health problem and efforts to understand this epidemic and to mitigate the disease burden are needed. If obesity and DM continue to increase at current and historical rates, both NAFLD and NASH prevalence are expected to increase. Since both are reversible, public health campaigns to increase awareness and diagnosis, and to promote diet and exercise can help manage the growth in future disease burden. Lay summary Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis can lead to advanced liver disease. Both conditions are becoming increasingly prevalent as the epidemics of obesity and diabetes continue to increase. A mathematical model was built to understand how the disease burden associated with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis will change over time. Results suggest increasing cases of advanced liver disease and liver-related mortality in the coming years. KW - burden of disease KW - cardiovascular disease KW - health care resource utilization KW - metabolic syndrome KW - NAFLD KW - NASH KW - cirrhosis KW - HCC KW - diabetes mellitus KW - obesity Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227286 VL - 69 ER - TY - THES A1 - Bredemeyer, Cynthia Natascha T1 - Akademisierung und Professionalisierung der Zahnheilkunde, insbesondere der Zahnchirurgie, in Würzburg und Unterfranken im 19. Jahrhundert T1 - The dental surgical instrument collection of the Juliusspital in Würzburg: The professionalization of dentistry, especially the dental surgery in 19th century Würzburg and Franconia / Bavaria N2 - Die Arbeit befasst sich mit der Akademisierung und Professionalisierung der Zahnheilkunde, insbesondere der Zahnchirurgie, in Würzburg und Unterfranken im 19. Jahrhundert. Dies wurde insbesondere anhand des zahnchirurgischen Teils der Lehrchirurgischen Instrumentensammlung der Universität Würzburg bzw. des Juliusspitals erforscht. Der zahnchirurgische Teil der Instrumentensammlung war bisher noch nicht erforscht worden und besteht aktuell aus 34+1 Instrumenten, die für diese Arbeit komplett katalogisiert wurden. Für die Entwicklung der Instrumente im Verlauf des 19. Jahrhunderts wurde die Provenienz der Teilsammlung ergründet und diese in den Kontext der Akademisierungsbewegung des 19. Jahrhunderts eingeordnet. Die Forschung wurde anhand der tatsächlich in der Praxis tätigen und nach und nach akademisch ausgebildeten Personen nachvollzogen. Hierzu wurden neben den Instrumenten als Quelle die Adressbücher der Stadt Würzburg und die Matrikel-, Personal- und Vorlesungsverzeichnisse der Universität Würzburg des gesamten 19. Jahrhunderts systematisch durchgearbeitet. Außerdem wurden Lehrbücher aus dem nichtakademischen zahnchirurigischen Bereich (Bader) mit denen aus dem sich beginnenden akademischen Bereich analysiert. Anhand dieser Forschungsarbeit konnte dargelegt werden, dass die Zahnchirurgie sich analog zur Chiurgie aus dem handwerklichen Bereich abgekoppelt und nach und nach auf verschiedenen Stufen akademisiert hat. Die Zahnchirurgie hat sich "von unten nach oben" durch das Bestreben nichtakademisch ausgebildeter Menschen akademisiert. N2 - The thesis deals with the academization and professionalization of dentistry, especially dental surgery, in Würzburg and lower Franconia in the 19th century. This was researched in particular on the basis of the dental surgical part of the surgical instrument collection of the University of Würzburg and the Juliusspital. The dental surgical part of the instrument collection had not yet been researched and currently consists of 34+1 instruments, which were completely catalogued for this work. For the development of the instruments over the course of the 19th century, the provenance of the partial collection was investigated and placed in the context of the academization movement of the 19th century. The research was traced on the basis of the people who actually worked in the field and were gradually trained academically. In addition to the instruments as sources, the address books of the city of Würzburg and the matriculation, personnel and lecture directories of the University of Würzburg for the entire 19th century were systematically analyzed. In addition, textbooks from the non-academic dental surgery field (so called "Bader") were analyzed with those from the emerging academic field. On the basis of this research, it was possible to demonstrate that dental surgery, like surgery, separated itself from the craft sector and gradually became academicized at various stages. Dental surgery has developed and academized "from bottom up" due to efforts of non-academic trained people. KW - Zahnchirurgie KW - Akademisierung KW - Professionalisierung KW - Instrument KW - Lehrchirurgische Sammlung KW - Juliusspital Würzburg KW - 19. Jahrhundert Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-363878 ER - TY - THES A1 - Morabbian, Jasamin T1 - Etablierung von Stammzell-Sphäroiden mit inkorporierten Biokeramik-Partikeln zur Förderung der osteogenen Differenzierung T1 - Establishment of stem cell spheroids with incorporated bioceramic particles for the promotion of osteogenic differentiation N2 - In der vorliegenden Dissertationsarbeit wurden Sphäroide aus mesenchymalen Stammzellen aus dem Fettgewebe oder dem Knochenmark mittels der Micromold-Methode hergestellt. Den Sphäroiden wurden entweder Calciumphosphat- oder Calcium-Magnesium-Phosphat-Partikel hinzugefügt. Zum einen sollte überprüft werden, ob die Zugabe von Partikeln die osteogene Differenzierung der Sphäroide fördert und somit zur weiteren Entwicklung von körpereigenem Knochenersatzmaterial in der regenerativen Medizin beiträgt. Zum anderen sollte festgestellt werden, ob eine der beiden Biokeramiken hinsichtlich der osteogenen Differenzierung überlegen ist. N2 - In this dissertation, spheroids were produced from mesenchymal stem cells from adipose tissue or bone marrow using the micromold method. Either calcium phosphate or calcium magnesium phosphate particles were added to the spheroids. On the one hand, it was to be examined whether the addition of particles promotes the osteogenic differentiation of the spheroids and thus contributes to the further development of endogenous bone replacement material in regenerative medicine. Secondly, to determine whether one of the two bioceramics is superior in terms of osteogenic differentiation. KW - Stammzelle KW - Calciumphosphat KW - Spheroid KW - Knochenzement KW - Knochenersatzmaterial KW - Calcium-Magnesium-Phosphat Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-369256 ER - TY - JOUR A1 - Bugai, Andrii A1 - Quaresma, Alexandre J. C. A1 - Friedel, Caroline C. A1 - Lenasi, Tina A1 - Düster, Robert A1 - Sibley, Christopher R. A1 - Fujinaga, Koh A1 - Kukanja, Petra A1 - Hennig, Thomas A1 - Blasius, Melanie A1 - Geyer, Matthias A1 - Ule, Jernej A1 - Dölken, Lars A1 - Barborič, Matjaž T1 - P-TEFb Activation by RBM7 Shapes a Pro-survival Transcriptional Response to Genotoxic Stress JF - Molecular Cell N2 - DNA damage response (DDR) involves dramatic transcriptional alterations, the mechanisms of which remain ill defined. Here, we show that following genotoxic stress, the RNA-binding motif protein 7 (RBM7) stimulates RNA polymerase II (Pol II) transcription and promotes cell viability by activating the positive transcription elongation factor b (P-TEFb) via its release from the inhibitory 7SK small nuclear ribonucleoprotein (7SK snRNP). This is mediated by activation of p38MAPK, which triggers enhanced binding of RBM7 with core subunits of 7SK snRNP. In turn, P-TEFb relocates to chromatin to induce transcription of short units, including key DDR genes and multiple classes of non-coding RNAs. Critically, interfering with the axis of RBM7 and P-TEFb provokes cellular hypersensitivity to DNA-damage-inducing agents due to activation of apoptosis. Our work uncovers the importance of stress-dependent stimulation of Pol II pause release, which enables a pro-survival transcriptional response that is crucial for cell fate upon genotoxic insult. KW - Pol II elongation KW - Pol II pause release KW - P-TEFb KW - CDK9 KW - 7SK snRNP KW - RBM7 KW - genotoxic stress KW - DNA damage response KW - p38 MAP kinase KW - apoptosis Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-221726 VL - 74 ER - TY - THES A1 - Laqua, Caroline T1 - Association of myocardial tissue characteristics and functional outcome in biopsy-verified myocarditis assessed by cardiac magnetic resonance imaging T1 - Zusammenhänge zwischen geweblichen Eigenschaften des Myokards und funktionellem Outcome bei biopsie-verifizierter Myokarditis im Kardio-MRT N2 - The relation between LV function and cardiac MRI tissue characteristics in separate myocardial segments and their change over time has yet to be explored in myocarditis. Thus, our research aimed to investigate possible associations between global and regional myocardial T1 and T2 times and peak strain in patients with suspected myocarditis. From 2012 to 2015, 129 patients with clinically suspected myocarditis of the prospective, observational MyoRacer-Trial underwent systematic biventricular EMB at baseline and cardiac MRI at baseline and after three months as a follow-up. We divided the LV myocardium into 17 segments and estimated the segmental myocardial strain using FT. We registered T1 and T2 maps to the cine sequences and transferred the segmentations used for FT to ensure conformity of the myocardial segments. Multi-level multivariable linear mixed effects regression was applied to investigate the relation of segmental myocardial strain to relaxation times and their respective change from baseline to follow-up. We found a significant improvement in myocardial peak strain from baseline to follow-up (p < 0.001; all p-values given for likelihood ratio tests) and significant associations between higher T1 and T2 times and lower segmental myocardial peak strain (p ranging from < 0.001 to 0.049). E.g., regression coefficient (Reg. coef.) for segmental radial peak strain in short axis view (SRPS_SAX) and T1 time: -1.9, 95% CI (-2.6;-1.2) %/100 ms, p < 0.001. A decrease in T1 and T2 times from baseline to follow-up was also significantly related to a recovery of segmental peak strains (p ranging from < 0.001 to 0.050). E.g., Reg. coef. for SRPS_SAX per ΔT1: -1.8, 95% CI (-2.5;-1.0) %/100 ms, p < 0.001. Moreover, the higher the baseline T1 time, the more substantial the functional recovery from baseline to follow-up (p ranging from 0.004 to 0.042, e.g., for SRPS_SAX: Reg. coef. 1.3, 95% CI (0.4;2.1) %/100 ms, p 0.004). We did not find an effect modification by the presence of myocarditis in the EMB (p > 0.1). Our cross-sectional and longitudinal analyses provide evidence of dose-dependent correlations between T1 and T2 relaxation times and myocardial peak strain in patients with clinical presentation of myocarditis, regardless of the EMB result. Thus, assessing strain values and mapping relaxation times helps estimate the functional prognosis in patients with clinically suspected myocarditis. N2 - Die Zusammenhänge zwischen der kardialen linksventrikulären (LV) Funktion und magnetresonanztomographisch erhebbaren Parametern des Myokards sowie deren jeweiligen Entwicklungen im zeitlichen Verlauf einer Myokarditis sind bisher nicht umfassend untersucht. Daher beschäftigt sich die vorliegende Arbeit mit der Erforschung des Verhältnisses von globalen und regionalen peak strain-Werten und T1 und T2 Zeiten des LV Myokards in der Magnetresonanztomographie (MRT) bei Patienten mit Verdacht auf Myokarditis. Die MyoRacer-Studie ist eine prospektive Beobachtungsstudie, die von 2012 bis 2015 am Herzzentrum des Universitätsklinikums Leipzig durchgeführt wurde. Dabei wurden 129 Patienten mit klinischem Verdacht auf Myokarditis mittels biventrikulärer Myokardbiopsie sowie kardialer MRT untersucht. Drei Monate nach der Erstuntersuchung (EU) erfolgte eine MRT-Folgeuntersuchung (FU). Für unsere Analysen unterteilten wir das LV Myokard standardmäßig in 17 Segmente, um mithilfe der Technik des feature trackings den segmentalen peak strain zu evaluieren. Weiterhin registrierten wir T1 und T2 maps gegen cine-Sequenzen der MRT und übertrugen die Segmentierungen aus den cine-Sequenzen zwecks Übereinstimmung in die MRT maps. Anschließend analysierten wir die Zusammenhänge zwischen segmentalem strain und T1 und T2 Zeiten und deren jeweiligen Veränderungen im zeitlichen Verlauf mithilfe eines hierarchischen, multivariablen, gemischten linearen Regressionsmodells. Unsere Ergebnisse zeigen eine signifikante Verbesserung der peak strain-Werte von der EU zur FU (p < 0.001; alle p-Werte für likelihood ratio tests angegeben) sowie eine signifikante Assoziation von erhöhten T1 und T2 Zeiten mit verminderten segmentalen peak strain-Werten (p zwischen < 0.001 und 0.049). Weiterhin war ein Abfall der T1 und T2 Zeiten von der EU zur FU signifikant mit einer Erholung der segmentalen peak strain-Werte verknüpft (p zwischen < 0.001 und 0.050). Je höher die T1 Zeiten bei der EU ausfielen, desto stärker erholte bzw. verbesserte sich der peak strain von der EU zur FU (p zwischen 0.004 und 0.042). Eine Effektmodifikation durch den bioptischen Nachweis einer Myokarditis war nicht zu beobachten (p > 0.1). Unsere Quer- und Längsschnittanalysen belegen dosisabhängige Zusammenhänge zwischen T1 und T2 Zeiten und myokardialen peak strain-Werten bei Patienten mit dem klinischen Bild einer Myokarditis, unabhängig vom Ergebnis der Myokardbiopsie. Daher ist die Bestimmung von T1 und T2 Zeiten und myokardialem strain mittels kardialer MRT zur Abschätzung der funktionellen Prognose bei Patienten mit klinischem Verdacht auf Myokarditis hilfreich. KW - Myokarditis KW - Kernspintomografie KW - T1-Zeit KW - T2-Zeit KW - strain KW - t1 time KW - t2 time KW - myocarditis KW - MRI Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-363903 ER - TY - JOUR A1 - Baluapuri, Apoorva A1 - Hofstetter, Julia A1 - Dudvarski Stankovic, Nevenka A1 - Endres, Theresa A1 - Bhandare, Pranjali A1 - Vos, Seychelle Monique A1 - Adhikari, Bikash A1 - Schwarz, Jessica Denise A1 - Narain, Ashwin A1 - Vogt, Markus A1 - Wang, Shuang-Yan A1 - Düster, Robert A1 - Jung, Lisa Anna A1 - Vanselow, Jens Thorsten A1 - Wiegering, Armin A1 - Geyer, Matthias A1 - Maric, Hans Michael A1 - Gallant, Peter A1 - Walz, Susanne A1 - Schlosser, Andreas A1 - Cramer, Patrick A1 - Eilers, Martin A1 - Wolf, Elmar T1 - MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation JF - Molecular Cell N2 - The MYC oncoprotein binds to promoter-proximal regions of virtually all transcribed genes and enhances RNA polymerase II (Pol II) function, but its precise mode of action is poorly understood. Using mass spectrometry of both MYC and Pol II complexes, we show here that MYC controls the assembly of Pol II with a small set of transcription elongation factors that includes SPT5, a subunit of the elongation factor DSIF. MYC directly binds SPT5, recruits SPT5 to promoters, and enables the CDK7-dependent transfer of SPT5 onto Pol II. Consistent with known functions of SPT5, MYC is required for fast and processive transcription elongation. Intriguingly, the high levels of MYC that are expressed in tumors sequester SPT5 into non-functional complexes, thereby decreasing the expression of growth-suppressive genes. Altogether, these results argue that MYC controls the productive assembly of processive Pol II elongation complexes and provide insight into how oncogenic levels of MYC permit uncontrolled cellular growth. KW - MYC KW - SPT5 KW - SUPT5H KW - SPT6 KW - RNA polymerase II KW - transcription KW - elongation rate KW - processivity KW - directionality KW - tumorigenesis Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-221438 VL - 74 ER - TY - JOUR A1 - McColl, Erin A1 - Groll, Jürgen A1 - Jungst, Tomasz A1 - Dalton, Paul D. T1 - Design and fabrication of melt electrowritten tubes using intuitive software JF - Materials and Design N2 - This study approaches the accurate continuous direct-writing onto a cylindrical collector from a mathematical perspective, taking into account the winding angle, cylinder diameter and length required for the final 3D printed tube. Using an additive manufacturing process termed melt electrowriting (MEW), porous tubes intended for tissue engineering applications are fabricated from medical-grade poly(ε-caprolactone) (PCL), validating the mathematically-derived method. For the fabricated tubes in this study, the pore size, winding angle and printed length can all be planned in advance and manufactured as designed. The physical dimensions of the tubes matched theoretical predictions and mechanical testing performed demonstrated that variations in the tubular morphology have a direct impact on their strength. MEWTubes, the web-based application developed and described here, is a particularly useful tool for planning the complex continuous direct writing path required for MEW onto a rotating, cylindrical build surface. KW - additive manufacturing KW - 3D printing KW - electrohydrodynamic printing KW - biomaterials KW - polycaprolactone Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-223891 VL - 155 ER - TY - JOUR A1 - Colunga, Thomas A1 - Hayworth, Miranda A1 - Kreß, Sebastian A1 - Reynolds, David M. A1 - Chen, Luoman A1 - Nazor, Kristopher L. A1 - Baur, Johannes A1 - Singh, Amar M. A1 - Loring, Jeanne F. A1 - Metzger, Marco A1 - Dalton, Stephen T1 - Human Pluripotent Stem Cell-Derived Multipotent Vascular Progenitors of the Mesothelium Lineage Have Utility in Tissue Engineering and Repair JF - Cell Reports N2 - In this report we describe a human pluripotent stem cell-derived vascular progenitor (MesoT) cell of the mesothelium lineage. MesoT cells are multipotent and generate smooth muscle cells, endothelial cells, and pericytes and self-assemble into vessel-like networks in vitro. MesoT cells transplanted into mechanically damaged neonatal mouse heart migrate into the injured tissue and contribute to nascent coronary vessels in the repair zone. When seeded onto decellularized vascular scaffolds, MesoT cells differentiate into the major vascular lineages and self-assemble into vasculature capable of supporting peripheral blood flow following transplantation. These findings demonstrate in vivo functionality and the potential utility of MesoT cells in vascular engineering applications. KW - stem cells KW - mesothelium KW - vascular progenitor KW - tissue engineering KW - regenerative medicine Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-223217 VL - 26 ER - TY - JOUR A1 - Chhatbar, Chintan A1 - Detje, Claudia N. A1 - Grabski, Elena A1 - Borst, Katharina A1 - Spanier, Julia A1 - Ghita, Luca A1 - Elliott, David A. A1 - Jordão, Marta Joana Costa A1 - Mueller, Nora A1 - Sutton, James A1 - Prajeeth, Chittappen K. A1 - Gudi, Viktoria A1 - Klein, Michael A. A1 - Prinz, Marco A1 - Bradke, Frank A1 - Stangel, Martin A1 - Kalinke, Ulrich T1 - Type I Interferon Receptor Signaling of Neurons and Astrocytes Regulates Microglia Activation during Viral Encephalitis JF - Cell Reports N2 - In sterile neuroinflammation, a pathological role is proposed for microglia, whereas in viral encephalitis, their function is not entirely clear. Many viruses exploit the odorant system and enter the CNS via the olfactory bulb (OB). Upon intranasal vesicular stomatitis virus instillation, we show an accumulation of activated microglia and monocytes in the OB. Depletion of microglia during encephalitis results in enhanced virus spread and increased lethality. Activation, proliferation, and accumulation of microglia are regulated by type I IFN receptor signaling of neurons and astrocytes, but not of microglia. Morphological analysis of myeloid cells shows that type I IFN receptor signaling of neurons has a stronger impact on the activation of myeloid cells than of astrocytes. Thus, in the infected CNS, the cross talk among neurons, astrocytes, and microglia is critical for full microglia activation and protection from lethal encephalitis. KW - encephalitis KW - regulation of microglia activation KW - neurons KW - astrocytes KW - type I IFN receptor signaling Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-222456 VL - 25 ER - TY - JOUR A1 - Kusch, Valentin A1 - Bornschein, Grit A1 - Loreth, Desiree A1 - Bank, Julia A1 - Jordan, Johannes A1 - Baur, David A1 - Watanabe, Masahiko A1 - Kulik, Akos A1 - Heckmann, Manfred A1 - Eilers, Jens A1 - Schmidt, Hartmut T1 - Munc13-3 Is Required for the Developmental Localization of Ca2+ Channels to Active Zones and the Nanopositioning of Cav2.1 Near Release Sensors JF - Cell Reports N2 - Spatial relationships between Cav channels and release sensors at active zones (AZs) are a major determinant of synaptic fidelity. They are regulated developmentally, but the underlying molecular mechanisms are largely unclear. Here, we show that Munc13-3 regulates the density of Cav2.1 and Cav2.2 channels, alters the localization of Cav2.1, and is required for the development of tight, nanodomain coupling at parallel-fiber AZs. We combined EGTA application and Ca2+-channel pharmacology in electrophysiological and two-photon Ca2+ imaging experiments with quantitative freeze-fracture immunoelectron microscopy and mathematical modeling. We found that a normally occurring developmental shift from release being dominated by Ca2+ influx through Cav2.1 and Cav2.2 channels with domain overlap and loose coupling (microdomains) to a nanodomain Cav2.1 to sensor coupling is impaired in Munc13-3-deficient synapses. Thus, at AZs lacking Munc13-3, release remained triggered by Cav2.1 and Cav2.2 microdomains, suggesting a critical role of Munc13-3 in the formation of release sites with calcium channel nanodomains. KW - coupling KW - nanodomain KW - synapse KW - active zone KW - development KW - Ca2+ channels KW - Munc13-3 KW - cerebellar cortex KW - transmitter release Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-233468 VL - 22 ER - TY - JOUR A1 - Gerber, Bertram A1 - König, Christian A1 - Fendt, Markus A1 - Andreatta, Marta A1 - Romanos, Marcel A1 - Pauli, Paul A1 - Yarali, Ayse T1 - Timing-dependent valence reversal: a principle of reinforcement processing and its possible implications JF - Current Opinion in Behavioral Sciences N2 - Punishment feels bad, but relief upon its termination feels good. As a consequence of such timing-dependent valence reversal, memories of opposite valence can result from associating stimulus A with, for example, the occurrence of punishment (A-) versus punishment termination (-A): A- training results in aversive memory, but -A training in appetitive memory (corresponding effects exist for reward occurrence and termination). Whereas learning through the occurrence of punishment is well studied, much less is known about learning through its termination. Current research investigates how dopaminergic system function contributes to these processes in Drosophila, rats and humans. We argue that dopamine-related psychopathology may entail distortions in learning through punishment termination, and that this may contribute, for example, to non-suicidal self-injury or post-traumatic stress disorder. Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-232933 VL - 26 ER - TY - THES A1 - Fleißner, Janik Frank Hans-Werner T1 - Die Bedeutung von Oncostatin M für die Lipidhomöostase Apoe- und Ldlr-deletierter Mäuse T1 - The Significance of Oncostatin M for the Lipid Homeostasis in Apoe and Ldlr Knockout Mice N2 - OSM, ein Vertreter der IL-6-Typ-Zytokine, ist nicht nur für entzündliche, sondern auch für metabolische Prozesse von Bedeutung. Vorarbeiten der Arbeitsgruppe GEIER/HERMANNS und Studien von KOMORI et al. legen protektive Eigenschaften des Zytokins nahe, da Mäuse, denen OSMR fehlte, Charakteristika des metabolischen Syndroms aufwiesen. Zur eingehenderen Untersuchung der von OSM vermittelten Wirkung auf den murinen Lipidstoffwechsel wurden zwei für die NAFLD und Atherosklerose anfällige Modelle herangezogen und jeweils in Gegenwart und Abwesenheit des Osmr studiert: Weibliche Apoe-/-(Osmr-/-) und Ldlr-/-(Osmr-/-) Mäuse wurden über einen Zeitraum von zwölf Wochen mit westlicher Diät gefüttert, wöchentlich gewogen, am Ende der Diät geopfert und geerntet. Wildtypische C57Bl/6-Mäuse erfuhren die gleiche Behandlung und dienten als Referenzgruppe. Im Rahmen des Promotionsprojektes wurden Leberfettgehalt, Serumlipidspiegel, Lipoproteinfraktionen und Stuhllipide von Apoe-deletierten Mäusen bestimmt und mit bereits vorhandenen Daten der Ldlr-/-(Osmr-/-) und wildtypischen Mäuse in Beziehung gesetzt. Expressionsanalysen von am Lipidstoffwechsel beteiligten Genen in Darm-, Leber- und Fettgewebe trugen dazu bei, OSM-abhängige Regulationen aufzudecken. Ldlr-/- Tiere nahmen unter der Diät exzessiv zu, hatten hohe Serumspiegel an Leptin, Gluco-se und Lipiden, eine Lebersteatose und, begleitet von einer Induktion des Vldlr, erhöhte inflammatorische Marker im visceralen Fettgewebe. Der zusätzliche Knockout des Osmr ging mit einer geringeren Vldlr-Expression im Fettgewebe und einer hepatozytären Induktion von Cyp7a1 einher und resultierte in einem metabolisch günstigeren Phänotyp. Apoe-defiziente Tiere unterschieden sich hinsichtlich ihrer Gewichtszunahme nicht von Ldlr-/-Osmr-/- und C57Bl/6-Mäusen. Überraschenderweise zeigten sich im Serum von Apoe-/-Osmr-/- jedoch gegenüber Apoe-/- Mäusen erhöhte Konzentrationen des Gesamt- und VLDL-Cholesterins, der Triglyceride und freien Fettsäuren. Obwohl Lebern der Apoe-/-Osmr-/- Mäuse geringere Ldlr- und Lrp1-mRNA-Spiegel als die der Apoe-/- Mäuse aufwiesen, hatten sie einen höheren hepatischen Cholesteringehalt. Bei gesteigerter Cpt1a-Expression fiel der hepatische Tri-glyceridgehalt Apoe-deletierter Mäuse geringer aus als in Ldlr-/-(Osmr-/-) und wildtypischen Tieren. Unter Umgehung einer Fettgewebsentzündung präsentierten Apoe-defiziente Mäuse Hinweise einer inflammatorischen Leberschädigung, die pathogenetisch am ehesten mit einer gestörten Cholesterinhomöostase in Verbindung zu bringen war. Abhängig vom genetischen Hintergrund des Mausmodells hatte OSM schützende oder schädliche Effekte auf den Lipidmetabolismus. Die Ergebnisse der vorliegenden Arbeit betonen die entscheidende Bedeutung entzündlicher, von OSM modulierter Prozesse für den Fettstoffwechsel in Leber- und Fettgewebe. Weiterführende Experimente sind nötig, um die den Beobachtungen zugrunde liegenden molekularen Mechanismen zu entschlüsseln. N2 - OSM, a member of the IL-6-type family, plays a pivotal role not only in inflammatory pro-cesses, but also in the regulation of metabolism. In line with studies conducted by KOMORI et al., findings obtained by GEIER/HERMANNS revealed characteristics of the metabolic syndrome in mice lacking the OSMR. Therefore, protective properties of OSM were suggested. In order to further investigate OSM-mediated effects on murine lipid metabolism, two models prone to NAFLD and atherosclerosis were employed and studied in the presence and absence of Osmr: Female Apoe-/-(Osmr-/-) and Ldlr-/-(Osmr-/-) mice were fed a Western-type diet for twelve weeks, weighed weekly, sacrificed and harvested at the end of the diet. Wild-type C57Bl/6 mice underwent the same procedure and were used as a reference group. Thereafter, lipid levels and lipoprotein fractions in the sera of Apoe-deleted mice were deter-mined. In addition, their lipid content in liver tissue and stool was measured. Findings were compared with data from Ldlr-/-(Osmr-/-) and wild-type mice. To reveal OSM-dependent regulations of genes playing a key role in lipid metabolism, gene expression analyses were performed in intestinal, liver, and adipose tissue samples from all mice groups. Ldlr-/- animals excessively gained weight during the diet, had high serum levels of leptin, glucose, and lipids, hepatic steatosis, and, accompanied by induction of Vldlr, increased inflammatory markers in visceral adipose tissue. The additional knockout of Osmr was accom-panied by a lower Vldlr expression in adipose tissue and an induction of liver Cyp7a1, resulting in a metabolically favorable phenotype. In terms of weight gain, Apoe-deficient animals were not different from Ldlr-/-Osmr-/- and C57Bl/6 mice. Surprisingly, however, serum from Apoe-/-Osmr-/- mice showed increased concentrations of total and VLDL cholesterol, triglyc-erides, and free fatty acids when compared to Apoe-/- animals. Despite lower hepatic Ldlr and Lrp1 mRNA levels, Apoe-/-Osmr-/- mice had a higher hepatic cholesterol content than Apoe-/- mice. Fitting to an increased Cpt1a expression, the hepatic triglyceride content of Apoe-deleted mice was lower than in Ldlr-/-(Osmr-/-) and wild-type mice. Most likely due to an impaired hepatic cholesterol homeostasis, liver sections of Apoe-deleted mice displayed features of inflammation, whereas the adipose tissues of these animals remained rather unscathed. Depending on the genetic background of the mouse model, OSM had protective or deleterious effects on lipid metabolism. The results of this project emphasize the significance of OSM regarding both inflammation and metabolism in liver and adipose tissue. Further ex-periments are needed to unravel the molecular mechanisms underlying these observations. KW - Apolipoprotein E KW - LDL-Rezeptor KW - Oncostatin M KW - Oncostatin-M-Rezeptor KW - Lipoprotein KW - Oncostatin M receptor KW - lipoprotein KW - Interleukin-6-Typ-Zytokine KW - Interleukin-6 type cytokines Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-280592 ER - TY - THES A1 - Das [geb. Nitschke], Felix Marcel T1 - DNA-Methylierung und Genexpression von FKPB5 als Teil des Stresshormonsystems bei von Depressionen und Herzinsuffizienz Betroffenen sowie gesunden Kontrollen T1 - DNA methylation and gene expression of FKPB5 as part of the stress hormone system in people affected by depression and heart failure as well as healthy controls N2 - FKBP5 stellt im Stresssystem der HPA-Achse ein zentrales Gen bei der Regulation der Sensitivität des Glukokortikoidrezeptors und somit der Reaktion auf Stress dar. Zur Adaptation an Umwelteinflüsse ist es selbst in ein komplexes System von Regulationsmechanismen eingebettet, die unter anderem epigenetische Modifikationen in Form von DNA-Methylierung umfassen. Bisherige Studien legen eine starke Assoziation von FKBP5 zu stressinduzierten psychischen Erkrankungen nahe und weisen auf eine Dysregulation der HPA-Achse als möglichen Pathomechanismus hin. Für die enge klinische Interaktion von Depression und Herzinsuffizienz sowie eine ebenfalls vermutete Rolle der HPA-Achse in der Pathogenese letzterer, könnte FKBP5 daher ein entscheidendes Bindeglied darstellen. Gleichzeitig bietet die Identifikation einer über FKBP5 ausgedrückten Dysregulation der HPA-Achse einen biologischen Befund, der als Marker für das Ansprechen einer antidepressiven Therapie herangezogen werden könnte. Ziel dieser Arbeit war daher die Untersuchung eines möglichen Einflusses regulatorischer Parameter von FKBP5 auf die Herzinsuffizienz sowie eine Prüfung dieser als mögliche Biomarker für einen Erfolg der antidepressiven Therapie. Dazu wurden Blutproben von ProbandInnen der GEParD- bzw. DaCFail-Studie mit Depression, Herzinsuffizienz sowie gesunde Kontrollen untersucht. Durch Pyrosequenzierung bisulfitkonvertierter DNA erfolgte die Bestimmung der Methylierung regulatorischer CpGs. Die Messung der relativen mRNA-Expression erfolgte durch den Einsatz einer qPCR. In der Auswertung fand sich keine differentielle mRNA-Expression oder Methylierung zwischen den vier Untersuchungsgruppen. Allerdings reagierten depressive PatientInnen verglichen mit der Kontrollgruppe mit einer geringeren Zunahme der mRNA-Expression als Reaktion auf den mDST. Das Therapieansprechen in der Depressionsgruppe wiederum war mit einer niedrigeren Methylierung auf CpG7 sowie einer höheren mRNA-Expression zu Therapiebeginn assoziiert. Im Behandlungsverlauf führte eine Abnahme der mRNA-Expression bei den Respondern zu einer Annäherung beider Gruppen. Diese Arbeit konnte keine Hinweise für eine Rolle von FKBP5 in der Pathogenese der Herzinsuffizienz finden. Allerdings zeigten die Befunde zur Regulation des Gens bei Glukokortikoidstimulation eine hohe Konstanz zu vorherigen Ergebnissen. In diesen Kontext reihen sich auch die Ergebnisse für das Therapieansprechen ein, die aufgrund einer Herabregulation der HPA-Achse im Therapieverlauf die Idee einer ursächlichen HPA-Dysregulation in der Gruppe der Responder bekräftigen. Für sich allein genommen lassen sich mRNA-Expression und Methylierung aufgrund mangelnder Sensitivität und Spezifität nicht als Biomarker für das Therapieansprechen einsetzen. Die bisherigen Befunde bestärken aber eine mögliche Rolle in einer Batterie unterschiedlicher Biomarker auf verschiedenen Ebenen, wie Klinik, Psychometrie und Physiologie. N2 - FKBP5 represents a central gene in the stress system of the HPA axis in the regulation of the sensitivity of the glucocorticoid receptor and thus the reaction to stress. To adapt to environmental influences, it is itself embedded in a complex system of regulatory mechanisms, including epigenetic modifications in the form of DNA -Methylation. Previous studies suggest a strong association of FKBP5 with stress-induced mental illnesses and point to a dysregulation of the HPA axis as a possible pathomechanism. FKBP5 could therefore represent a crucial link for the close clinical interaction between depression and heart failure as well as a suspected role of the HPA axis in the pathogenesis of the latter. At the same time, the identification of HPA axis dysregulation expressed via FKBP5 provides a biological finding that could be used as a marker for the response to antidepressant therapy. The aim of this work was therefore to investigate a possible influence of regulatory parameters of FKBP5 on heart failure and to examine these as possible biomarkers for the success of the antidepressive therapy. For this purpose, blood samples from subjects of the GEParD or DaCFail study with depression, heart failure and healthy controls were examined. Pyrosequencing of bisulfite-converted DNA was used to determine the methylation of regulatory CpGs. The relative mRNA expression was measured using qPCR. The analysis found no differential mRNA expression or methylation between the four study groups. However, depressed patients responded with a smaller increase in mRNA expression in response to the mDST compared to the control group. The treatment response in the depression group was associated with lower methylation on CpG7 and higher mRNA expression at the start of therapy. Over the course of treatment, a decrease in mRNA expression in responders led to a convergence of both groups. This work did not find any evidence for a role for FKBP5 in the pathogenesis of heart failure. However, the findings on the regulation of the gene during glucocorticoid stimulation showed a high degree of consistency with previous results. The results for the treatment response also fit into this context, which strengthen the idea of a causal HPA dysregulation in the group of responders due to a downregulation of the HPA axis during the course of therapy. Taken alone, mRNA expression and methylation cannot be used as biomarkers of treatment response due to a lack of sensitivity and specificity. However, the findings so far support a possible role in a battery of different biomarkers at different levels, such as clinical, psychometrics and physiology. KW - Gen FKBP5 KW - Methylierung KW - Genexpression KW - Depression KW - Herzinsuffizienz KW - FKBP5 Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-369730 ER - TY - THES A1 - Wucherpfennig, Sophia T1 - HTS (high-throughput drug screening) zur Untersuchung der Blut-Hirn-Schranken-Permeabilität in vitro beim zerebral metastasierten Mammakarzinom T1 - High-throughput drug screening to investigate blood-brain barrier permeability in vitro with a focus on breast cancer chemotherapeutic agents N2 - Die Blut-Hirn-Schranke (BHS) stellt eine selektiv durchlässige Barriere dar, die den Austausch von Stoffen zwischen Blut und ZNS kontrolliert und so neuroprotektiv wirkt. Sie verhindert allerdings nicht nur die Passage toxischer Metaboliten, sondern verwehrt auch vielen therapeutischen Wirkstoffen den Zugang zum Gehirn. Die Forschung an Methoden zum Erreichen höherer Arzneimittelkonzentrationen im Gehirn ist deshalb essenziell für die Behandlung zerebraler Erkrankungen wie dem zerebral metastasierten Mammakarzinom. Ziel dieser Arbeit war es deshalb, Wirkstoffe zu identifizieren, die die Permeabilität der BHS erhöhen. Die Substanzdatenbank LO1208 von Sigma-Aldrich wurde im Rahmen eines HTS auf ihre permeabilitätsbeeinflussenden Eigenschaften untersucht. Hierbei konnten 31 Substanzen identifiziert werden, welche die Permeabilität von BLECs um mindestens 50 % erhöhen. Aus diesen wurden 4-Amino-1,8-naphthalimid (PARP-Inhibitor) und GW2974 (TKI) für eine genauere Analyse ausgewählt. Als dritter Wirkstoff wurde Ibuilast (Inhibitor der PDE4, des MIF sowie des Toll-like-Rezeptor-4) untersucht, wobei dieser keine signifikante Veränderung der Permeabilität bewirkt. Die Messung des TEERs und der Permeabilität für Fluorescein bestätigten die Ergebnisse aus dem HTS, welches demnach zukünftig für Permeabilitätstests eingesetzt werden kann. Die Zellviabilität wird durch 4 Amino-1,8-naphthalmid nicht beeinflusst. GW2974 und Ibudilast zeigen bei 500 µM einen toxischen Einfluss auf MCF-7-Zellen. BLECs werden durch 100 µM GW2974 gehemmt. Es konnte gezeigt werden, dass die erhöhte Permeabilität mit einer Veränderung der TJ-Proteinexpression einhergeht. 4-Amino-1,8-naphthalimid senkt die Expression von Occludin auf mRNA- und Proteinebene. GW2974 vermindert zusätzlich die Expression von VE-Cadherin, Claudin-5 und ZO-1. Darüber hinaus wurde die Wirkung auf Effluxpumpen untersucht. Die Ergebnisse der mRNA- und Protein-expression weichen voneinander ab, weshalb eine genauere Untersuchung der Translationsvorgänge sinnvoll erscheint. Glut-1 wird in GW2974 behandelten Zellen überexprimiert, was auf eine erhöhte Aktivität der BLECs hinweist. GW2974 und 4-Amino-1,8-naphthalimid könnten durch ihre permeabilitätssteigernde Wirkung die Ansprechrate einer systemischen Behandlung von PatientInnen mit einem zerebral metastasierten Mammakarzinom erhöhen und somit ihre Prognose verbessern. Detaillierte Studien zu Kombinationstherapien, den notwendigen Wirkstoff-konzentrationen und eventuellen negativen neurologischen Wirkungen sollten erwogen werden. N2 - The Blood-Brain Barrier (BBB) represents a selectively permeable barrier that controls the exchange of substances between the blood and the brain and thus has a neuroprotective effect. However, it not only prevents the passage of toxic metabolites, but also limits the access of therapeutic agents to the brain. Further research into methods to achieve higher drug concentrations in the brain is essential for the treatment of cerebral diseases such as cerebral metastatic breast cancer. The goal of this study was to identify drugs that increase the permeability of the BBB. The substance database LO1208 from Sigma-Aldrich was examined for its permeability-influencing properties as part of a high throughput drug screening (HTS). 31 of the examined substances showed an increase of the permeability on brain-like endothelial cells (BLECs) by at least 50%. Thereof 4-amino-1,8-naphthalimide (PARP inhibitor) and GW2974 (TKI) were selected for a more detailed analysis. Ibudilast (inhibitor of PDE4, MIF and Toll-like receptor-4) was found to be the third most active substance, although it did not cause any significant change in permeability. The measurement of the trans endothelial electrical resistance (TEER) and the permeability for fluorescein confirmed the results from the HTS and therefore is suggested to be used in further permeability tests in the future. Cell viability is not affected by 4 amino-1,8-naphthalmide. GW2974 and Ibudilast have a toxic effect on MCF-7 cells at a concentration of 500 µM, whereas BLECs are inhibited at a concentration of 100 µM of GW2974. The results show that the increased permeability is associated with a change in tight junction protein expression. 4-Amino-1,8-naphthalimide decreases the expression of occludin at mRNA and protein level. GW2974 also reduces the expression of VE-cadherin, claudin-5 and ZO-1. In addition to the abovementioned analysis, also the effect on efflux pumps was investigated. As the results of the mRNA and protein expression differ from each other, a more detailed analysis will be necessary to investigate the translation process. Glut-1 is overexpressed in GW2974-treated cells, which indicates an increased activity of the BLECs. GW2974 and 4-amino-1,8-naphthalimide could increase the response rate to systemic therapy of patients with cerebral metastatic breast cancer through their permeability-enhancing effect and thereby improve their prognosis. Detailed studies on combination therapies, the necessary drug concentrations and possible negative neurological effects are recommended to gain further insight. KW - Blut-Hirn-Schranke KW - Brustkrebs KW - Hirnmetastase KW - zerebral matastasierte Mammakarzinom KW - High-throughput drug screening KW - Blut-Hirn-Schrankenpermeabilität KW - High throughput screening KW - Hochdurchsatzscreening Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-369964 ER - TY - THES A1 - Banaschewski, Nora Malaika Marcia Cathérine T1 - Erleichterungslernen bei Jugendlichen mit nicht-suizidalem selbstverletzendem Verhalten T1 - Pain relief learning in adolescents with non-suicidal self-injury N2 - Die Erleichterung von einem körperlichen Schmerzreiz besitzt appetitiven Charakter (Leknes et al., 2008; 2011; Seymour et al., 2005), aktiviert belohnungsassoziierte Hirnstrukturen (Leknes et al., 2011; Leknes & Brock, 2014; Leknes & Tracey, 2008; Navratilova & Porreca, 2014) und fördert durch ihre Konditionierbarkeit als Erleichterungslernen bezeichnete appetitive Lern- und Konditionierungsprozesse (Andreatta et al., 2010, 2012; 2013; 2017; Gerber et al., 2014; Tanimoto et al., 2004; Yarali et al., 2008). Die vorliegende Arbeit bestätigt das angewandte Versuchsparadigma als valides Modell für Erleichterungslernen im Menschen und zeigt erstmals, dass der appetitive Charakter von Schmerzerleichterung auch in Jugendlichen konditionierbar ist. Erfolgreiches Erleichterungslernen zeigte sich dabei in der untersuchten Stichprobe lediglich auf impliziter, nicht aber auf expliziter, kognitiver Ebene. Dies stützt Thesen und vorherige Forschungsbefunde einer Dualität assoziativen Lernens in ein implizites Lernen, welches vornehmlich subkortikale Strukturen erfordert und ein explizites Lernen, das vorrangig kortikale Strukturen wie den präfrontalen Cortex involviert (Andreatta et al., 2010; Strack & Deutsch, 2004; Williams et al., 2001). Die Beobachtungen einer differenten Furcht- versus Erleichterungs-Extinktion bestärken die Thesen eines diversen neuronalen Hintergrunds dieser beiden Lernformen (Diegelmann et al., 2013; Gerber et al., 2014; Yarali et al., 2009; Yarali & Gerber, 2010). Gleichzeitig werfen die Studienergebnisse die Frage auf, ob und inwiefern im Erleichterungslernen von Jugendlichen Unterschiede zu jenem in Erwachsenen bestehen. Die Hypothese einer verstärkten Akquisition von Erleichterungslernen bei Jugendlichen mit NSSV im Vergleich zu gesunden Jugendlichen ließ sich in der vorliegenden Studie nicht bestätigen. Somit liefern die Ergebnisse keinen direkten Hinweis darauf, dass ein verstärktes Lernen durch Schmerzerleichterung an der Ätiopathogenese von NSSV beteiligt sein könnte. Die vorliegende Arbeit zeigte vielmehr die Tendenz eines abgeschwächten impliziten Erleichterungslernens bei den Jugendlichen mit NSSV. Die tendenziellen Gruppenunterschiede ließen sich nicht hinreichend durch eine differente aktuelle Stimmungslage oder durch eine unterschiedlich starke Ausprägung aversiver emotionaler Anspannungen oder momentaner Angstaffekte erklären. Innerhalb der Gruppe Jugendlicher mit NSSV zeigte sich auch kein Hinweis darauf, dass der Erfolg von Erleichterungslernen vom Schweregrad des NSSV oder von der aktuellen Einnahme von Antidepressiva abhängig sein könnte. Explorative Analysen ergaben, dass Gruppeneffekte in der vorliegenden Studie womöglich aufgrund einer statistischen Unterschätzung, bedingt durch einen zu geringen Stichprobenumfang, nicht das Signifikanzniveau erreichten und dass Unterschiede im Erleichterungslernen von Jugendlichen mit und ohne NSSV tatsächlich sogar noch stärker ausgeprägt sein könnten. Somit sollte die vorliegende Arbeit als Pilotstudie für zukünftige größer angelegte Studien zu Erleichterungslernen bei NSSV betrachtet werden. Zukünftige Studien erscheinen insbesondere sinnvoll mit Blick auf die hohe klinische sowie gesellschaftliche Relevanz von NSSV für welches, trotz der hohen Prävalenzen und des deutlich erhöhten Morbiditäts- und Mortalitätsrisikos, zum aktuellen Zeitpunkt noch keine hinreichenden Erklärungsmodelle bestehen. Die Studie bestätigte das Vorliegen eines erhöhten Grades aversiver emotionaler Anspannung in Jugendlichen mit NSSV, welcher zuvor nur an Erwachsenen mit einer BPD untersucht und festgestellt worden war (Niedtfeld et al., 2010; Stiglmayr et al., 2005). Die Abnahme negativer Affekte bei den Jugendlichen mit NSSV im Studienverlauf repliziert die Ergebnisse vorheriger Studien, in denen eine Reduktion selbst-berichteter negativer Affekte durch die Beendigung eines Schmerzreizes beobachtet wurde (Bresin et al., 2010; Bresin & Gordon, 2013). Damit bestärken die Studienergebnisse bestehende Erklärungsmodelle für NSSV, welche eine entscheidende Beteiligung der körperlichen Schmerzen und der Schmerzerleichterung bei der Selbstverletzung an der Affektregulation vermuten. Weiterhin wirft die vorliegende Arbeit die Frage auf, welche Rolle eine veränderte Wahrnehmung von Schmerz und Schmerzerleichterung in der Ätiopathogenese von NSSV einnimmt und wie diese sich auf Lernprozesse auswirkt. Insgesamt erbrächten weitere Erkenntnisse über den potenziellen Zusammenhang von NSSV und abweichendem Erleichterungslernen ein besseres Verständnis für Mechanismen der Entstehung und Aufrechterhaltung von NSSV und böten zudem möglicherweise Ansätze für neue Therapiemöglichkeiten des Störungsbildes. N2 - Relief from a physical pain stimulus has an appetitive character (Leknes et al., 2008; 2011; Seymour et al., 2005), activates reward-associated brain structures (Leknes et al., 2011; Leknes & Brock, 2014; Leknes & Tracey, 2008; Navratilova & Porreca, 2014) and, due to its conditionability, promotes learning and conditioning processes called relief learning (Andreatta et al., 2010, 2012; 2013; 2017; Gerber et al., 2014; Tanimoto et al., 2004; Yarali et al., 2008). The present work confirms the applied experimental paradigm as a valid model for relief learning in humans and shows for the first time that the appetitive nature of pain relief is also conditionable in adolescents. Successful relief learning was shown in the investigated sample only on an implicit, but not on an explicit, cognitive level. This supports theses and prior research findings of a duality of associative learning into implicit learning, which primarily requires subcortical structures, and explicit learning, which primarily involves cortical structures such as the prefrontal cortex (Andreatta et al., 2010; Strack & Deutsch, 2004; Williams et al., 2001). The observations of differential fear versus relief extinction reinforce the hypotheses of a diverse neural background of these two forms of learning (Diegelmann et al., 2013; Gerber et al., 2014; Yarali et al., 2009; Yarali & Gerber, 2010). At the same time, the study results raise the question of whether and to what extent differences exist in the relief learning of adolescents compared to that in adults. The hypothesis of increased acquisition of relief learning in adolescents with non-suicidal self-injury (NSSI) compared with healthy adolescents could not be confirmed in the present study. Thus, the results do not provide direct evidence that enhanced relief learning may be involved in the etiopathogenesis of NSSI. Rather, the present work demonstrated a tendency for attenuated implicit relief learning among adolescents with NSSI. The tendential group differences could not be adequately explained by a differential current mood state or by different degrees of aversive emotional tension or momentary anxiety effects. Within the group of adolescents with NSSI, there was also no evidence that the success of relief learning might depend on the severity of NSSI or on the current use of antidepressants. Exploratory analyses revealed that group effects in the present study did not reach the significance level possibly because of statistical underestimation due to an insufficient sample size and that differences in relief learning between adolescents with and without NSSI might actually be even bigger. Thus, the present work should be considered as a pilot study for future larger-scale studies on relief learning in NSSI. Future studies seem particularly useful in view of the high clinical as well as societal relevance of NSSI for which, despite the high prevalences and the significantly increased risk of morbidity and mortality, no adequate explanatory models exist at the present time. The study confirmed the presence of increased levels of aversive emotional tension in adolescents with NSSI, which had previously been studied and found only in adults with a borderline personality disorder (Niedtfeld et al., 2010; Stiglmayr et al., 2005). The decrease in negative affect in adolescents with NSSI over the course of the study replicates the findings of previous studies in which a reduction in self-reported negative affect was observed as a result of the cessation of a pain stimulus (Bresin et al., 2010; Bresin & Gordon, 2013). Thus, the study results reinforce existing explanatory models for NSSI that suggest a crucial involvement of physical pain and pain relief during self-injury in affect regulation. Furthermore, the present work raises the question of the role of altered perception of pain and pain relief in the etiopathogenesis of NSSI and how this affects learning processes. Overall, further insights into the potential link between NSSI and deviant relief learning would provide a better understanding of mechanisms involved in the development and maintenance of NSSI, and, on top of that, might offer approaches for new treatment options for the disorder. KW - Selbstbeschädigung KW - Erleichterungslernen KW - Nicht-suizidales selbstverletzendes Verhalten KW - NSSV Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-323673 ER - TY - JOUR A1 - Mühlemann, Markus A1 - Zdzieblo, Daniela A1 - Friedrich, Alexandra A1 - Berger, Constantin A1 - Otto, Christoph A1 - Walles, Heike A1 - Koepsell, Hermann A1 - Metzger, Marco T1 - Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet JF - Molecular Metabolism N2 - Objectives Glycemic control by medical treatment represents one therapeutic strategy for diabetic patients. The Na+-d-glucose cotransporter 1 (SGLT1) is currently of high interest in this context. SGLT1 is known to mediate glucose absorption and incretin secretion in the small intestine. Recently, inhibition of SGLT1 function was shown to improve postprandial hyperglycemia. In view of the lately demonstrated SGLT1 expression in pancreatic islets, we investigated if loss of SGLT1 affects islet morphology and function. Methods Effects associated with the loss of SGLT1 on pancreatic islet (cyto) morphology and function were investigated by analyzing islets of a SGLT1 knockout mouse model, that were fed a glucose-deficient, fat-enriched diet (SGLT1−/−-GDFE) to circumvent the glucose-galactose malabsorption syndrome. To distinguish diet- and Sglt1−/−-dependent effects, wildtype mice on either standard chow (WT-SC) or the glucose-free, fat-enriched diet (WT-GDFE) were used as controls. Feeding a glucose-deficient, fat-enriched diet further required the analysis of intestinal SGLT1 expression and function under diet-conditions. Results Consistent with literature, our data provide evidence that small intestinal SGLT1 mRNA expression and function is regulated by nutrition. In contrast, pancreatic SGLT1 mRNA levels were not affected by the applied diet, suggesting different regulatory mechanisms for SGLT1 in diverse tissues. Morphological changes such as increased islet sizes and cell numbers associated with changes in proliferation and apoptosis and alterations of the β- and α-cell population are specifically observed for pancreatic islets of SGLT1−/−-GDFE mice. Glucose stimulation revealed no insulin response in SGLT1−/−-GDFE mice while WT-GDFE mice displayed only a minor increase of blood insulin. Irregular glucagon responses were observed for both, SGLT1−/−-GDFE and WT-GDFE mice. Further, both animal groups showed a sustained release of GLP-1 compared to WT-SC controls. Conclusion Loss or impairment of SGLT1 results in abnormal pancreatic islet (cyto)morphology and disturbed islet function regarding the insulin or glucagon release capacity from β- or α-cells, respectively. Consequently, our findings propose a new, additional role for SGLT1 maintaining proper islet structure and function. KW - glucose transporter SGLT1 KW - pancreatic islet cytomorphology KW - pancreatic islet function KW - β-cell KW - α-cell Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-224230 VL - 13 ER - TY - JOUR A1 - Hauke, Jan A1 - Horvath, Judit A1 - Groß, Eva A1 - Gehrig, Andrea A1 - Honisch, Ellen A1 - Hackmann, Karl A1 - Schmidt, Gunnar A1 - Arnold, Norbert A1 - Faust, Ulrike A1 - Sutter, Christian A1 - Hentschel, Julia A1 - Wang-Gohrke, Shan A1 - Smogavec, Mateja A1 - Weber, Bernhard H. F. A1 - Weber-Lassalle, Nana A1 - Weber-Lassalle, Konstantin A1 - Borde, Julika A1 - Ernst, Corinna A1 - Altmüller, Janine A1 - Volk, Alexander E. A1 - Thiele, Holger A1 - Hübbel, Verena A1 - Nürnberg, Peter A1 - Keupp, Katharina A1 - Versmold, Beatrix A1 - Pohl, Esther A1 - Kubisch, Christian A1 - Grill, Sabine A1 - Paul, Victoria A1 - Herold, Natalie A1 - Lichey, Nadine A1 - Rhiem, Kerstin A1 - Ditsch, Nina A1 - Ruckert, Christian A1 - Wappenschmidt, Barbara A1 - Auber, Bernd A1 - Rump, Andreas A1 - Niederacher, Dieter A1 - Haaf, Thomas A1 - Ramser, Juliane A1 - Dworniczak, Bernd A1 - Engel, Christoph A1 - Meindl, Alfons A1 - Schmutzler, Rita K. A1 - Hahnen, Eric T1 - Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer JF - Cancer Medicine N2 - The prevalence of germ line mutations in non-BRCA1/2 genes associated with hereditary breast cancer (BC) is low, and the role of some of these genes in BC predisposition and pathogenesis is conflicting. In this study, 5589 consecutive BC index patients negative for pathogenic BRCA1/2 mutations and 2189 female controls were screened for germ line mutations in eight cancer predisposition genes (ATM, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, and TP53). All patients met the inclusion criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for germ line testing. The highest mutation prevalence was observed in the CHEK2 gene (2.5%), followed by ATM (1.5%) and PALB2 (1.2%). The mutation prevalence in each of the remaining genes was 0.3% or lower. Using Exome Aggregation Consortium control data, we confirm significant associations of heterozygous germ line mutations with BC for ATM (OR: 3.63, 95%CI: 2.67–4.94), CDH1 (OR: 17.04, 95%CI: 3.54–82), CHEK2 (OR: 2.93, 95%CI: 2.29–3.75), PALB2 (OR: 9.53, 95%CI: 6.25–14.51), and TP53 (OR: 7.30, 95%CI: 1.22–43.68). NBN germ line mutations were not significantly associated with BC risk (OR:1.39, 95%CI: 0.73–2.64). Due to their low mutation prevalence, the RAD51C and RAD51D genes require further investigation. Compared with control datasets, predicted damaging rare missense variants were significantly more prevalent in CHEK2 and TP53 in BC index patients. Compared with the overall sample, only TP53 mutation carriers show a significantly younger age at first BC diagnosis. We demonstrate a significant association of deleterious variants in the CHEK2, PALB2, and TP53 genes with bilateral BC. Both, ATM and CHEK2, were negatively associated with triple-negative breast cancer (TNBC) and estrogen receptor (ER)-negative tumor phenotypes. A particularly high CHEK2 mutation prevalence (5.2%) was observed in patients with human epidermal growth factor receptor 2 (HER2)-positive tumors. KW - breast cancer predisposition KW - hereditary breast cancer Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227902 ER - TY - JOUR A1 - Charbonnier, Baptiste A1 - Baradaran, Aslan A1 - Sato, Daisuke A1 - Alghamdi, Osama A1 - Zhang, Zishuai A1 - Zhang, Yu-Ling A1 - Gbureck, Uwe A1 - Gilardino, Mirko A1 - Harvey, Edward A1 - Makhoul, Nicholas A1 - Barralet, Jake T1 - Material-Induced Venosome-Supported Bone Tubes JF - Advanced Science N2 - The development of alternatives to vascular bone grafts, the current clinical standard for the surgical repair of large segmental bone defects still today represents an unmet medical need. The subcutaneous formation of transplantable bone has been successfully achieved in scaffolds axially perfused by an arteriovenous loop (AVL) and seeded with bone marrow stromal cells or loaded with inductive proteins. Although demonstrating clinical potential, AVL-based approaches involve complex microsurgical techniques and thus are not in widespread use. In this study, 3D-printed microporous bioceramics, loaded with autologous total bone marrow obtained by needle aspiration, are placed around and next to an unoperated femoral vein for 8 weeks to assess the effect of a central flow-through vein on bone formation from marrow in a subcutaneous site. A greater volume of new bone tissue is observed in scaffolds perfused by a central vein compared with the nonperfused negative control. These analyses are confirmed and supplemented by calcified and decalcified histology. This is highly significant as it indicates that transplantable vascularized bone can be grown using dispensable vein and marrow tissue only. This is the first report illustrating the capacity of an intrinsic vascularization by a single vein to support ectopic bone formation from untreated marrow. KW - angiogenesis KW - axial vascularization KW - bioceramic KW - bioinorganic KW - material-host interactions KW - osteogenesis Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-222318 VL - 6 ER - TY - JOUR A1 - Kirsch, Anna Dalal A1 - Hassin-Baer, Sharon A1 - Matthies, Cordula A1 - Volkmann, Jens A1 - Steigerwald, Frank T1 - Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects JF - Parkinsonism and Related Disorders N2 - Introduction Stimulation settings of deep brain stimulation (DBS) have evolved empirically within a limited parameter space dictated by first generation devices. There is a need for controlled clinical studies, which evaluate efficacy and safety of established programming practice against novel programming options provided by modern neurostimulation devices. Methods Here, we tested a polarity reversal from conventional monopolar cathodic to anodic stimulation in an acute double-blind, randomized, cross-over study in patients with PD implanted with bilateral STN DBS. The primary outcome measure was the difference between efficacy and side-effect thresholds (current amplitude, mA) in a monopolar review and the severity of motor symptoms (as assessed by MDS-UPDRS III ratings) after 30 min of continuous stimulation in the medication off-state. Results Effect and side effect thresholds were significantly higher with anodic compared to cathodic stimulation (3.36 ± 1.58 mA vs. 1.99 ± 1.37 mA; 6.05 ± 1.52 mA vs. 4.15 ± 1.13 mA; both p < 0.0001). However, using a predefined amplitude of 0.5 mA below the respective adverse effect threshold, blinded MDS-UPDRS-III-ratings were significantly lower with anodic stimulation (anodic: median 17 [min: 12, max: 25]; cathodic: 23 [12, 37]; p < 0.005). Conclusion Effective anodic stimulation requires a higher charge injection into the tissue, but may provide a better reduction of off-period motor symptoms within the individual therapeutic window. Therefore, a programming change to anodic stimulation may be considered in patients suffering from residual off-period motor symptoms of PD despite reaching the adverse effect threshold of cathodic stimulation in the subthalamic nucleus. KW - deep brain stimulation KW - subthalamic nucleus KW - Parkinson's disease KW - anodic stimulation Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-325820 VL - 55 ER - TY - JOUR A1 - Godel, Tim A1 - Pham, Mirko A1 - Kele, Henrich A1 - Kronlage, Moritz A1 - Schwarz, Daniel A1 - Brunée, Merle A1 - Heiland, Sabine A1 - Bendszus, Martin A1 - Bäumer, Philipp T1 - Diffusion tensor imaging in anterior interosseous nerve syndrome – functional MR Neurography on a fascicular level JF - NeuroImage: Clinical N2 - Purpose By applying diffusor tensor imaging (DTI) in patients with anterior interosseous nerve syndrome (AINS), this proof of principle study aims to quantify the extent of structural damage of a peripheral nerve at the anatomical level of individual fascicles. Methods In this institutional review board approved prospective study 13 patients with spontaneous AINS were examined at 3 Tesla including a transversal T2-weighted turbo-spin-echo and a spin-echo echo-planar-imaging pulse sequence of the upper arm level. Calculations of quantitative DTI parameters including fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity (AD) for median nerve lesion and non-lesion fascicles as well as ulnar and radial nerve were obtained. DTI values were compared to each other and to a previously published dataset of 58 healthy controls using one-way Analysis of Variance with Bonferroni correction and p-values <.05 were considered significant. Receiver operating characteristic (ROC) curves were performed to assess diagnostic accuracy. Results FA of median nerve lesion fascicles was decreased compared to median nerve non-lesion fascicles, ulnar nerve and radial nerve while MD, RD, and AD was increased (p < .001 for all parameters). Compared to median nerve values of healthy controls, lesion fascicles showed a significant decrease in FA while MD, RD, and AD was increased (p < .001 for all parameters). FA of median nerve non-lesion fascicles showed a weak significant decrease compared to healthy controls (p < .01) while there was no difference in MD, RD, and AD. ROC analyses revealed an excellent diagnostic accuracy of FA, MD and RD in the discrimination of median nerve lesion and non-lesion fascicles in AINS patients as well as in the discrimination of lesion fascicles and normative median nerve values of healthy controls. Conclusion By applying this functional MR Neurography technique in patients with AINS, this proof of principle study demonstrates that diffusion tensor imaging is feasible to quantify structural nerve injury at the anatomical level of individual fascicles. KW - anterior interosseous nerve syndrome KW - diffusion tensor imaging KW - functional MR Neurography Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-233061 VL - 21 ER - TY - JOUR A1 - Counsell, John R. A1 - Karda, Rajvinder A1 - Diaz, Juan Antiano A1 - Carey, Louise A1 - Wiktorowicz, Tatiana A1 - Buckley, Suzanne M. K. A1 - Ameri, Shima A1 - Ng, Joanne A1 - Baruteau, Julien A1 - Almeida, Filipa A1 - de Silva, Rohan A1 - Simone, Roberto A1 - Lugarà, Eleonora A1 - Lignani, Gabriele A1 - Lindemann, Dirk A1 - Rethwilm, Axel A1 - Rahim, Ahad A. A1 - Waddington, Simon N. A1 - Howe, Steven J. T1 - Foamy Virus Vectors Transduce Visceral Organs and Hippocampal Structures following In Vivo Delivery to Neonatal Mice JF - Molecular Therapy: Nucleic Acids N2 - Viral vectors are rapidly being developed for a range of applications in research and gene therapy. Prototype foamy virus (PFV) vectors have been described for gene therapy, although their use has mainly been restricted to ex vivo stem cell modification. Here we report direct in vivo transgene delivery with PFV vectors carrying reporter gene constructs. In our investigations, systemic PFV vector delivery to neonatal mice gave transgene expression in the heart, xiphisternum, liver, pancreas, and gut, whereas intracranial administration produced brain expression until animals were euthanized 49 days post-transduction. Immunostaining and confocal microscopy analysis of injected brains showed that transgene expression was highly localized to hippocampal architecture despite vector delivery being administered to the lateral ventricle. This was compared with intracranial biodistribution of lentiviral vectors and adeno-associated virus vectors, which gave a broad, non-specific spread through the neonatal mouse brain without regional localization, even when administered at lower copy numbers. Our work demonstrates that PFV can be used for neonatal gene delivery with an intracranial expression profile that localizes to hippocampal neurons, potentially because of the mitotic status of the targeted cells, which could be of use for research applications and gene therapy of neurological disorders. KW - foamy virus KW - spumavirus KW - viral vector KW - gene therapy KW - vector tropism KW - bioimaging KW - hippocampus Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-223379 VL - 12 ER - TY - JOUR A1 - Griemert, Eva-Verena A1 - Schwarzmaier, Susanne M. A1 - Hummel, Regina A1 - Gölz, Christina A1 - Yang, Dong A1 - Neuhaus, Winfried A1 - Burek, Malgorzata A1 - Förster, Carola Y. A1 - Petkovic, Ivan A1 - Trabold, Raimund A1 - Plesnila, Nikolaus A1 - Engelhard, Kristin A1 - Schäfer, Michael K. A1 - Thal, Serge C. T1 - Plasminogen activator inhibitor-1 augments damage by impairing fibrinolysis after traumatic brain injury JF - Annals of Neurology N2 - Objective Plasminogen activator inhibitor-1 (PAI-1) is the key endogenous inhibitor of fibrinolysis, and enhances clot formation after injury. In traumatic brain injury, dysregulation of fibrinolysis may lead to sustained microthrombosis and accelerated lesion expansion. In the present study, we hypothesized that PAI-1 mediates post-traumatic malfunction of coagulation, with inhibition or genetic depletion of PAI-1 attenuating clot formation and lesion expansion after brain trauma. Methods We evaluated PAI-1 as a possible new target in a mouse controlled cortical impact (CCI) model of traumatic brain injury. We performed the pharmacological inhibition of PAI-1 with PAI-039 and stimulation by tranexamic acid, and we confirmed our results in PAI-1–deficient animals. Results PAI-1 mRNA was time-dependently upregulated, with a 305-fold peak 12 hours after CCI, which effectively counteracted the 2- to 3-fold increase in cerebral tissue-type/urokinase plasminogen activator expression. PAI-039 reduced brain lesion volume by 26% at 24 hours and 43% at 5 days after insult. This treatment also attenuated neuronal apoptosis and improved neurofunctional outcome. Moreover, intravital microscopy demonstrated reduced post-traumatic thrombus formation in the pericontusional cortical microvasculature. In PAI-1–deficient mice, the therapeutic effect of PAI-039 was absent. These mice also displayed 13% reduced brain damage compared with wild type. In contrast, inhibition of fibrinolysis with tranexamic acid increased lesion volume by 25% compared with vehicle. Interpretation This study identifies impaired fibrinolysis as a critical process in post-traumatic secondary brain damage and suggests that PAI-1 may be a central endogenous inhibitor of the fibrinolytic pathway, promoting a procoagulatory state and clot formation in the cerebral microvasculature. Ann Neurol 2019;85:667–680 Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-228682 VL - 85 ER - TY - JOUR A1 - Figel, Benedikt A1 - Brinkmann, Leonie A1 - Buff, Christine A1 - Heitmann, Carina Y. A1 - Hofmann, David A1 - Bruchmann, Maximilian A1 - Becker, Michael P. I. A1 - Herrmann, Martin J. A1 - Straube, Thomas T1 - Phasic amygdala and BNST activation during the anticipation of temporally unpredictable social observation in social anxiety disorder patients JF - NeuroImage: Clinical N2 - Anticipation of potentially threatening social situations is a key process in social anxiety disorder (SAD). In other anxiety disorders, recent research of neural correlates of anticipation of temporally unpredictable threat suggests a temporally dissociable involvement of amygdala and bed nucleus of the stria terminalis (BNST) with phasic amygdala responses and sustained BNST activation. However, the temporal profile of amygdala and BNST responses during temporal unpredictability of threat has not been investigated in patients suffering from SAD. We used functional magnetic resonance imaging (fMRI) to investigate neural activation in the central nucleus of the amygdala (CeA) and the BNST during anticipation of temporally unpredictable aversive (video camera observation) relative to neutral (no camera observation) events in SAD patients compared to healthy controls (HC). For the analysis of fMRI data, we applied two regressors (phasic/sustained) within the same model to detect temporally dissociable brain responses. The aversive condition induced increased anxiety in patients compared to HC. SAD patients compared to HC showed increased phasic activation in the CeA and the BNST for anticipation of aversive relative to neutral events. SAD patients as well as HC showed sustained activity alterations in the BNST for aversive relative to neutral anticipation. No differential activity during sustained threat anticipation in SAD patients compared to HC was found. Taken together, our study reveals both CeA and BNST involvement during threat anticipation in SAD patients. The present results point towards potentially SAD-specific threat processing marked by elevated phasic but not sustained CeA and BNST responses when compared to HC. KW - FMRI KW - threat anticipation KW - social anxiety disorder KW - bed nucleus of stria terminalis KW - amygdala Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-228071 VL - 22 ER - TY - JOUR A1 - Fazzini, Federica A1 - Lamina, Claudia A1 - Fendt, Liane A1 - Schultheiss, Ulla T. A1 - Kotsis, Fruzsina A1 - Hicks, Andrew A. A1 - Meiselbach, Heike A1 - Weissensteiner, Hansi A1 - Forer, Lukas A1 - Krane, Vera A1 - Eckardt, Kai-Uwe A1 - Köttgen, Anna A1 - Kronenberg, Florian T1 - Mitochondrial DNA copy number is associated with mortality and infections in a large cohort of patients with chronic kidney disease JF - Kidney International N2 - Damage of mitochondrial DNA (mtDNA) with reduction in copy number has been proposed as a biomarker for mitochondrial dysfunction and oxidative stress. Chronic kidney disease (CKD) is associated with increased mortality and risk of cardiovascular disease, but the underlying mechanisms remain incompletely understood. Here we investigated the prognostic role of mtDNA copy number for cause-specific mortality in 4812 patients from the German Chronic Kidney Disease study, an ongoing prospective observational national cohort study of patients with CKD stage G3 and A1-3 or G1-2 with overt proteinuria (A3) at enrollment. MtDNA was quantified in whole blood using a plasmid-normalized PCR-based assay. At baseline, 1235 patients had prevalent cardiovascular disease. These patients had a significantly lower mtDNA copy number than patients without cardiovascular disease (fully-adjusted model: odds ratio 1.03, 95% confidence interval [CI] 1.01-1.05 per 10 mtDNA copies decrease). After four years of follow-up, we observed a significant inverse association between mtDNA copy number and all-cause mortality, adjusted for kidney function and cardiovascular disease risk factors (hazard ratio 1.37, 95% CI 1.09-1.73 for quartile 1 compared to quartiles 2-4). When grouped by causes of death, estimates pointed in the same direction for all causes but in a fully-adjusted model decreased copy numbers were significantly lower only in infection-related death (hazard ratio 1.82, 95% CI 1.08-3.08). A similar association was observed for hospitalizations due to infections in 644 patients (hazard ratio 1.19, 95% CI 1.00-1.42 in the fully-adjusted model). Thus, our data support a role of mitochondrial dysfunction in increased cardiovascular disease and mortality risks as well as susceptibility to infections in patients with CKD. KW - chronic kidney disease KW - infections KW - mitochondrial DNA copy number KW - mortality Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227662 VL - 96 ER - TY - JOUR A1 - Kiser, Dominik P. A1 - Popp, Sandy A1 - Schmitt-Böhrer, Angelika G. A1 - Strekalova, Tatyana A1 - van den Hove, Daniel L. A1 - Lesch, Klaus-Peter A1 - Rivero, Olga T1 - Early-life stress impairs developmental programming in Cadherin 13 (CDH13)-deficient mice JF - Progress in Neuropsychopharmacology & Biological Psychiatry N2 - Objective Cadherin-13 (CDH13), a member of the calcium-dependent cell adhesion molecule family, has been linked to neurodevelopmental disorders, including autism spectrum (ASD) and attention-deficit/hyperactivity (ADHD) disorders, but also to depression. In the adult brain, CDH13 expression is restricted e.g. to the presynaptic compartment of inhibitory GABAergic synapses in the hippocampus and Cdh13 knockout mice show an increased inhibitory drive onto hippocampal CA1 pyramidal neurons, leading to a shift in excitatory/inhibitory balance. CDH13 is also moderating migration of serotonergic neurons in the dorsal raphe nucleus, establishing projections preferentially to the thalamus and cerebellum during brain development. Furthermore, CDH13 is upregulated by chronic stress as well as in depression, suggesting a role in early-life adaptation to stressful experience. Here, we therefore investigated the interaction between Cdh13 variation and neonatal maternal separation (MS) in mice. Methods Male and female wild-type (Cdh13+/+), heterozygous (Cdh13+/−) and homozygous (Cdh13−/−) knockout mice exposed to MS, or daily handling as control, were subjected to a battery of behavioural tests to assess motor activity, learning and memory as well as anxiety-like behaviour. A transcriptome analysis of the hippocampus was performed in an independent cohort of mice which was exposed to MS or handling, but remained naïve for behavioural testing. Results MS lead to increased anxiety-like behaviour in Cdh13−/− mice compared to the other two MS groups. Cdh13−/− mice showed a context-dependent effect on stress- and anxiety-related behaviour, impaired extinction learning following contextual fear conditioning and decreased impulsivity, as well as a mild decrease in errors in the Barnes maze and reduced risk-taking in the light-dark transition test after MS. We also show sex differences, with increased locomotor activity in female Cdh13−/− mice, but unaltered impulsivity and activity in male Cdh13−/− mice. Transcriptome analysis revealed several pathways associated with cell surface/adhesion molecules to be altered following Cdh13 deficiency, together with an influence on endoplasmic reticulum function. Conclusion MS resulted in increased stress resilience, increased exploration and an overall anxiolytic behavioural phenotype in male Cdh13+/+ and Cdh13+/− mice. Cdh13 deficiency, however, obliterated most of the effects caused by early-life stress, with Cdh13−/− mice exhibiting delayed habituation, no reduction of anxiety-like behaviour and decreased fear extinction. Our behavioural findings indicate a role of CDH13 in the programming of and adaptation to early-life stress. Finally, our transcriptomic data support the view of CDH13 as a neuroprotective factor as well as a mediator in cell-cell interactions, with an impact on synaptic plasticity. KW - Cadherin-13 (CDH13) KW - T-cadherin KW - neurodevelopment KW - autism KW - ADHD KW - depression KW - psychiatric disorders KW - early-life stress KW - mouse KW - RNA sequencing KW - endoplasmic reticulum stress KW - adhesion Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-325859 VL - 89 ER - TY - JOUR A1 - Germain, Dominique P. A1 - Elliott, Perry M. A1 - Falissard, Bruno A1 - Fomin, Victor V. A1 - Hilz, Max J. A1 - Jovanovic, Ana A1 - Kantola, Ilkka A1 - Linhart, Aleš A1 - Renzo, Mignani A1 - Namdar, Mehdi A1 - Nowak, Albina A1 - Oliveira, João-Paulo A1 - Pieroni, Maurizio A1 - Viana-Baptista, Miguel A1 - Wanner, Christoph A1 - Spada, Marco T1 - The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts JF - Molecular Genetics and Metabolism Reports N2 - Background Enzyme replacement therapy (ERT) with recombinant human α-galactosidase has been available for the treatment of Fabry disease since 2001 in Europe and 2003 in the USA. Treatment outcomes with ERT are dependent on baseline patient characteristics, and published data are derived from heterogeneous study populations. Methods We conducted a comprehensive systematic literature review of all original articles on ERT in the treatment of Fabry disease published up until January 2017. This article presents the findings in adult male patients. Results Clinical evidence for the efficacy of ERT in adult male patients was available from 166 publications including 36 clinical trial publications. ERT significantly decreases globotriaosylceramide levels in plasma, urine, and in different kidney, heart, and skin cell types, slows the decline in estimated glomerular filtration rate, and reduces/stabilizes left ventricular mass and cardiac wall thickness. ERT also improves nervous system, gastrointestinal, pain, and quality of life outcomes. Conclusions ERT is a disease-specific treatment for patients with Fabry disease that may provide clinical benefits on several outcomes and organ systems. Better outcomes may be observed when treatment is started at an early age prior to the development of organ damage such as chronic kidney disease or cardiac fibrosis. Consolidated evidence suggests a dose effect. Data described in male patients, together with female and paediatric data, informs clinical practice and therapeutic goals for individualized treatment. KW - Fabry disease KW - systematic literature review KW - agalsidase beta KW - agalsidase alfa KW - enzyme replacement therapy KW - adult male patients Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-232987 VL - 19 ER - TY - JOUR A1 - Flunkert, Julia A1 - Maierhofer, Anna A1 - Dittrich, Marcus A1 - Müller, Tobias A1 - Horvath, Steve A1 - Nanda, Indrajit A1 - Haaf, Thomas T1 - Genetic and epigenetic changes in clonal descendants of irradiated human fibroblasts JF - Experimental Cell Research N2 - To study delayed genetic and epigenetic radiation effects, which may trigger radiation-induced carcinogenesis, we have established single-cell clones from irradiated and non-irradiated primary human fibroblasts. Stable clones were endowed with the same karyotype in all analyzed metaphases after 20 population doublings (PDs), whereas unstable clones displayed mosaics of normal and abnormal karyotypes. To account for variation in radiation sensitivity, all experiments were performed with two different fibroblast strains. After a single X-ray dose of 2 Gy more than half of the irradiated clones exhibited radiation-induced genome instability (RIGI). Irradiated clones displayed an increased rate of loss of chromosome Y (LOY) and copy number variations (CNVs), compared to controls. CNV breakpoints clustered in specific chromosome regions, in particular 3p14.2 and 7q11.21, coinciding with common fragile sites. CNVs affecting the FHIT gene in FRA3B were observed in independent unstable clones and may drive RIGI. Bisulfite pyrosequencing of control clones and the respective primary culture revealed global hypomethylation of ALU, LINE-1, and alpha-satellite repeats as well as rDNA hypermethylation during in vitro ageing. Irradiated clones showed further reduced ALU and alpha-satellite methylation and increased rDNA methylation, compared to controls. Methylation arrays identified several hundred differentially methylated genes and several enriched pathways associated with in vitro ageing. Methylation changes in 259 genes and the MAP kinase signaling pathway were associated with delayed radiation effects (after 20 PDs). Collectively, our results suggest that both genetic (LOY and CNVs) and epigenetic changes occur in the progeny of exposed cells that were not damaged directly by irradiation, likely contributing to radiation-induced carcinogenesis. We did not observe epigenetic differences between stable and unstable irradiated clones. The fact that the DNA methylation (DNAm) age of clones derived from the same primary culture varied greatly suggests that DNAm age of a single cell (represented by a clone) can be quite different from the DNAm age of a tissue. We propose that DNAm age reflects the emergent property of a large number of individual cells whose respective DNAm ages can be highly variable. KW - copy number variation (CNV) KW - delayed radiation effects KW - DNA methylation (DNAm) age KW - global DNA methylation KW - loss of chromosome Y (LOY); KW - methylation array analysis KW - radiation-induced genome instability (RIGI) Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-228177 VL - 370 ER - TY - JOUR A1 - Germain, Dominique P. A1 - Arad, Michael A1 - Burlina, Alessandro A1 - Elliott, Perry M. A1 - Falissard, Bruno A1 - Feldt-Rasmussen, Ulla A1 - Hilz, Max J. A1 - Hughes, Derralynn A. A1 - Ortiz, Alberto A1 - Wanner, Christoph A1 - Weidemann, Frank A1 - Spada, Marco T1 - The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease – A systematic literature review by a European panel of experts JF - Molecular Genetics and Metabolism N2 - Background Heterozygous females with Fabry disease have a wide range of clinical phenotypes depending on the nature of their mutation and their X-chromosome inactivation pattern; it is therefore important to examine outcomes of enzyme replacement therapy (ERT) in the female patient population specifically. This paper presents the findings of a systematic literature review of treatment outcomes with ERT in adult female patients. Methods A comprehensive systematic literature review was conducted through January 2017 to retrieve published papers with original data on ERT in the treatment of Fabry disease. The review included all original articles that presented ERT outcomes data on patients with Fabry disease, irrespective of the study type. Results Clinical evidence for the efficacy of ERT in female patients was available from 67 publications including six clinical trial publications, and indicates significant reductions in plasma and urine globotriaosylceramide (GL-3) accumulation (in female patients with elevated pre-treatment levels) and improvements in cardiac parameters and quality of life (QoL). To date, data are insufficient to conclude on the effects of ERT on the nervous system, gastrointestinal manifestations, and pain in female patients with Fabry disease. Conclusions This review of available literature data demonstrates that ERT in adult female patients with Fabry disease has a beneficial effect on GL-3 levels and cardiac outcomes. The current evidence also suggests that ERT may improve QoL in this patient population, though further studies are needed to examine these results. KW - Fabry disease KW - agalsidase alfa KW - agalsidase beta KW - systematic literature review KW - enzyme replacement therapy KW - adult female patients Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-232963 VL - 126 ER -